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Abstract 
 
Axon guidance cues are crucial signals for neurons to build complex networks during 
early developmental stages. Netrin is one of the main guidance cues that in most cases 
attracts neurons to their destinations. Distinct Netrins and Netrin receptors have been 
identified to carry out the guidance function. However, no direct Netrin modulator has 
been described yet. In this study, we used AVEXIS (Avidity based Extracellular 
Interaction Screen), a large-scale protein-protein interaction screen assay, to identify 
novel binding partners for Netrin proteins, and zebrafish as model organism to study 
the function of the newly identified interactions.  
 
We found Draxin, a secreted axon guidance protein, to directly interact with Netrin. 
The novel interaction is conserved for the orthologous human proteins. Furthermore, 
Draxin is able to outcompete Netrin receptors for Netrin-1 binding in a biochemical 
competition assay. The binding of Netrin receptors to Netrin-1 is reduced or even 
abolished in the presence of Draxin, indicating an inhibitory function of Draxin by 
breaking the communication between Netrin and its receptors. By generating Netrin 
truncations, I narrowed down the interaction interface to the third EGF domain of 
Netrin-1, the domain described to be necessary for Netrin-Netrin receptor interactions. 
I further narrowed down the interaction interface to a highly conserved 22 amino acid 
fragment within Draxin. This Draxin 22 amino acid fragment is sufficient for binding 
to Netrin-1 and the protein sequence is conserved across vertebrate species including 
chick, mouse and human. Furthermore, the 22 amino acid peptide fused to the Fc 
protein (the constant region of an immunoglobulin molecule) is able to outcompete 
Netrin receptors for Netrin binding.  
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Expression analysis in zebrafish embryos shows that both draxin and netrin mRNAs 
are expressed in the neural tube. They are co-expressed in regions surrounding the 
forebrain commissures. In the spinal cord, draxin is mainly expressed dorsally 
whereas netrin is located ventrally. Since both Draxin and Netrin are secreted proteins 
and have been reported to act as long-range guidance cues, the expression patterns 
suggests that reciprocal gradients of active Draxin and Netrin proteins can form along 
the dorsal-ventral axis of the developing spinal cord to regulate the correct formation 
of spinal cord commissures. Two independent embryonic binding assays revealed that 
Draxin and Netrin are able to interact in zebrafish embryos.  
 
Thus, we propose a model in which Draxin functions as a secreted Netrin signaling 
modulator influencing vertebrate axon pathfinding. Draxin might shape the functional 
extracellular Netrin gradient by sequestering Netrin proteins. Since human Netrin-1 
serves as a survival factor for specific tumors, Draxin—or the Netrin binding 
fragment of Draxin—could be potentially used to activate cell death in human cancer 
cells.  
 
 
 
Key words:  
Draxin, Netrin, DCC, UNC5, AVEXIS, protein-protein interaction, axon guidance, 
neural development, neural wiring, commissures, zebrafish (danio rerio)  
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Zusammenfassung 
 
Axonale Lenkungsmoleküle (engl.:Axon guidance cues) sind wichtige Signalstoffe, 
ohne die Nervenzellen während der frühen Embryonalentwicklung keine komplexen 
Netzwerke etablieren könnten. Netrin ist eines dieser wichtigen Signalproteine und 
lockt/zieht Axone allermeistens hin zu ihren Zielgebieten. Verschiedene Netrine und 
Netrin-Rezeptoren wurden in unterschiedlichen Geweben beschrieben. Komponenten, 
die direkt im extrazellulären Bereich auf Netrin wirken sind bisher unbekannt. In der 
vorliegenden Arbeit wurde ein sogenannter ‚Avidity based Extracellular interaction 
Screen’ (AVEXIS: Protein-Protein-Interaktionsscreen) benutzt, um neue Partner für 
Netrin-Proteine zu identifizieren. Die neu gefundenen Interaktionspartner wurden im 
Zebrafisch auf ihre in vivo Funktionen hin untersucht. 
 
Wir identifizierten Draxin, ein sezerniertes Protein, das an der Axonführung beteiligt 
ist, als direkten Bindungspartner von Netrin. Diese, bislang noch nicht beschriebene 
Interaktion, kann auch für die menschlichen Orthologe nachgewiesen werden. Im 
biochemischen Kompetitions-Assay hemmt Draxin die Bindung von Netrin-1 an den 
entsprechenden Rezeptor. Dabei wird die Bindung von Netrin-1 an den Rezeptor stark 
abgeschwächt oder gänzlich aufgehoben. Indem das Protein die Kommunikation 
zwischen Netrinen und den entsprechenden Rezeptoren hemmt kann Draxin eine 
inhibitorische Funktion zugeschrieben werden. Durch gezielte Verkürzungen des 
Proteins konnte ich zeigen, dass die Interaktion mit Draxin über die dritte 
EGF-Domäne von Netrin-1 stattfindet. Diese Domäne ist ebenfalls für die Interaktion 
mit dem Netrin-Rezeptor notwendig. Ich identifizierte außerdem ein 
hoch-konserviertes 22 Aminosäuren umfassendes Peptid in Draxin, das an der 
Interaktion mit Netrin beteiligt ist. Dieses Peptid ist ausreichend für eine Bindung an 
Netrin-1 und die Aminosäuresequenz ist hochkonserviert innerhalb der Wirbeltiere, 
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einschließlich Huhn, Maus und Mensch. Zudem kann dieses Peptid, als Fusion mit 
dem Fc Protein (der konstanten Region eines Antikörpermoleküls), die Bindung von 
Netrin an den Rezeptor hemmen. 
 
Eine Expressionsanalyse in Zebrafischembryonen zeigt sowohl netrin als auch draxin 
mRNAs werden im Neuralrohr exprimiert. In den Arealen nahe der 
Vorderhirn-Kommissur sind beide Gene ko-exprimiert, wohingegen im Rückenmark 
draxin hauptsächlich dorsal lokalisiert, netrin hingegen ventral. Sowohl Netrin als 
auch Draxin werden sezerniert, und beide Proteine sind über längere Distanzen 
hinweg als Signalmoleküle aktiv. Somit legen die Expressionsmuster nahe, dass die 
aktiven Proteine möglicherweise reziproke Gradienten entlang der dorso-ventralen 
Achse des sich entwickelnden Rückenmarks bilden, anhand derer die richtige Bildung 
der Kommissuren reguliert wird. In zwei unabhängigen Tests wurde gezeigt, dass 
Draxin und Netrin in vivo in Zebrafisch-Embryonen miteinander interagieren können. 
 
Wir schlagen ein Modell vor, bei dem Draxin als sezernierter Modulator die Funktion 
von Netrin bei der Steuerung der axonalen Zielfindung beeinflusst indem es 
extrazelluläres Netrin komplexiert, seine Bindung an den Rezeptor verhindert und so 
die Form des aktiven Netrin-Gradienten negativ verändert. Da Netrin-1 bei 
bestimmten menschlichen Tumoren als Überlebenssignal dient könnte Draxin– oder 
das identifizierte Fragment, das an Netrin bindet – eine Möglichkeit bieten Zelltod in 
menschlichen Tumorzellen auszulösen. 
 
 
v 
 
 
 
 
Contents 
 
Abstracts……………………………………………………………….....i 
 
Zusammenfassung……………………………………………………...iii 
 
1 Introduction ............................................................................................ 1 
 
1.1 Molecular mechanisms of neural wiring........................................................... 2 
1.2 Building brain and spinal cord commissures during vertebrate neural 
development .................................................................................................... 4 
1.3 Netrin signaling in embryonic nervous system ................................................. 6 
1.3.1 Members of Netrin and Netrin receptor families .................................... 6 
1.3.2 Netrin signaling mechanisms ................................................................ 10 
1.3.3 Netrin expression patterns and function ............................................... 12 
1.4 Draxin in embryonic neural development ....................................................... 15 
1.4.1 Draxin protein family ............................................................................ 15 
2.4.2 Draxin expression patterns .................................................................... 15 
1.4.3 Proposed functions of Draxin ............................................................... 16 
1.5 Using AVEXIS as method to discover novel protein-protein interactions 
in neural wiring ............................................................................................. 19 
1.5.1 Advantages of AVEXIS ......................................................................... 19 
1.5.2 How AVEXIS works ............................................................................. 20 
1.5.3 Comparison of AVEXIS with other high throughput screening 
methods ................................................................................................ 23 
1.6 AVEXIS detected a direct interaction between Draxin and Netrin ................. 25 
1.7 Goals of this study .......................................................................................... 26 
 
 
vi 
 
 
2 Results ...................................................................................................................... 27 
 
2.1 Biochemical analysis of the Draxin-Netrin interaction in vitro ...................... 28 
2.1.1 Conservation of the binding specificity of Draxins to Netrins ............. 29 
2.1.1.1 Adaptation of AVEXIS for small-scale interaction screening ..... 29 
2.1.1.2 Binding specificity of zebrafish Draxins and Netrins ................. 30 
2.1.1.3 Conservation of the Netrin-Draxin interaction in human 
orthologs ................................................................................... 32 
2.1.1.4 Cross-species interactions between zebrafish and human 
proteins ...................................................................................... 32 
2.1.2 Draxin binds to Netrin, but not to Netrin receptors .............................. 35 
2.1.3 In vitro competition between Draxin and Netrin receptors for 
Netrin binding ...................................................................................... 36 
2.1.3.1 Establishment of an AVEXIS-based competition assay .............. 36 
2.1.3.2 Results of the competition assay ................................................. 38 
2.1.4 Kinetic analysis of the Draxin-Netrin interaction using SPR ............... 42 
2.2 Characterization of the binding sites for the interaction between Draxin 
and Netrin...................................................................................................... 44 
2.2.1 The Draxin binding interaface to Netrin is mapped to a highly 
conserved 22 aa peptide ....................................................................... 45 
2.2.1.1 Protein domain analysis of zebrafish Draxin .............................. 45 
2.2.1.2 Mapping the Netrin-binding-interface in Draxin to a 22 aa 
motif .......................................................................................... 47 
2.2.1.3 Binding specificity of the Draxin derived 22 aa peptide 
(library screen) .......................................................................... 50 
2.2.1.4 The 22 aa motif of Draxin is highly conserved within 
vertebrate Draxins ..................................................................... 50 
2.2.1.5 The 22 aa Draxin peptide (fused to the Fc region of IgG) is 
sufficient to compete with Netrin receptors for Netrin 
binding ...................................................................................... 52 
2.2.2 The 3rd EGF domain of Netrin1a is sufficient for binding to Draxin ... 54 
2.2.2.1 Netrin1a domain boundary analysis and protein linker design ... 54 
2.2.2.2 Mapping the Draxin-binding-interface to the 3rd EGF domain 
of Netrin1a .................................................................................. 54 
2.2.2.3 Binding specificity of the 3rd EGF domain in Netrin1a 
(library screen) .......................................................................... 57 
vii 
 
2.2.2.4 The 3rd Netrin EGF domain is highly conserved within 
γ-Netrins .................................................................................... 59 
2.3 Characterization of the Draxin-Netrin interaction in zebrafish embryos........ 61 
2.3.1 In vivo detection of the Draxin-Netrin interaction in zebrafish 
embryos ................................................................................................ 62 
2.3.1.1 Establishing an in vivo binding assay ......................................... 62 
2.3.1.2 Result of the in vivo binding analysis ......................................... 62 
2.3.2 draxin and netrin gene expression analysis in zebrafish ...................... 65 
2.3.2.1 draxin mRNA expression analysis in zebrafish .......................... 66 
2.3.2.2 Co-expression of draxin and netrin in zebrafish embryos .......... 68 
2.3.3 Draxin-Netrin binding is detected in situ in zebrafish larvae ............... 70 
2.3.3.1 Establishing an in situ protein detection assay ........................... 70 
2.3.3.2 In situ binding result 1: WT and morphant zebrafish larvae ....... 71 
2.3.3.3 In situ binding result 2: netrin1a mutant larvae .......................... 74 
 
 
3 Discussion................................................................................................................. 79 
 
3.1 Draxin as a Netrin antagonist .......................................................................... 80 
3.1.1 Inhibitory hypothesis ............................................................................ 80 
3.1.2 Zebrafish and human binding networks of Draxins, Netrins, and 
Netrin receptors .................................................................................... 82 
3.1.3 Kinetic binding data of the Draxin-Netrin interaction indicates 
biological relevance ............................................................................. 85 
3.1.4 Proposed working model based on in vitro experiments ...................... 85 
3.1.5 Different expression patterns of zebrafish nerin1a and netrin1b ......... 87 
3.1.6 Potential co-expression regions of Draxin and Netrin proteins ............ 88 
3.1.7 In vivo working model for the Draxin-Netrin interaction .................... 91 
3.2 Potential usage of the Netrin-binding-peptide in Netrin dependent cancer 
cells ............................................................................................................... 94 
3.3 Novel methods developed in this study .......................................................... 95 
 
 
4 Materials & Methods .............................................................................................. 97 
 
    4.1 Zebrafish embrological methods……………………………………………98 
    4.2 Molecular methods………………………………………………………...102 
    4.3 Biochemical methods……………………………………………………...103 
viii 
 
 
Tables ......................................................................................................................... 106 
 
Bibliography ............................................................................................................. 121 
 
Contributions 
 
CV 
 
Acknowledgements
ix 
 
 
 
 
List of Figures 
 
Fig. 1.1   Molecular mechanism of axon guidance………………………………….3 
Fig. 1.2   Models for commissural axon midline crossing…………………………..5 
Fig. 1.3   Netrins and Netrin receptors in various organisms………………………..8 
Fig. 1.4   Molecular domain structure of Netrins and Netrin receptors……………..9 
Fig. 1.5   Netrin expression patterns in mouse, chick and zebrafish embryos……..13 
Fig. 1.6   Phenotypes of netrin knockout mice in the central nervous system……..14 
Fig. 1.7   Draxin expression patterns in mouse, chick and zebrafish embryos…….17 
Fig. 1.8   Phenotypes of draxin knockout mice in the central nervous system…….18 
Fig. 1.9   How AVEXIS works……………………………………………………..22 
Fig. 1.10  AVEXIS identified a physical interaction between Netrin and Draxin….25 
Fig. 2.1   Zebrafish Draxin-Netrin interactions…………………………………….31 
Fig. 2.2   Human Draxin-Netrin interactions………………………………………33 
Fig. 2.3   Zebrafish and human Draxin-Netrin cross-species interactions…………34 
Fig. 2.4   Netrin-Netrin receptor and Draxin-Netrin receptor interactions………...34 
Fig. 2.5   Schematic representation of the AVEXIS-based competition assay…….37 
Fig. 2.6   Draxin is able to outcompete Netrin receptors for Netrin binding………39 
Fig. 2.7   Draxin inhibits the binding of Netrin to Netrin receptors in vitro……….40 
Fig. 2.8   Draxin outcompetes the binding of Netrin to Netrin receptor…………...41 
Fig. 2.9   Surface Plasmon Resonance analysis of Draxin as analyte……………...43 
Fig. 2.10  Draxin protein alignment and analysis………………………….……......46 
Fig. 2.11  A Draxin-derived 22 aa fragment is sufficient for binding to Netrin1a.....48 
Fig. 2.12  Binding selectivity of the 22 aa Draxin-derived peptide………………...51 
Fig. 2.13  Conservation of the Netrin-binding motif in Draxin homologs………….51 
Fig. 2.14  The Netrin-binding 22aa peptide in Draxin is sufficient to compete  
         with Netrin receptor for Netrin binding………………………………….53 
Fig. 2.15  Identification of the Draxin-binding domain in Netrin1a………………..56 
Fig. 2.16  Binding selectivity of the 3rd EGF domain of Netrin1a…………………58 
Fig. 2.17  The 3rd Netrin EGF domain is highly conserved within Laminin-γ- 
         -chain derived Netrins…………………………………………………....60 
x 
 
 
 
 
 
 
Fig. 2.18  Pair wise protein sequence alignment of individual EGF domains  
         from human and zebrafish Netrins…………………………………….....60 
Fig. 2.19  in vivo detection of the Draxin-Netrin interaction in zebrafish embryos...64 
Fig. 2.20  draxin mRNA expression in the CNS of zebrafish embryos…………….67 
Fig. 2.21  Co-expression of draxin and netrin at axonal tracts in zebrafish 24- 
         hpf embryos………………………………………………………..……..69 
Fig. 2.22  In situ detection of the Draxin-Netrin interaction in zebrafish larvae  
         using an affinity probe……………………………………………………72 
Fig. 2.23  Detailed representation of Netrin distributions detected by the Draxin- 
         Fc probe in zebrafish larvae……………………………………………...73 
Fig. 2.24  Netrin1a mutant allele: netrin1aSA12269…………………………………..75 
Fig. 2.25  The 3rd EGF domain in Netrin1a is required for in situ detection of  
         Netrin by the Draxin 209-284aa affinity probe………………………………76 
Fig. 2.26  Netrin1b but not Netrin1a is highly concentrated in the region of  
         the zebrafish floor plate…………………………………………………..77 
Fig. 3.1   Inhibitory hypothesis for Draxin by direct binding to Netrin……………81 
Fig. 3.2   Summary of the Draxin-Netrin-Netrin receptor binding networks  
         obtained by AVEXIS……………………………………………………..82 
Fig. 3.3   Working model of Draxin’s function in Netrin signaling………………..86 
Fig. 3.4   In vivo working model for the Draxin-Netrin interaction in the  
         vertebrate spinal cord…………………………………………………….92 
 
 
 
xi 
 
 
 
List of Tables 
 
Tab. 4.1 List of primers……………………………………………………………..106 
Tab. 4.2 List of antibodies…………………………………………………………..108 
Tab. 4.3 List of molecular kits………………………………………………………109 
Tab. 4.4 Protein identities used in library screen……………………………………110
xii 
 
 
 
List of Abbreviations 
 
aa: amino acid 
alb: zebrafish albino mutant 
AP-MS: Affinity Purification-Mass Spectrometry 
AVEXIS: AVidity-based EXtracellular Interaction Screen 
BCIP: 5-bromo-4-chloro-3-indoyl-phosphate 
BMP: bone morphogenetic proteins 
bp: base pair 
BSA: bovine serum albumin 
c.elegans: Caenorhabditis elegans 
CAM: cell adhesion molecule 
cAMP: cyclic Adenosine monophosphate 
Cdc42: cell division control protein 42 homolog 
Co-IP: Co-Immunoprecipitation 
COMP domain: Cartilage Oligomeric Matrix Protein 
D.melanogaster: Drosophila melanogaster 
DB: Dcc-binding domain 
Dcc: Deleted in colorectal carcinoma (Netrin receptor) 
DD: death domain 
DIG: Digoxigenin 
Dkk: Dickkopf 
DNA: deoxyribonucleic acid 
dpf: days post fertilization 
DSCAM: Down Syndrome Cell Adhesion Molecule (Netrin receptor) 
E. coli: Escherichia coli 
ECD: ectodomain (extracellular domain of a protein) 
xiii 
 
EGF domain: epidermal growth factor-like domain 
ELISA: Enzyme-Linked Immuno-sorbant Assays 
ExPASy: Expert Protein Analysis System 
FBS: fetal bovine serum 
FCS: Fluorescence correlation spectroscopy 
Fgf: Fibroblast growth factor 
FISH: Fluorescence In Situ Hybridization 
FN III domain: fibronectin type III domain 
FRET: fluorescence resonance energy transfer 
Fz: Frizzled (Wnt receptor) 
GAG: glycosaminoglycan 
GFP: green fluorencent protein 
GPI: glycosylphosphatidylinositol 
GRASP: GFP Reconstitution Across Synaptic Partners 
GTP: guanosine triphosphate 
GTPase: hydrolase enzymes that can bind and hydrolyze GTP 
HBS: HEPES-buffered saline 
HEK cells: Human Embryonic Kidney cell 
hFc: fragment crystallizable region of human IgG protein 
His-tag: Affinity purification tag Histidine 
Hpf: hours post fertilization 
HRP: horseradish peroxidase 
IC50: Inhibitor concentration at 50 % inhibition  
Ig domain: immunoglobulin domain 
ISH: In situ hybridization 
KD: knockdown 
KO: knockout animal 
LRP6 receptor: LDL receptor – related protein 6 
LRR: leucine-rich repeat domain 
Matn4: Matrilin-4 
xiv 
 
memRFP: membrane RFP 
MESAB: ethyl -m-aminobenzoate methanesulfonate  
min: minute  
MeOH: Methanol 
MO: morpholino 
Morphant: animal that injected with morpholinos 
mRNA: messenger RNA 
NBT: 4-nitro blue tetrazolium 
Neo: Neogenin (Netrin receptor) 
NGL: The ligand of Netrin-G proteins 
NGS: normal goat serum 
nm: nanometer 
nM: nanomolar 
Ntn: Netrin 
P0: postnatal day 0 
P1, P2 and P3: conserved regions in the cytoplasmic domain of DCC 
PBS: phosphate buffer saline 
PCR: polymerase chain reaction 
PEI: polyethylenimine 
PFA: paraformaldehyde 
PKA: protein kinase A 
pNPP: para-Nitrophenylphosphate 
PTU: 1-phenyl 2-thiourea 
RFP: red fluorencent protein 
RGM: repulsive guidance molecule 
RNA: Ribonucleic acid 
Robo: Roundabout, receptor of axon guidance cues from the Slit family 
RT: room temperature 
s.d.: standard deviation 
sfGFP: superfolder GFP 
xv 
 
shh: sonic hedgehog 
SMART: Simple Modular Architecture Research Tool 
SP: signal peptide 
SPR: surface plasmon resonance 
SST: signal sequence trap 
TSA: Tyramide Signal Amplification TSA 
TSP: thrombospondin domain 
Unc5s: Netrin receptor Uncoordinated locomotion-5 
vs.: versus 
WT: wild type 
Y2H: Yeast two Hybrid 
ZU5: zona occludens 5 domain 
μM: micomolar 
 
xvi 
 
 
Neuroanatomy:  
 
AC: anterior commissure 
CC: corpus callosum 
CNS: central nervous system 
di: diencephalon 
DVDT: dorsalventral diencephalic tract 
FB: forebrain 
HB: hindbrain 
HC: hippocampal commissure 
MB: mindbrain 
MDB: mibrain-diencephalon boundary 
MHB: midbrain-hindbrain boundary 
NC: notochord 
PC: posterior commissure 
PNS: peripheral nervous system 
POC: postoptic commissure 
SC: spinal cord 
SOT: supraoptic tract 
tel: telencephalon 
 
 
 
 
 
 
  
 
 
 
Chapter 1 
 Introduction 
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1.1 Molecular mechanisms of neural wiring 
The nervous system is composed of billions of neurons in vertebrates. How this large 
number of cells build complicated networks during development still remains a key 
question in neurobiology. Ramón y Cajal, the pioneer Spanish neuroanatomist, first 
approached this question. He studied the commissural neurons in the developing chick 
spinal cord and discovered the axonal growth cone as “the distal tip of all growing 
nerve fibers” that navigates the path for nerve cells (1890). From his observation that 
the growth cone changed its shape according to the environment, he proposed the 
“neurotropic theory” (Sotelo, 2004): 
“The target cells were able to secrete inducing or attracting substances, and 
that growth cones are provided with chemotactic sensitivity or chemically 
elicited ameboidism……”           --Ramón y Cajal, 1892 (translated) 
This neurotropic theory was under debate for several decades until Sperry elaborated 
it as “chemoaffinity theory” in 1963 (Sperry, 1963). According to the observation of 
axon pathfinding in the frog retina, Sperry hypothesized a chemical tag on each single 
neuron in the retina that “preferentially selects” its pathway to the target region.  
The chemoaffinity theory has not been generally accepted until the 1980s, after 
Bonhoeffer and Huf developed a new explant tissue culture method (Bonhoeffer and 
Huf, 1980, 1982). With this method, the primary neurons can be cultured in vitro 
under finely controlled conditions, this allowed to obtain direct experimental evidence 
for the chemoaffinity theory. Using this method, Lumsden and Davies co-cultured 
embryonic mouse sensory neurons with their targets and other tissues in collagen gels, 
and found an unknown factor involved in attracting neurons directly to their innate 
targets (Lumsden & Davies, 1983). A few years later, Marc Tessier-Lavigne and his 
coworkers improved the explant method and found the spinal cord floor plate to secret 
diffusible factor(s) that attract the spinal cord commissural axons (Tessier-Lavigne et 
al., 1988). After several years of hard work, his group purified Netrin-1, the first 
attractive substance, by combining the explant method with biochemical purification 
from floor plate tissue (Serafini et al., 1994). This approach helped to identify the 
diffusible guidance cue that Ramón y Cajal predicted one-hundred years earlier.    
Thanks to the fast-developing era of modern molecular biology and genetics, 
scientists greatly expanded the molecular vocabulary of neural wiring. Four groups of 
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evolutionary highly conserved axon guidance cues and their receptors have been 
found in the 1990s (Guan & Rao, 2003; Kolodkin & Tessier-Laigne, 2011): 
Netrin-DCC/Unc5b (Hedgecock et al., 1990; Kennedy et al., 1994; Serafini et al., 
1994; Keino-Masu et al., 1996), Slit-Robo (Rothberg et al., 1988; Brose et al., 1999; 
Kidd et al., 1999; Li et al., 1999; Wang et al., 1999; Kidd et al., 1998), Ephrins-Eph 
receptors (Holzman et al., 1990; Cheng & Flanagan, 1994) and Semaphorins-Plexins/ 
Neuropilin (Kolodkin et al., 1992; Luo et al., 1993; Takahashi et al., 1999; 
Tamagnone et al., 1999; Pasterkamp & Kolodkin, 2003). Besides these diffusible cues, 
cell adhesion molecules (CAMs) also play an irreplaceable role in the guidance 
process. Altogether, axon guidance cues direct a variety of different groups of neurons 
to their respective targets and work in combination with each other to ensure proper 
development of the nervous system.    
A basic understanding of the molecular wiring code and how it is acting in vivo was 
summarized by Marc Tessier-Lavigne and Corey Goodman (Tessier-lavigne et al., 
1996). Basically, the known molecules can be categorized according to four types of 
mechanisms based on their mode of action: chemoattraction, chemorepulsion, contact 
attraction and contact repulsion (Fig. 1.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1  Molecular mechanism of axon guidance 
Cartoon shows four types of axon guidance mechanisms: chemoattraction, chemorepulsion, 
contact attraction and contact repulsion. The main groups of guidance cues are shown according to 
the four working mechanisms. (From Tessier-lavigne et al., 1996)
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1.2 Building brain and spinal cord commissures during 
vertebrate neural development  
Forebrain commissures  
The forebrain commissures connect the two cerebral hemispheres in vertebrate brains. 
The forebrain commissural neurons project their axons far away from their soma 
following axon guidance cues; they develop in a highly stereotyped sequence. They 
are ideal models for studying axon guidance in vivo. The architecture of major 
forebrain commissures is highly conserved between vertebrates. Figure 1.2 A shows 
mouse and zebrafish forebrain commissures at stages when the first axonal bundles 
are settled. Mouse and fish display similar commissures such as anterior and posterior 
commissures as well as the postoptic commissure.   
Spinal cord commissures  
A classical model for studying axon guidance is the midline crossing behavior of the 
spinal cord commissural neurons. Commissural neurons extend axon across the 
midline, forming sensory and motor connections between the left and right side of the 
body (Dickson and Zou, 2010). These commissural neurons are born in the dorsal 
spinal cord. They first extend axons towards the ventral midline—the floor plate. 
Once reaching the floor plate, they cross the midline, and then join to form posterior 
projecting longitude tracts. Figure 1.2 B shows the pathfinding of commissure 
neurons in transverse sections of the spinal cord. Figure 1.2 B (a) is the original 
drawings of Ramón y Cajal showing the Golgi staining of neurons in E4 stage chick 
spinal cord. Ramón y Cajal described the diverse shapes of the commissural axon 
growth cones and correctly predicted the position of the floor plate. Figure 1.2 B (b) 
shows commissure axons visualized by the TAG-1 antibody in E11.5 mouse (Dickson 
and Zou, 2010).  
The spinal cord midline is composed of ependymal cells including gliacytes. Multiple 
guidance cues derived from both dorsal and ventral midline cells direct the trajection 
of pathfinding commissural axons (Fig. 1.2 B (c)). Netrin-1 and Shh expressed by 
floor plate cells attract the precrossing commissural axons whereas Draxin and BMPs 
derived from roof plate cells repel these axons (Placzek & Briscoe, 2005; Dickson & 
Zou, 2010).  
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Figure 1.2  Models for commissural axon midline crossing 
(A) Forebrain commissures in E14 mouse and 24 hpf zebrafish embryos. The embryonic 
stages corresponding to the time point when first axonal bundles are settled. Mouse and 
zebrafish share highly conserved forebrain commissures. The picture shows the lateral 
view with anterior left. FB: forebrain, MB: midbrain, HB: hindbrain; AC: anterior 
commissure, PC: posterior commissure, OC: optic chiasm, POC: postoptic commissure, 
HBC: habenular commissure, TPOC: tract of postoptic commissure, SOT: supraoptic tract, 
DVDT: dorsoventral diencephalic tract, TPC: tract of posterior commissure, VLT: ventral 
longitudinal tract. (adapted from Suárez et al., 2014; Raper & Mason, 2010, fish figure 
originally from Ross et al, 1992) (B) Pathfinding of the spinal cord commissural axons in 
chick and mouse (transverse section). a) Drawing by Ramón y Cajal shows the Golgi 
staining of E4 chick spinal cord. b) Spinal cord commissural axons are labeled by the 
TAG-1 antibody in E11.5 mouse. c) Multiple guidance cues control the pathfinding of 
spinal cord commissural axons. (Adapted from Dickson & Zou, 2010) 
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1.3 Netrin signaling in embryonic nervous system   
1.3.1 Members of Netrin and Netrin receptor families 
Netrin family members 
Netrins are present in both invertebrates and vertebrates. They are highly conserved 
molecules across a variety of species and can be found even in leeches and the sea 
anemone Nematostella vectensis (Fig. 1.3 A). The vertebrate Netrin family includes 
secreted Netrins (Netrin 1, 2, 3, 4, and 5) and GPI-anchored membrane proteins 
(Netrin-Gs) (Moore et al., 2007).  
All Netrins are composed of roughly 600 amino acids and are related to the Laminin 
proteins, extracellular matrix components which form heterotrimers consisting of α, β 
and γ subunits (Miner and Yurchenco, 2004). Netrins have three distinct protein 
domains: domain VI (so called N-terminal domain), domain V (contains three EGF 
domains) and domain C (C-terminal domain). The Netrin N-terminal domain plus 
three EGF domains are homologous to the N-terminus of Laminin protein. Based on 
sequence similarity, the Netrin family is divided into three groups: The Netrin-1, 2, 3, 
5 group, the Netrin-4 group and the Netrin-G group. Netrin-1, 2, 3, 5 are 
evolutionarily closer to the γ-chain of Laminin whereas Netrin-4 is related to the 
laminin β-chain. Netrin-Gs are GPI anchored Netrins, they are more distantly related 
to the secreted Netrins (Fig. 1.4 A, Koch et al., 2000; Leclère & Rentzsch, 2012). The 
expression patterns as well as the receptors are quite distinct for each Netrin group. 
Figure 1.3 B lists the members of all three groups of Netrins in several vertebrate 
species.     
 
 
Netrin receptor members  
In vertebrates, receptors for Netrin-1, 2, 3, 5 are Deleted in colorectal carcinoma 
(DCC), Neogenin (Neo, a DCC paralogue), Uncoordinated locomotion-5 (Unc5s) and 
Down Syndrome Cell Adhesion Molecule (DSCAM). All these Netrin-receptors are 
type-I receptors (single-pass transmembrane proteins), which belong to the 
immunoglobulin superfamily. NGLs are the ligands for the membrane associated 
Netrin-G group (Fig. 1.3 B and Fig. 1.4 B) (Sun et al., 2011).  
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Other Netrin binding partners 
Besides the classical Netrin receptors summarized above, there are two additional 
groups of binding partners for Netrin-1: Integrins and Heparins. Integrins are 
transmembrane receptors that act as mediators bridging cell-cell and cell-environment 
interactions. Integrin α6β4 and α3β1 were reported to bind to Netrin-1. These 
interactions were suggested to regulate epithelial cell migration and adhesion (Yebra 
et al., 2003). Heparin, a sulfated glycosaminoglycan, is another extracellular matrix 
component. Heparin binds to Netrin-1 with high affinity (Kappler et al., 2000). It was 
used to purify Netrin from membrane associate components in the initial discovery of 
Netrin (Serafini et al., 1994). Both Intergrins and Heparins bind to the C-terminal 
domain of Netrin, and are involved in regulating the association of Netrin with 
extracellular matrix components.  
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Figure 1.3  Netrins and Netrin receptors in various organisms 
(A) An evolutionary tree of Netrin homolgs in variety of animals with bilateral symmetry. (B) 
Members of Netrin and their receptors in human, mouse, chick and zebrafish. The list for 
Netrin receptors includes receptors only for Netrin-1, 2, 3, and 5, but not for Netrin-4 and 
Netrin-G families. (A from Moore et al., 2007; B summarizes published data from Sun et 
al., 2011; Leclère & Rentzsch, 2012) 
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Figure 1.4  Molecular domain structure of Netrins and Netrin receptors 
(A) Netrins are members of the Laminin superfamily. The N-terminal domains (domain VI) 
and the EGF domains (domain V 1-3) are homologous to the N-terminal part of Laminin 
protein. Netrin-1, 2, 3, 5 (in the square frame) are evolutionary related to the γ-chain of 
laminin whereas Netrin-4 is more closely related to the laminin β-chain. Netrin-Gs are only 
distantly related to the rest of the Netrins. (B) Netrin receptors of Netrin-1 and Netrin-G 
including DCC, Neogenin, Unc5s, DSCAM and NGL. GPI: Glycosylphosphatidylinositol; Ig: 
immunoglobulin domain; FNIII: fibronectin type III domain; P1, P2 and P3: conserved 
regions in the cytoplasmic domain of DCC; TSP: thrombospondin domain; ZU5: zona 
occludens 5 (ZU-5) domain; DB: DCC-binding domain; DD: death domain; LRR: 
leucine-rich repeat domain. (adapted from Bernet & Fitamant, 2008; Sun et al., 2011) 
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1.3.2 Netrin signaling mechanisms 
Ligand-receptor binding sites 
The receptor binding domains in Netrin-1 are within the N-terminal regions: domain 
VI plus V (N-terminal domain plus the three EGF domains) (Serafini et al., 1994). 
Two recent structural studies showed that the third EGF domain (V3) in Netrin-1 
binds to the Netrin receptor DCC. The N-terminal domain (VI) and the first EGF 
domain (V1) might also contribute to the binding (Finci et al., 2014; Xu et al., 2014). 
Although the two studies have a different opinion on the second binding site in 
Netrin-1, they both propose that DCC forms a homodimer upon binding to Netrin-1. 
The second EGF domain (V2) in Netrin-1 has been suggested to be involved in 
Netrin-Netrin homodimer formation in the 2:2 ligand-receptor complex (Xu et al., 
2014). 
Netrin-1 binds to the extracellular domains of Netrin recepotrs. The Netrin binding 
sites were mapped to FN III 4-5 domains in DCC and Ig 1-2 domains in Unc5 (see 
Fig. 1.4 B for Netrin receptor domain organization, Kruger et al., 2004). The fifth FN 
III domain in DCC was confirmed to be involved in the formation of Netrin-Netrin 
receptor crystal complex in the recent structural studies (Finci et al., 2014; Xu et al., 
2014). There are indications for a second Netrin binding site in the DCC FN III 
domains, however, further studies are required to determine which FN III domain(s) 
contribute to the second binding site.  
Attraction vs. repulsion: different roles of Netrin receptors DCC and Unc5 
Netrin-1 has conserved axon guidance functions in both invertebrate and vertebrate 
species. The main function is chemoattraction through its receptor DCC (Keino-Masu 
et al., 1996; Kolodziej et al., 1996). Netrin also functions as a chemorepulsive cue 
through another receptor—Unc5 (Hong et al., 1999).  
It is possible to distinguish between long- and short-range repulsion, which result 
from different Netrin receptor combinations. Unc5 alone mediates short-range 
repulsion, whereas long-range repulsion needs DCC as a co-receptor for Unc5. The 
intracellular DCC binding domain (“DB”) of Unc5 is required for signal transduction 
in long-range repulsion through DCC (Hong et al., 1999; Keleman and Dickson, 
2001).  
11 
 
Netrin intracellular signaling 
The Netrin signaling cascade from extracellular ligand-receptor binding to the 
response of pathfinding neurons goes through several steps. The signal transduction 
starts when Netrin activates its receptors on the growth cone membrane. Growth 
cones are the leading tips of growing neurons, they are highly dynamic, actin- and 
microtubule- supported extensions of developing neurites. The activated Netrin 
receptor triggers the regulation of small GTPases inside the cell. Cdc42, Rac and Rho 
are the three main GTPases that directly regulate the dynamics of actin and 
microtubules. The Netrin receptor DCC can activate Cdc42 and Rac as well as 
indirectly Rho, thus inducing actin reorganization (Huber et al., 2003). In summary, 
during axon outgrowth, Netrin signaling converges on GTPases that reorganize the 
cytoskeleton and therefore controls the directions of growing growth cones.  
Regulation of Netrin signaling 
The Netrin receptors are the crucial factors for Netrin signaling regulation. Netrin 
signaling can be silenced by activation of Robo, a Slit receptor. The cytoplasmic 
domain of Robo directly binds to the Netrin receptor DCC causing silencing of the 
attraction but not affecting the growth-stimulation by Netrin-1. The silencing of 
Netrin-mediated attraction prevents spinal cord commissural axons from re-crossing 
the midline (Stein and Tessier-Lavigne, 2001). In addition, there is evidence showing 
that DCC can be regulated at translational and post-translational levels. Protein kinase 
A (PKA) activation promotes membrane insertion of DCC enhancing the attraction 
through Netrin-1 (Bouchard et al., 2004). Local DCC synthesis within the growth 
cone was also suggested to enhance the response to Netrin-1 (Huber et al., 2003).   
Netrin signaling can also be regulated on downstream converging steps such as 
intracellular small GTPases. cAMP concentration and PKA activation negatively 
regulate Rho, a small GTPase, thus regulating the sensitivity of chemoattraction to 
Netrin-1 (Huber et al., 2003; Moore and Kennedy, 2006). Factors that directly 
regulate cytoskeletal organization can also influence the output of Netrin signaling.  
So far, no Netrin modulator acting directly on the ligand has been found.  
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1.3.3 Netrin expression patterns and function 
Netrin-1 expression in vertebrates 
netrin-1 mRNA is highly expressed in the floor plate region during the developmental 
stages when commissural axons navigate in mouse, chick and zebrafish embryos (Fig. 
1.5). Mouse netrin-1 is not only highly expressed in the floor plate cells, in addition, 
the expression spans roughly two thirds into the spinal cord. It is also highly 
expressed in the somites of E9.5 embryos (Fig. 1.5 A and E, (Filosa et al., 1997; 
Serafini et al., 1996). Chick netrin-1 is expressed at high levels in the floor plate of 
the hindbrain, midbrain, caudal diencephalon and the spinal cord. At early stages 
(st.15), the expression domains are slightly broader. At this stage, chick netrin-1 was 
also detected in the developing optic cup and stalk as well as in somites outside the 
CNS. Chick netrin-2 is not expressed by the floor plate; instead, it is expressed 
throughout two thirds of the ventral spinal cord however with lower levels compared 
to netrin-1 (Fig. 1.5 B, G, I; Kennedy et al., 1994; Kennedy et al., 2006). Similarly, 
zebrafish netrin1a and netrin1b are expressed in large areas of the ventral CNS with 
dynamic patterns. At 24 hpf, netrin1a is expressed in the ventral midbrain, the midline 
of the hindbrain and the ventral half of the spinal cord (Fig. 1.5 K, L, M; Lauderdale 
et al., 1997). The expression of netrin1b in the spinal cord is slightly different from 
netrin1a. It is only expressed in the floor plate region (arrowheads in Fig. 1.5 N; 
Strähle et al., 1997). 
The Netrin protein is secreted and highly diffusible. In E9.5 mouse and stage 17 chick 
embryos, Netrin-1 proteins were detected far away from their sources forming a 
gradient towards the dorsal spinal cord (Fig. 1.5 F and H; Kennedy et al., 2006).   
 
 
Netrin-1 knockout mice phenotypes 
netrin-1 knockout mice have severe defects in forebrain commissures and spinal cord 
commissures. The netrin-1 mutants lack the corpus callosum (CC), the hippocampal 
commissure (HC) and the anterior commissure (AC). Only very few commissural 
axons cross the floor plate in the spinal cord (Fig. 1.6) and the ventral commissure is 
much thinner than in wild types (Serafini et al., 1996).  
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Netrin functions besides axon guidance 
In the last ten years, Netrins were shown to be involved in diverse processes outside 
neuronal tissues. It has been reported that Netrins elicit the migration and support the 
survival of neurons in the CNS (Bloch-Gallego et al.,1999). This function is 
maintained in other tissues such as the olfactory bulb and intestinal tract. Besides, 
Netrins are also regulating cell adhesion and branching morphogenesis in terminal 
end buds of the mammary glands, during lung development and in angiogenesis 
(Yebra et al., 2007; Sun et al., 2011). Netrins and their receptors also participated in 
tumor formation (Mehlen et al., 2011).  
 
 
Figure 1.5  Netrin expression patterns in mouse, chick and zebrafish embryos 
Expression of Nerin transcripts and distribution of Netrin proteins in mouse (A, E, F), chick 
(B, G-J, with B, G, H Netirn-1 and I, J Netrin-2) and zebrafish (C, D, K-N) at indicated 
stages. Whole mount embryos: A-D; spinal cord transverse sections: E-J, M; midbrain (K) 
and hindbrain (L) transverse sections; spinal cord lateral view: N. f: forebrain; m: midbrain; 
h:hindbrain; fp: floor plate; sc: spinal cord. t: tectum. (rearranged: Filosa et al., 1997 (A), 
Kennedy et al., 1994 (B), Park et al., 2008 (C,D), Serafini et al., 1996 (E), Kennedy et al., 
2006(F, G-J), Lauderdale et al., 1997 (K, L, M), Strähle et al., 1997 (N))
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Figure 1.6  Phenotypes of netrin knockout mice in the central nervous system 
Defects of netrin-1 KO mouse compared to wt siblings in forebrain commissures (A, B, 
coronal sections) and spinal cord commissures (C, D, transverse sections, commissural 
axons are visualized with the TAG-1 antibody). Compared to wild type animals, netrin-1 
mutant mice lack forebrain commissures CC and HC. Their spinal cord commissural 
axons are disorganized and only few axons reach the floor plate. The majority of 
commissural axons can not cross the floor plate. Arrows show the defects in the mutants 
(B, D). CC: corpus callosum, HC: hippocampal commissure; ctx: cerebral cortex; cp: 
caudo-putamen; dg: dentate gyrus; fr: fasciculus retroflexus; c: commissural neurons and 
their axons; d: dorsal root ganglion; drez: dorsal root entry zone; fp: floor plate; mc: motor 
column; v: ventricle. (rearranged: Serafini et al., 1996) 
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1.4 Draxin in embryonic neural development 
1.4.1 Draxin protein family 
Draxin (Dorsal repulsive axon guidance protein) has been identified in a screen 
searching for novel axon guidance proteins (Islam et al., 2009). In this screen, the 
signal sequence trap (SST) method was used to identify secreted and 
membrane-anchored proteins (Shirozu et al., 1996). Draxin was found in a chick 
embryonic cDNA library enriched for floor plate, roof plate and motor neuron 
transcripts. Draxin was reported to inhibit or repel neurite outgrowth (Islam et al., 
2009). Thus, Draxin was defined as a novel chemorepulsive axon guidance cue.  
The draxin gene can be found in vertebrate genomes such as chick, mouse and human, 
but not in invertebrates. Mouse and human Draxin proteins are highly similar, they 
share 76 % sequence identity (Miyake et al., 2009). Draxin has a signal peptide at the 
N-terminus, but no membrane association sequence, confirming that it is a secreted 
protein (Islam et al., 2009). A cysteine-rich domain is present in the C-terminal region 
of Draxin, and the spacing of the 10 cysteine residues in this domain is similar to the 
position of cysteines found in Dickkopf (Dkk) family members (Miyake et al., 2009), 
suggesting a potential similar function between Draxin and Dickkopf family proteins.     
  
2.4.2 Draxin expression patterns 
Previous studies revealed that Draxin is highly expressed in developing mouse, chick 
and zebrafish embryos (Fig.1.7, Islam et al., 2009; Miyake et al., 2012). In mouse, 
during early embryonic stages, draxin mRNA was observed in the dorsal part of the 
brain and in regions surrounding the forebrain commissures as well as in the dorsal 
spinal cord (Fig.1.7 A and E). The expression was also detected at postnatal day 0 (P0) 
in the olfactory bulb, the cortex, midbrain, cerebellum and pontine nuclei (Islam et al., 
2009). In chick, draxin mRNA was detected in a similar spatiotemporal distribution. 
draxin is strongly expressed in dorsal regions of the CNS, including the roof plate, as 
well as the dorsal lip of the dermomyotome (Fig.1.7 B and G) (Islam et al., 2009). In 
zebrafish, draxin is expressed in the telencephalon, diencephalon, dorsal tectum and 
in lateral regions of the hindbrain in 24 hpf embryos. The CNS expression is 
maintained until 36 hpf (Fig.1.7 C, D, I and J). Strong spinal cord expression is 
16 
 
observed during segmentation stages (arrows in Fig.1.7 C, D and K) and maintained 
until at least 36 hpf. The draxin expression pattern in zebrafish is consistent with that 
of draxin in mouse (Miyake et al., 2012).  
 
Long range diffusibility of Draxin protein was detected in the mouse and chick spinal 
cord. In mouse E10.5 embryos, Draxin protein was detected along the basement 
membrane of the spinal cord. A similar discribution was detected within chick stage 
19 embryos. Compared to the region of mRNA expression, Draxin protein diffused far 
away from its source (Fig. 1.7 F and H; Islam et al., 2009).  
 
1.4.3 Proposed functions of Draxin  
Draxin is a repulsive axon guidance cue. In vitro experiments showed that Draxin 
repelled neurites from spinal cord commissural neurons. Along the same direction, 
draxin knockout (KO) mice showed absence of forebrain commissures, including the 
commissures AC, CC and HC. Abnormal fasciculation of spinal cord commissural 
axons was also observed in the KO animals (Fig. 1.8, Islam et al., 2009). Thus, this 
data highlights the function of Draxin in commissure formation. Since Draxin and 
DCC (a classic Netrin receptor) KO mice share similar phenotypes in commissural 
axon pathfinding, Draxin was proposed to directly associate with Netrin signaling. 
Subsequently, Ahmed and his colleagues reported that Draxin directly binds to a 
structurally diverse set of Netrin receptors (DCC/Neo1, Unc5 and Dscam) (Ahmed et 
al., 2011). This is further support for a direct involvement of Draxin in Netrin 
signaling.  
 
Besides the function in axon guidance, Draxin was proposed to have an inhibitory 
function on Wnt signaling (Miyake et al., 2009). Draxin was shown to bind to the 
LRP6 receptor (LDL receptor – related protein 6) with its cysteine-rich domain in a 
pull down assay. The LRP6 receptor is a co-receptor of the Wnt receptor Frizzled (Fz). 
In an in vitro assay, the induction of intracellular signaling by Wnt (beta-catenin) was 
reduced through the LRP6-Draxin interaction. This indicates Draxin might be a Wnt 
antagonist by preventing the formation of the LRP6-Fz receptor complex with its 
cysteine-rich domain, similar as reported for Dkk family proteins.   
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Figure 1.7  Draxin expression patterns in mouse, chick and zebrafish embryos 
Expression of Draxin transcripts and distribution of Draxin proteins in mouse (A, E, F), 
chick (B, G, H) and zebrafish (C, D, I, J, K) at indicated stages. Whole mount embryos: A, 
B, C and D; Spinal cord transverse sections: E, F, G, H and K; midbrain (I) and hindbrain (J) 
transverse sections. mb: midbrain, hb: hindbrain, te: telencephalon (in cerebrum), di: 
diencephalon (interbrain). The arrows in (C) and (D) indicate the spinal cord. Scale bar: 
500 μm in (A), 1000 μm in (B), 100 μm in (C) and (D), 100 μm in (E) and (G), 50 μm in (K).   
(rearranged: Islam et al., 2009; Miyake et al., 2012) 
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Figure 1.8  Phenotypes of draxin knockout mice in the central nervous system 
Abnormal projections of forebrain commissures (Aa to Bb, coronal sections) and if spinal 
cord commissural axons (Ca to Db, transverse sections) in Draxin knockout mice. Arrows 
and arrowhead in (Ba) indicate tangled and misprojecting CC axons. Arrows in (Cb) and 
(Db) indicate Tag-1 labeled axon bundles of the spinal cord commissures. CC: corpus 
callosum, HC: hippocampal commissure. Scale bar: 500 μm in (Aa), 200μm in (Ca) and 
100 in (Cb). (rearranged: Islam et al., 2009) 
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1.5 Using AVEXIS as method to discover novel protein-protein 
interactions in neural wiring 
Searching for novel extracellular interactions 
So far, the majority of known axon guidance cues have been discovered either by 
elaborate biochemical purification, or by genetic screens using Caenorhabditis elegans 
(C.elegans) or Drosophila melanogaster (D.melanogaster). Surprisingly, a large 
number of protein-coding genes in the genomes are predicted to encode cell surface 
receptors or secreted proteins (Diehn et al., 2006; Liu & Rost, 2001). However, the 
interactions and the functions of these proteins in the developing nervous system are 
strongly underrepresented (Özkan et al., 2013; Söllner & Wright, 2009).This makes it 
likely that additional protein-protein interactions from these proteins remain to be 
uncovered. The starting point of our research was to perform a biochemical 
protein-protein interaction screen to identify novel extracellular interactions.  
 
1.5.1 Advantages of AVEXIS 
The AVidity-based EXtracellular Interaction Screen (AVEXIS) is a biochemical 
screening assay recently developed to detect extracellular protein-protein interactions 
on a large scale (Bushell et al., 2008; Kerr & Wright, 2012). It has several advantages 
for studying interactions involved in neural wiring.  
First, AVEXIS targets extracellular proteins, such as cell surface proteins and secreted 
proteins, which are centrally involved in neuron-neuron and neuron-environment 
communications. These proteins are biochemically difficult to work with since many 
of them contain hydrophobic transmembrane regions which make the proteins 
insoluble. Often they also contain structurally important posttranslational 
modifications such as glycosylation and disulfide bonds, which are not properly 
created in prokaryotic expression systems. By expressing the whole ectodomain of 
these proteins as soluble recombinant protein in mammalian cells, the AVEXIS assay 
overcomes the biochemical intractability of extracellular proteins.  
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Second, AVEXIS can be used for large-scale high throughput screening. This is due to 
the fact that cell culture supernatants can be used directly, avoiding extensive 
purification. Furthermore, proteins are normalized to detect interactions with a low 
false-positive rate. Therefore, large numbers of different protein fragments can be 
screened and interactions between uncharacterized proteins, as well as unknown 
interactions among known proteins can be reliably detected.  
Third, AVEXIS can be applied to screen for protein-protein interactions in different 
species of metazoans. This advantage enables to test orthologous interactions thus 
allowing to compare such interactions among different species. 
Finally, AVEXIS can detect low affinity interactions. Among extracellular proteins 
required for neural wiring, weak interactions between cell surface proteins, such as 
interactions between cell adhesion molecules, are common. In AVEXIS, prey proteins 
are pentamerized leading to an increase in the local concentration of the protein of 
interest, thus, increasing the avidity of the interaction. This enables the detection of 
very transient interactions with half-lives of less than 0.1 seconds.  
Therefore, since AVEXIS is able to detect transient extracellular interactions on a 
large scale without system-specific limitations, it is suitable for studying interactions 
involved in neural wiring.   
 
1.5.2 How AVEXIS works 
Basically, AVEXIS is an ELISA-style binding assay (Fig. 1.9 A). Normalized bait 
proteins are captured on streptavidin-coated microtiter plates. After washes with 
buffer, normalized recombinant prey proteins containing an enzyme activity are 
incubated with bait proteins on the plates. An enzyme substrate is added after brief 
washes. Positive interactions are detected by the enzyme activity of the captured prey 
measured by a color change from yellow to red (Absorbance at 486 nm).  
Libraries of proteins of interest are prepared by recombinant expression of the entire 
extracellular domains (ectodomains) of these proteins. (Fig. 1.9 B). The insoluble 
transmembrane regions are removed while the extracellular binding function is 
retained; therefore, single-pass transmembrane proteins, such as type I and type II 
proteins as well as GPI-linked cell surface receptors and secreted proteins, are suitable 
for constructing the library. The recombinant proteins are produced in mammalian 
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expression systems (HEK293E cells), taking advantage of the glycosylation 
machinery in these cells and the oxidizing environment of the secretory pathway to 
ease the production of functional extracellular proteins.  
The ectodomains of the proteins of interest are designed in two different forms: 
monomeric captured “bait” and pentameric detected “prey” (Fig. 1.9 B). The bait 
proteins contain C-terminal in-frame fusions of rat CD4 domains 3 and 4, followed by 
a 17 amino acid peptide with a single biotinylation site (Schatz, 1993; Brown et al., 
1998). The CD4 tag allows determining the protein concentrations of the recombinant 
proteins independently of the ectodomains by standard ELISA techniques. The 
biotinylation peptide can be modified by the Escherichia coli (E. coli) biotin ligase 
BirA. The biotinylated tail allows capturing of the proteins on streptavidin-coated 
microtitre plates with the ectodomain facing outward. The prey proteins also contain 
an in-frame fusion of rat CD4 domains 3 and 4, followed by the pentamerization 
domain derived from the rat cartilaginous oligomeric matrix protein (COMP) 
(Tomschy et al, 1996) and the beta-lactamase protein from E.coli at the C-terminus. 
Prey pentamers are formed via the coiled-coil COMP pentamerization domain and 
detected through the beta-lactamase enzyme activity.  
Since it has been reported that the expression levels of recombinant proteins in cell 
culture supernatants can differ by up to 3 to 4 orders of magnitude (Bushell et al., 
2008; Özkan et al., 2013), it is essential that the protein concentrations can be 
normalized to predetermined levels prior to the AVEXIS binding test. The 
normalization step is crucial to reduce the number of false positive and false negative 
interactions. The concentrations of bait proteins captured on streptavidin-coated 
microtitre plates are determined by ELISA using anti-rat CD4 antibody. Bait protein 
concentrations are normalized to the level that the baits saturate the biotin binding 
sites on the plates. Prey protein concentrations are normalized by colorimetric 
detection of hydrolysis of nitrocefin by beta-lactamase. Protein concentrations are 
adjusted using spin concentrators or dilution with conditioned cell culture supernatant.  
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Figure 1.9  How AVEXIS works 
(A) Schematic illustration of AVEXIS. Biotinylated monomeric bait proteins (blue) are 
captured on a streptavidin-coated plate and probed against pentameric beta-lactamase 
tagged prey proteins (pink). Positive interactions are detected by the turnover of the 
enzyme substrate from yellow to red. (B) Domain architecture of bait and prey proteins. 
The entire extracellular domains of the proteins of interest (purple rectangle) are cloned in 
bait and prey. The bait proteins contain C-terminal in-frame fusion with rat CD4 domains 
3+4 (white circle) followed by a biotinylation peptide (bar with a dot). The prey proteins 
contain an in-frame fusion of rat CD4 domain 3+4 (white circle) followed by a 
pentamerization domain of rat COMP (“5” in white rectangle) and beta-lactamase (“β” in 
white ellipse) in the C-terminus. (adapted: Bushell et al. 2008; Soellner et al. 2009) 
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1.5.3 Comparison of AVEXIS with other high throughput screening 
methods 
AVEXIS is not the only high throughput protein-protein interaction screening method. 
The yeast two-hybrid (Y2H) assay is a standard method for screening intracellular 
interactions. However, since the proteins are targeted to the nucleus for detection, it is 
unlikely to produce properly folded and posttranslationally modified extracellular 
proteins. Another high-throughput screening method is affinity purification followed 
by mass spectrometry (AP-MS). Since it depends on co-purification of interaction 
partners, weak interactions and interactions involving membrane proteins cannot be 
reliably detected. 
Recently, several high throughput screening methods including AVEXIS have been 
developed to target extracellular protein-protein interactions. All of them are based on 
the expression of soluble ectodomain fragments. These approaches have several 
disadvantages as compared to the AVEXIS assay used in this study.  
The ELISA-based binding assay (Wojtowicz et al., 2007) is the first reported high 
throughput screening assay designed to determine the binding specificity of the vast 
number of splice variants of the fruit fly Dscam protein. This assay is based on 
bait-prey detection with separate tags: the ectodomain fused to alkaline phosphatase 
(AP) as bait (“receptor”) and the ectodomain fused to the Fc region of human IgG1 as 
prey (“ligand”). Bait-AP proteins are coated on the plate using an anti-AP antibody 
and the prey-Fc proteins are detected by an anti-Fc antibody conjugated to horseradish 
peroxidase (HRP). Binding is measured by HRP activity. As in AVEXIS, this method 
applies oligomerization to increase the avidity of the binding. Instead of prey 
pentamers, dimers of both prey and bait proteins are used. The main difference 
between this assay and AVEXIS is that additional steps are involved. First, the bait is 
indirectly bound to microtitre plates using antibodies; therefore, the captured bait 
protein concentration is difficult to monitor. Second, the HPR enzyme is not directly 
conjugated to the prey protein, thus adding another level of potential inaccuracy. 
Another high throughput screening method is the so-called extracellular interactome 
assay (ECIA) (Özkan et al., 2013). It also specifically targets weak extracellular 
interactions using the oligomerization principle. Dimers of bait proteins containing 
the Fc region of human IgG1 and pentamers of prey proteins containing the COMP 
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and AP domains are used. The Fc region is captured directly on protein-A coated 
plates and the AP activity of the prey proteins is measured to detect the interactions. 
As in AVEXIS, prey protein concentrations are easily determined by AP enzyme 
activity and the concentrations of captured bait proteins can be determined by 
standard ELISA. However, in contrast to AVEXIS, the ECIA method focuses on post 
experimental data analysis to rule out false positive and false negative interactions 
while AVEXIS focuses on normalizing protein concentrations in the first place to get 
better original data. This difference in the strategy results in different quality of data.  
A protein microarray (Ramani et al., 2012) has been specially designed for detecting 
interactions between secreted proteins and receptors by using multivalent 
protein-coated beads. Very small amounts of proteins are needed for each sample, 
which makes this method especially suitable for genome-wide screening. Though it is 
a high throughput method, purification of both bait and prey protein is needed. Also, 
since the signal is derived directly from the fluorescence of the recombinant proteins, 
the detection signal is not amplified. This differs from AVEXIS and other 
ELISA-style binding assays and makes this assay less sensitive. 
Since none of these alternative methods provide substantial advantages, the AVEXIS 
assay was used to study the interactions of neuronal extracellular proteins to get a 
better understanding of the molecular mechanism of zebrafish neural development. 
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1.6 AVEXIS detected a direct interaction between Draxin and Netrin 
To systematically identify new molecules involved in neural wiring, the AVEXIS 
assay was used to screen for novel interactions (Söllner and Wright, 2009). Signals 
potentially occurring between neurons and their microenvironment were of great 
interest for studying neural wiring. A library has been generated, which contains 
several hundreds of zebrafish secreted proteins and ectodomains of cell-surface 
receptors expressed mainly in neural tissues in early zebrafish embryos. The protein 
library has been screened for novel interactions within cell-surface receptors and 
secreted proteins. 
The novel interaction between Netrin and Draxin was detected in the Tübingen 
discovery screen by Dr. Christian Söllner (Gao et al., 2015). The Draxin prey protein 
bound to members of the Netrin family. Within 158 bait proteins, zebrafish Netrin1a 
and Nerin-2 were the only positive hits besides the positive control (Matn4) (Fig 
1.10).  
 
 
Figure 1.10  AVEXIS identified a physical interaction between Netrin and Draxin 
Bar chart figure depicting the screening results for the Draxin prey in the discovery screen. 
Three hits were detected: Netrin1a, the positive control Matn4, and Netrin2. The positive 
signals had a Z-score >3, that is, the signals were >3 standard deviations above the mean. 
The Z-scores of the hits are indicated (see Tab 4.4 for the protein identities). ECD: 
ectodomain. Ntn1a: Netrin1a, Ntn2: Netrin2.  
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1.7 Goals of this study  
 
Netrin and Draxin are both known diffusible axon guidance molecules expressed in 
the developing CNS in vertebrates. Both Netrin-1 and Draxin knockout mice were 
reported to have defects in commissural neuron projections in the embryonic brain 
and spinal cord (Kennedy et al., 1994; Serafini et al., 1994; Islam et al., 2009). The 
large scale extracellular protein-protein interaction screen detected a novel direct 
interaction between these two guidance cues. This indicates Netrin-1 and Draxin 
function in the same biological process and/or same signaling pathway. Draxin might 
be a very interesting candidate for a potential Netrin modulator and could help to 
uncover a novel regulatory mechanism of Netrin signaling regulation.   
 
The specific goals of this study are: 
1) To analyze the interactions between Draxin and Netrin in vitro: examine binding 
specificity and define binding networks between known Draxin and Netrin family 
members 
2) To explore the binding mechanisms of the Draxin-Netrin interaction 
3) To test the function of the binding between Draxin and Netrin in vitro 
4) To characterize the potential function of the interaction in vivo in zebrafish 
embryos 
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Chapter 2 
Results 
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2.1 Biochemical analysis of the Draxin-Netrin interaction in 
vitro 
My first goal was to confirm the initial finding of a Netrin/Draxin interaction in the 
Tübingen AVEXIS screen (Fig. 1.10). I also aimed to characterize the interaction 
between the two secreted proteins in greater detail. To this end, I used an extracellular 
protein-protein interaction assay and addressed specifically each of the following 
questions:  
 
1) Is the interaction between Draxin and Netrin conserved within vertebrates?  
2) What would be the potential function of this interaction in the context of Netrin 
signaling?  
3) Does the direct binding of Draxin to Netrin influence Netrin/Netrin receptor 
interactions?  
4) What are the kinetic parameters of the Draxin-Netrin interaction?   
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2.1.1 Conservation of the binding specificity of Draxins to Netrins   
2.1.1.1 Adaptation of AVEXIS for small-scale interaction screening 
The AVEXIS method was designed for large-scale, protein-protein-interaction 
screening. Thus, several modifications were implemented to optimize this method in 
order to assay in detail binding events between Draxin and Netrin at a smaller scale.  
The original AVEXIS method was designed to detect infrequent interactions among a 
large number of proteins. False negative signals—due to very weak 
protein-protein-interactions, low protein concentrations or misfolded proteins—were 
tolerated. In this apporch, all prey proteins were normalized using β-lactamase 
enzymatic activity (Bushell et al., 2008). However, this may potentially cause an 
overestimation of the levels of prey proteins, since free β-lactamase in 
solution—which cannot bind to captured bait proteins in this assay—also can convert 
substrat. In my small-scale assay, it was crucial to detect all positive interactions. 
Therefore, an additional internal control was needed to normalize prey protein 
concentrations more accurately. Matrilin-4 (Matn4) had been shown to bind to the 
pentamerization domain of Cartilage Oligomeric Matrix Protein (COMP) (Mann et al., 
2004), which is designed in prey proteins. In each experiment, we add Matn4 bait 
protein as an internal contral to monitor prey protein concentrations. In this way, we 
can normalize prey protein concentrations accoding to the amount of captured prey 
proteins. This helps to increase the sensitivity of this assay.  
The identification of what is called a “positive interaction” (“hit”) was also adapted to 
a small-scale assay. AVEXIS was developed to identify novel interactions by 
screening a large-scale protein library. The identification of “hits” was, therefore, 
based on assumed normal distribution of the detected binding values. A signal was 
considered as a “hit” if the intensity was above the absorbance mean value by a 
defined number of standard devitions (Z-score). In the large-scale AVEXIS, the hit 
rate is between 0.4 % and 0.6 % of defined positive interactions among all of the 
tested interactions (Bushell et al., 2008). However, in a targeted small-scale screen 
with low sample numbers, the hit rate is expected to be substantially higher. Thus I 
replaced the Z-score based standard for calling hits with a combined hit definition, 
computing absolute binding value overal background level. Absobance values that 
were 1.5 fold above background level were defined positive interactions.  
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2.1.1.2 Binding specificity of zebrafish Draxins and Netrins 
To explore the interaction between Draxin and Netrin in detail, I wanted to know 
whether the interaction occurs among all members of their respective protein families, 
or between a few specific members. Thus, I examined all known zebrafish Draxin and 
Netrin proteins for binding specificity using AVEXIS.  
As a first step, I cloned the draxin paralog (gene name: si:dkey-1c11.1) and the 
annotated diffusible netrin genes including netrin1b, netrin-2 and netrin-4 (Fig. 1.4). 
For all of the cloned netrin genes, truncated constructs were generated which 
contained the Netrin N-terminal domain and three EGF domains. The C-terminal 
domain of Netrin was excluded because it binds to components of the extracellular 
matrix (e.g. heparins) (Serafini et al., 1994). Removing the Netrin C-terminal domain 
does not affect receptor binding (Geisbrecht et al., 2003; Xu, Wu et al., 2014). In fact, 
expressing truncated versions of Netrin in eukaryotic cell cultures result higher 
protein yields (Serafini et al., 1994; Özkan et al., 2013). The expression level of 
Netrin-2 was low even after the removal of C-terminal domain, so that Netrin-2 was 
not included in further experiments.  
As shown in Figure 2.1 A1, Netrin1a bound strongly to both Draxin and the Draxin 
paralog (si:dkey-1c11.1), weakly to itself and to Netrin1b. Figure 2.1 A2 shows that 
Draxin bound strongly to both Netrin1a and Netrin1b, but not to Netrin-4. For all 
bait/prey pairs, reciprocal pairs (e.g. A-bait to B-prey and B-bait to A-prey) were 
tested. The results are summarized in Figure 2.1 B. Reciprocal tests confirmed the 
initial observation that both Draxin and the Draxin paralog bound strongly to Netrin1a 
and Netrin1b, whereas Netrin1a and Netrin1b showed homophilic binding as well as 
heterophilic binding to each other. Netrin-4 did not bind to any of the tested proteins.  
Figure 2.1 C summarizes the result of the AVEXIS binding test for zebrafish Netrins 
and Draxins. It confirms the initial result that was obtained for Draxin and Netrin1a in 
the large-scale AVEXIS screen. Interestingly, both Draxin paralogs bound to the tested 
Netrin members belonging to Laminin γ-chain derived Netrins (Netrin1a, Netrin1b), 
but not to Laminin β-chain derived Netrins (Netrin-4). Not all of the Netrins bound to 
Draxin, which suggests that Draxin is a selective binder of Laminin γ-chain derived 
Netrins.  
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Figure 2.1  Zebrafish Draxin-Netrin interactions 
(A) AVEXIS pair wise binding results for zebrafish Netrin-Draxin binding experiments. A1) 
zebrafish Netrin1a as prey. A2) zebrafish Draxin as prey. The values show absorbance 
reads of substrate turnover at 486 nm, mean ± SD, n=3. The dashed line shows the 
absorbance of the negative control (a construct containing only the CD4 tag as bait) and 
corresponds to the background level. The screen was performed in both bait-prey 
orientations using pentameric prey proteins. (B) Heatmap view of the results. Values show 
486 nm absorbance means of triplicates. Red: binding (binding value/background >1.5), 
yellow: no binding (binding value/background <1.5). (C) Network view of the results. The 
dashed line indicates two different groups of Netrin proteins: Laminin γ-chain derived 
Netrins (γ-Netrin group) and β-chain derived Netrin (β-Netrin). Ntn: Netrin.
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2.1.1.3 Conservation of the Netrin-Draxin interaction in human orthologs  
Since both Draxin and Netrin are present in a wide range of vertebrate genomes (Fig. 
1.3 A), I wondered whether the interactions between zebrafish Draxin and Netrin are 
conserved to human. To test for binding conservation, I examined the binding of 
different human Draxin and Netrin orthologs. Clones of human Netrin-1, Netrin-3, 
Netrin-4, Netrin-G1 and Netrin-G2 as well as Draxin protein were generated and 
expressed. Just as we did for the zebrafish Netrin proteins, we generated truncated 
versions for all human Netrins, which contained the Laminin domain and the EGF 
domains (domain VI+V).   
As seen in Figure 2.2 A1, human Draxin bound to human Netrin-1. Draxin strongly 
bound to Netrin-1 and weakly to Netrin-3 (Fig. 2.2 A2). Netrin-4, Netrin-G1 and 
Netrin-G2 did not bind to any of the tested proteins. The reciprocal bait/prey tests 
confirm the binding results (Fig. 2.2 B). In sum, the interactions between Draxins and 
Netrins observed in zebrafish are conserved for the human orthologs (Fig. 2.2 C). 
Human Draxin bound to Netrin-1 and Netrin-3, both of these proteins are members of 
Laminin γ-chain derived Netrins, and Draxin did not bind to all of the Netrins. These 
findings are in agreement with the binding specificity that was observed within 
zebrafish proteins.   
 
2.1.1.4 Cross-species interactions between zebrafish and human proteins 
Since the binding between Draxin and Netrin is conserved among zebrafish paralogs 
and human orthologs, I further asked whether the binding interface is conserved 
across species. To this end, I carried out cross-species interaction experiments. I tested 
the binding specificity of human Draxin to zebrafish Netrin as well as human Netrin 
to zebrafish Draxin. 
As shown in Figure 2.3 A, I detected strong binding between human Draxin bait and 
zebrafish Netrin1a prey. The signal strength was comparable to the signal that was 
observed when zebrafish Netrin bound to zebrafish Draxin. Similarly, I observed 
strong binding when the human Netrin-1 prey bound to the zebrafish Draxin bait (Fig. 
2.3 B). These results show cross-species interactions. Thus, the interaction interfaces 
between Draxin and Netrin are most likely highly conserved.  
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Figure 2.2  Human Draxin-Netrin interactions 
A) AVEXIS pairwise binding results of human Netrin-Draxin interactions. A1) human 
Netrin-1 as prey. A2) human Draxin as prey. The values show absorbance of the substrate 
at 486 nm, mean ± SD, n=3. The dashed lines show the absorbance of the negative 
control (construct with CD4 tag as bait), indicating the background level. The screen has 
been performed in both bait-prey orientations using pentameric prey proteins. B) Heatmap 
view of the results. The values show the 486 nm absorbance means of triplicates. Red: 
binding, yellow: no binding. C) Network view of the results. The dashed line indicates two 
different groups of human Netrin. NTN: Netrin
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Figure 2.3  Zebrafish and human Draxin-Netrin cross-species interactions 
AVEXIS screen results: (A) zebrafish Netrin1a as prey and (B) human Netrin1 as prey. 
The values show absorbance of the substrate at 486 nm, mean ± SD, n=3. The dashed 
line corresponds to the absorbance read from the negative control (CD4 tag as bait), and 
this corresponds to the background level. NTN: Netrin. 
 
 
 
 
 
Figure 2.4  Netrin-Netrin receptor and Draxin-Netrin receptor interactions 
Targeted AVEXIS screen results for zebrafish (A) and human (B) Netrin-Netrin receptor 
and Draxin-Netrin receptor binding experiments. The values show 486 nm absorbance 
means of triplicates. Both bait-prey orientations are indicated. Red: binding, yellow: no 
binding. Zebrafish Draxin paralog: si:dkey-1c11.1. “/”: not tested; Ntn or NTN: Netrin. 
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2.1.2 Draxin binds to Netrin, but not to Netrin receptors 
Draxin and Netrin are both secreted proteins of similar size; they are both axon 
guidance cues; and Netrin is a known ligand of several receptors. This brings up an 
interesting question: how does the direct interaction between Draxin and Netrin 
proteins influence their respective functions?  
As Draxin is reported to bind to all Netrin receptors (Ahmed et al., 2011), the first 
hypothesis was that the binding of Draxin to Netrin might influence the interaction 
between Draxin and Netrin receptors. In order to test this, I first studied the direct 
interactions between various Netrins, Draxins and Netrin receptors using AVEXIS.  
I focused on Netrin-1 and receptors of Netrin-1 for several reasons: 1) Draxin appears 
to specifically interact with Laminin γ-chain derived Netrins, and Netrin-1 is the 
major and the best studied Netrin in this group. 2) The receptors of Netrin-1, DCC 
and Unc5, are also the best studied Netrin receptors. The functions of these receptors 
are known, which enables the follow-up functional studies of the interactions. All of 
the Netrin-1 receptors were cloned for the binding tests, including Dcc, Neogenin, 
Unc5b and Dscam. Dscam was excluded from the binding tests because of low 
protein expression level.  
Figure 2.4 shows the protein binding results. The three tested zebrafish Netrin-1 
receptors bound to both Netrin1a and Netrin1b; they did not bind to Netrin-4. 
Interestingly, I did not detect binding of any of the three Netrin receptors to Draxins. I 
observed similar results in the reciprocal prey/bait orientation. On the other hand, the 
human Netrin receptors DCC and UNC5B specifically bound to Netrin-1, but not to 
any other of the tested Netrins, including Netrin-3, Netrin-4 and two Netrin-G 
proteins. Neither of these human Netrin receptors interacts with Draxin, similarly to 
the results obtained using zebrafish proteins.  
 
In summary, all of the tested Netrin receptors, from both zebrafish and human, were 
able to directly bind to Netrin but not to Draxin. These findings give a different view 
from the previous observations in which Draxin directly bound to all of the Netrin 
receptors.  
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2.1.3 In vitro competition between Draxin and Netrin receptors for 
Netrin binding  
The second hypothesis addressing the function of the interaction between Draxin and 
Netrin was that Draxin might compete with Netrin receptors for Netrin binding. I 
developed a competition assay to test this hypothesis.   
2.1.3.1 Establishment of an AVEXIS-based competition assay 
The competition assay was designed as a modification of the AVEXIS assay (Fig. 2.5). 
In this competition assay, Netrin-1 was used as bait, and the extracellular domains of 
Netrin receptors were used as prey proteins. The binding between Netrin-1 bait and 
Netrin receptor prey proteins was challenged by addition of increasing concentrations 
of purified soluble Draxin (the potential competitor). By design, this assay is able to 
distinguish among three different possibilities: (i) an increase in the substrate turnover 
rate (deriving from Netrin-Netrin receptor binding) would indicate that Draxin 
facilitates the interaction between Netrin and Netrin receptors; (ii) no change in the 
substrate turnover rate would suggest that Draxin has no effect on binding; (iii) a 
decrease in the substrate turnover rate (even to a rate of zero) would indicate that 
Draxin inhibits the binding of Netrin to Netrin receptors, quanlifying as a novel 
negative regulator of Netrin signaling.  
I modified the AVEXIS assay to measure competition by introducing a new way of 
normalizing prey protein concentrations. To exclude any possibility of signal 
saturation and to avoid a too low signal baseline that may interfere with the detection 
of the inhibition, prey proteins were normalized to absorbance values 2 to 5 fold 
above the background level within the reaction incubation time. 
The percentage of binding was calculated as:  
% binding = %100∗





inhibitorwithoutbinding
inhibitorwithbinding  
Background levels (the average binding value using BSA) were subtracted from all of 
the binding values prior to the calculation. The percentage of binding reflects the 
competition effect.  
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Figure 2.5  Schematic representation of the AVEXIS-based competition assay 
Netrin1a (green, monomer) is used as bait protein, Netrin receptors (green, pentarmer) 
are used as prey proteins probed together with purified Draxin (red, monomer) as the 
tested inhibitor. This assay is able to distinguish among three different possibilities: (i) 
Draxin facilitates the interaction between Netrin to Netrin receptors; (ii) Draxin has no 
effect on binding; (iii) Draxin inhibits the binding of Netrin to Netrin receptors. The Draxin 
construct contained rat CD4 and histine tag: N’ Draxin-CD4 d3+4-6XHis-stop C’. (adapted: 
Söllner et.al., 2009) 
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2.1.3.2 Results of the competition assay 
Using the competition assay, I tested whether Draxin is able to compete with Netrin 
receptors for Netrin binding. Figure 2.6 shows the raw data from one of the 
experiments. Concentrations of Draxin between 100 nM and 1 μM are able to 
outcompete all the tested Netrin receptors from Netrin binding. The inhibition effect 
of Draxin is variable among different Netrin receptor-Netrin pairs. Unc5b-Netrin 
interaction is most sensitive to the Draxin-dependent inhibition among all of the tested 
binding pairs.  
In order to quantitate the inhibitory effect, I used purified Draxin in the competition 
assay. Figure 2.7 A shows that purified Draxin is able to reduce the binding between 
Netrin1a and Dcc. Draxin concentrations higher than 1 μM completely abolished 
binding. Similarly, the interaction between Netrin1a and Unc5b was inhibited by 
addition of Draxin (Figure 2.7 B). The concentration of Netrin at which 50 % 
inhibition was observed (IC50), measured 50 nM (Netrin1a-Dcc interaction) and 10 
nM (Netrin1a-Unc5b interaction). In addition, Draxin interfered with the 
Netrin1a-Neo1 interaction, although it appears that higher concentrations of Draxin 
are required to trigger this effect (red line in Fig. 2.7 C). Since the competition effect 
of Draxin to Netrin1a-Neo1 is not as strong as the effect seen with Netrin1a-Dcc or 
Netrin1a-Unc5b, I wanted to rule out the possibility of a non-specific result. Figure 
2.7 C shows that equal amounts of BSA did not interfere with the binding between 
Netrin1a and Neo1 (dotted black line). Thus, the capability of Draxin to interfere with 
the interaction between Netrin and its receptors is a specific property of Draxin in my 
analysis. 
To further test whether Netrin is a specific target of Draxin, Netrin was replaced with 
another ligand in the competition test. The Netrin receptor Neo1 has other known 
ligands belonging to the membrane-bound repulsive guidance molecule (RGM) 
protein family (Rajagopalan et al., 2004). RGMc (Hfe2) is one of these RGMs. As 
shown in Figure 2.7 D, high concentrations of Draxin were not able to influence 
Hfe2-Neo1 binding. These data indicate that the inhibitory effect of Draxin is specific 
to Netrin1a and does not affect the binding of Hfe2 to Neo1.   
Finally, to test how efficiently Draxin is able to disrupt Netrin-Netrin receptor 
interactions, I designed an experiment including different initial ratios of Netrin / 
Netrin receptor subjected to competion (Fig. 2.8 A). After Netrin-1 bait proteins were 
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immobilized, Netrin receptor preys were either added before, together with, or after 
the addition of Draxin. In the first condition, the Netrin-Netrin receptor complex 
formed before the presence of the inhibitor. Figure 2.8 B shows the results of this 
competition experiments. The Netrin1a-Dcc binding level was reduced in response to 
increasing concentrations of Draxin in all three conditions. The inhibition effect of 
Draxin to preformed Netrin-Netrin receptor complexes was similar to the other two 
competition conditions. This indicates that Draxin is able to outcompete Netrin 
receptors, disrupting preformed Netrin-Netrin receptor complex.   
In conclusion, Draxin specifically interferes with the interaction between Netrin and 
Netrin receptors in vitro, thereby, confirming the second hypothesis.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6  Draxin is able to outcompete Netrin receptors for Netrin binding (raw 
data) 
Raw data of the AVEXIS-based competition assay. Netrin1a was used as bait and the 
indicated Netrin receptors were used as prey proteins. Two-fold dilution series of prey 
proteins are displayed from top to botton. For each group, the two columns on the left 
show binding without Draxin, the two right colunns show binding with Draxin. Red wells 
show the colorimetric enzyme reactions indicating binding events, yellow wells indicate no 
binding. Equal concentrations of Draxin were added as inhibitor. A Netrin1a version 
containing the Laminin N-terminal domain plus 3xEGF domains (Netrin VI+V) was used 
as bait protein; complete ectodomains of Netrin receptors were used as prey proteins; 
Monomeric Draxin (with the concentration between 100 nM and 1 μM) is harvested from 
tissue culture medium. 
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Figure 2.7  Draxin inhibits the binding of Netrin to Netrin receptors in vitro 
(A) Binding curve of Netrin1a-Netrin receptor Dcc interaction challenged by Draxin. The 
binding value from Netrin1a to Dcc is reduced with increasing concentrations of Draxin. 
This effect is also observed for other Netrin receptors Unc5b (B) and Neo1 (C, indicated 
with red line). Equal amounts of BSA were not able to compete for Netrin1a-Neo1 binding 
(C, indicated with dashed black line). (D) Draxin is not able to interfere with the binding of 
Neo1 to Hfe2 (RGMc), another known Neo1 ligand. Zebrafish proteins were used in this 
assay. A Netrin1a version containing the Laminin N-terminal domain plus 3xEGF domains 
(Netrin VI+V) was used as bait protein; complete extracellular regions of Netrin receptors 
were used as prey proteins; His6-tagged full length Draxin in frame fusion with rat CD4 
domain3+4 was used as the potential inhibitor; binding reads were taken within 1-2 hours 
at room temperature. % binding: (binding with inhibitor / binding without inhibitor) X100 %. 
Error bars indicate mean±s.d; n=4. Similar results were obtained three times 
independently, and with monomeric prey proteins of Dcc and Unc5b.  
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Figure 2.8  Draxin outcompetes the binding of Netrin to Netrin receptor 
(A) Schematic illustration of the assay.  After 1 hour incubation with bait proteins, Draxin 
was added 30 min before, together with or 30 min after addition of prey proteins. (B) The 
competition curves of three different conditions. In all of the cases, the binding of Dcc to 
Netrin is reduced with increasing concentrations of Draxin. Zebrafish proteins were used 
in this assay. Netrin1a containing Laminin N-terminal plus 3xEGF domains (Netrin VI+V) 
was used as the bait protein; extracellular region of Dcc was used as monomoeric prey 
protein; full-length His6- tagged Draxin fused to rat CD4 domain3+4 was used as potential 
inhibitor. A486nm 1 hour reads were taken. % binding: (binding with inhibitor / binding 
without inhibitor) X100 %, error bars indicate mean±s.d. n=4. 
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2.1.4 Kinetic analysis of the Draxin-Netrin interaction using SPR 
To independently confirm the interaction between Draxin and Netrin detected using 
the AVEXIS assay, we performed surface plasmon resonance (SPR) experiments. SPR 
is a method to determine the kinetics of protein-protein interactions in real time. It can 
measure whether a binding event occurs, and allows to determine how strong and how 
fast the interaction is. SPR-based methods are currently the golden standard method to 
determine the kinetics of protein-protein interactions.  
 
We injected serial dilutions of purified human Draxin (R&D systems, monomer) over 
immobilized C-terminal biotinalyated human Netrin-1 on a streptavidin-coated sensor 
chip and used Netrin-G1 as the reference. We also performed similar experiments 
with Draxin and the ectodomain of human Netrin receptors Unc5B and DCC 
immobilized on the chip.  
 
As seen in Figure 2.9 A, we detected direct binding between Draxin and Netrin-1. The 
binding curve is not well fitted a simple 1:1 dissociation model but more closely fitted 
the heterogeneous ligand model (ka1 2.12 10-6; M-1 s-1; kd1 0.0212 s-1; ka2 5.03 10-6 M-1 s-1; 
kd2 6.19 10-4 s-1). The binding dissociation constant (KD) was 10 nM, which falls within 
the known range detected for Netrin-Netrin receptor interactions. These kinetic data 
support our previous conclusions showing that Draxin can disrupt Netrin binding to 
its receptors. No binding of Draxin to UNC5B and DCC was detected (Fig. 2.9 B and 
C), which confirmed the results we obtained using AVEXIS.  
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Figure 2.9  Surface Plasmon Resonance analysis of Draxin as analyte 
Binding of Draxin to immobilized recombinant Netrin-1, UNC5B, and DCC was monitored 
using SPR experiments on a Biacore 3000 instrument. The binding curves are fitted with 
1:1 dissociation model. Recombinant Netrin-G1 was used as a reference. Human proteins 
were used in the analysis.  
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2.2 Characterization of the binding sites for the interaction 
between Draxin and Netrin 
 
In order to uncover the molecular mechanism of the interaction between Draxin and 
Netrin, my next goal was to characterize the protein regions that mediate the 
Draxin-Netrin interaction. By using orthologous protein alignment and protein feature 
analysis, I designed a series of constructs encoding different protein versions. These 
protein contained deletions or were truncated, allowing the mapping of zebrafish 
Draxin and Netrin1a binding interfaces. The AVEXIS assay was used for the 
mapping.   
 
I asked the following specific questions: 
1) Where is the binding interface of Draxin and Netrin when they interacting? 
2) Are the binding sites in both proteins specific to the Draxin-Netrin interaction?  
3) The Draxin-Netrin interactions is conserved from zebrafish to human, is the 
binding site formed by conserved protein sequence? 
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2.2.1 The Draxin binding interface to Netrin is mapped to a highly 
conserved 22 aa peptide 
2.2.1.1 Protein domain analysis of zebrafish Draxin 
Since no structural or domain prediction data was available for Draxin, I aligned 
protein sequences of Draxin orthologs from different species in order to identify 
conserved regions of the protein. In addition, protein features were analyzed using the 
following online bioinformatics’ tools: SMART (Simple Modular Architecture 
Research Tool) for protein domain annotation; SignalP 4.0 for signal-peptide 
prediction; HHpred (from the Tuebingen Bioinformatics Toolkit) for homologous 
protein detection and protein structure prediction; NetNGlyc 1.0 and other prediction 
programs in ExPASy (Expert Protein Analysis System) for the identification of 
protein-sugar binding regions. 
Figure 2.10 shows the alignment of human, mouse, chick and zebrafish Draxin 
proteins as well as the protein feature analysis. The N-terminal half of Draxin is 
poorly conserved, whereas a highly conserved region is recognizable from the middle 
of zebrafish Draxin onwards (aa 209, indicated by the arrowhead in Fig. 2.10). This 
region includes a highly conserved 22 aa stretch (zebrafish Draxin 231-252 aa, 
underlined in red) followed by a 10-cysteines containing region (zebrafish Draxin 
284-360 aa, underlined in magenta). The amino acid cysteine is highly conserved 
within proteins that share similar functions, because the cysteines form disulfide 
bridges that play essential roles in both the stabilization of protein structure and the 
preservation of biological function. The 10-cysteines containing region in Draxin is 
known as Dickkopf (Dkk)-like domain, and contains a similar number and spacing of 
cysteines as found in Dkk proteins (Miyake et al., 2009). By HHpred analysis, I was 
able to characterize the starting point of the Dkk-like domain (zebrafish Draxin aa 275, 
underlined in blue). In addition, a positively charged motif was detected (zebrafish 
Draxin 260-268 aa, KRKDKRRSK, underlined in yellow), which likely binds to 
negatively charged glycosaminoglycans (sugars). I used these properties to design 
mapping constructs for the Draxin protein.  
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Figure 2.10  Draxin protein alignment and analysis 
ClustalW alignment of human, mouse, chick, and zebrafish Draxin proteins. Draxin display 
high conservation from a central region (zebrafish Draxin 231-252 aa, red line). In the 
C-terminus of the protein, a conserved domain (magenta line, Dkk-like domain) containing 
10-cysteines is recognizable. By HHpred analysis, this domain is identified from 275 aa to 
360 aa of zebrafish Draxin (blue line). The signal peptide in zebrafish Draxin is underlined 
in green, and a positively charged sequence is underlined in yellow. The name of the 
zebrafish Draxin paralog is si:dkey-1c11.1.  
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2.2.1.2 Mapping the Netrin-binding-interface in Draxin to a 22 aa motif 
In order to map the Netrin-binding-interface in Draxin, I first generated a series of 25 
different zebrafish Draxin protein truncations. These truncations were tested against 
Netrin for binding activity using the AVEXIS assay.  
Several considerations were taken into account to adapt the AVEXIS assay for the 
mapping experiments. Draxin prey proteins were normalized to concentrations 
yielding a signal 2-5 fold above background level in the binding assay. This expedient 
provided an increase in the detection sensitivity of the binding test. To reduce the 
non-specific binding signal, a monomeric Netrin1a prey protein lacking the COMP 
domain (pentamerization domain) was generated. For monomeric prey proteins, the 
avidity effect generated by pentermerized prey proteins does not apply (Bushell et al., 
2008). Hence, using the monomeric prey protein versions helped to reduce signals 
derived from weak and transient interactions, whereas strong binding events were still 
detectable. Similar to the binding experiments mentioned in the Results, section 2.1, a 
zebrafish Netrin1a protein consisting the domain VI (Netrin N-terminal domain) and 
domain V (the three EGF domains) was used in the mapping experiments. 
Figure 2.11 shows the mapping result of the Netrin-binding-interface in Draxin. All 
constructs comprising a 22 aa protein motif (zebrafish Draxin 231-252 aa) bound to 
Netrin1a (Fig. 2.11 A); the positive binding signals were higher than 5-fold above 
background level, indicating that truncated Draxin protein have the same binding 
activity as full-length Draxin (Fig. 2.11 B). Interestingly, the 22 aa peptide alone 
(Draxin 231-252 aa) is sufficient for binding. Removal of the 22 aa motif from 
full-length Draxin (Draxin △209-284 aa and Draxin △231-252 aa) completely 
abolished the binding ability. These results emphasize the requirement of the 22 aa 
motif in Draxin for successful binding to Netrin1a. Furthermore, shortening this motif 
by 5 aa from C-terminus (Draxin 209-247 aa, 226-247 aa) resulted in weak binding to 
Netrin1a. The binding signal was less than 1.5 fold above background level.  
In conclusion, the binding region of Draixn to Netrin1a was mapped to a 22 aa motif 
(zebrafish Draxin 231-252 aa). The identified peptide is both necessary and sufficient 
to mediate the interaction between Draxin and Netrin1a. 
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Figure 2.11  A Draxin-derived 22 aa fragment is sufficient for binding to Netrin1a  
(A) AVEXIS binding results from a set of Draxin protein fragments tested against Netrin1a. 
Binding is indicated in black, weak binding in grey, and no-binding in white.  
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Figure 2.11  A Draxin-derived 22 aa fragment is sufficient for binding to Netrin1a 
(continued) 
(B) Original data of the mapping experiments. The prey proteins were normalized to 
substrate turnover levels 2-5 fold above background by using the Matn4 bait as positive 
control; 2 % BSA serves as negative control. The average of duplicates is shown. “/”: not 
tested.  
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2.2.1.3 Binding specificity of the Draxin-derived 22 aa peptide (library screen) 
Next, I determined whether the Draxin-derived 22 aa peptide specifically binds to 
Netrin. To this end, I took advantage of the AVEXIS method and the large 
extracellular protein library generated by our group. In these experiments, the Draxin 
22 aa peptide was screened against a diverse set of cell surface and secreted proteins 
including 132 bait and 172 prey proteins (see Tab. 4.4 for protein identities).  
As shown in Figure 2.12, one strong hit corresponding to Netrin1a was detected in 
both bait and prey orientations. The binding value of the Draxin-derived peptide to the 
rest of the library was within background level. This result demonstrates that the 
binding between the Draxin-derived 22 aa peptide and Netrin1a is highly selective 
among a diverse set of protein families.  
   
2.2.1.4 The 22 aa motif of Draxin is highly conserved within vertebrate Draxins 
I was interested in the protein features of the Draxin 22 aa peptide sequence because 
of its binding selectivity to Netrin1a. BLAST (Basic Local Alignmnet Search Tool) 
searches detected similar motifs only within vertebrate Draxin homologos. Figure 
2.13 shows the protein alignment of Draxins from human, mouse, rat, cow, pig, 
chimpanzee, chick, frog, puffer fish and zebrafish. This alignment shows that the 22 
aa motif from zebrafish Draxin is highly conserved between distant vertebrate species.  
Together, these results from section 2.2.1.3 and 2.2.1.4 indicate that the identified 22 
aa peptide in Draxin selectively binds to Netrin1a and is uniquetly found in the 
vertebrate Draxin protein family.  
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Figure 2.12  Binding selectivity of the 22 aa Draxin-derived peptide 
The 22 aa Draxin-derived peptide was screened against 132 different bait proteins and 
172 prey proteins from a variety of protein families (see Tab. 4.4 for protein identities). 486 
nm absorbance values were obtained after a two-hour incubation of the substrate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13  Conservation of the Netrin-binding motif in Draxin homologs 
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2.2.1.5 The 22 aa Draxin peptide (fused to the Fc region of IgG) is sufficient to 
compete with Netrin receptors for Netrin binding 
Since the 22 aa Draxin motif is sufficient for binding to Netrin1a, I next asked 
whether the same peptide was also able to block Netrin receptor-Netrin interactions in 
the same way as the full-length Draxin. The in vitro AVEXIS-based competition assay 
was used for this purpose. Here, the 22 aa Draxin peptide, the full-length Draxin, and 
a truncated Draxin version containing a deletion of the 22 aa motif (Draxin △22 aa) 
were fused to the Fc region of human IgG protein (hFc), which serves as a 
dimerization tag. I used the three fusion proteins above as “competitors” in the 
competition assay. Netrin receptor-Netrin binding was “challenged” by addition of 
Draxin fusion proteins in order to determine their inhibitory effect.   
Figure 2.14 shows that the fusion protein containing Draxin 22 aa peptide (Draxin 
231-252aa-hFc) was able to block Netrin1a-Dcc interactions. Furthermore, Draxin 
231-252aa-hFc and dimeric full-length Draxin (Draxin-hFc) had a similar inhibitory 
capability. On the other hand, deletion-containing Draxin (Draxin ∆231-252aa-hFc) 
was unable to effectively influence the interaction beween Netrin and its receptors. 
These results show that the 22 aa Netrin-binding region of Draxin is required to 
outcompete Netrin receptors from Netrin binding, and the Draxin derived 22 aa 
peptide is sufficient for exert inhibition.   
 
In order to further test whether the inhibitory effect is specific to Netrin-Netrin 
receptor interaction, I used the same set of Draxin-hFc to examine their effect on other 
interactions. Figure 2.15 B-D shows no detectable interference with Cntn1a-Ptprz1b 
(B), Vasna-Islr2 (C), or EphB4a-EphrinB2a (D). These results further demonstrate 
that Draxin specifically inhibits Netrin/Netrin receptor interaction via its conserved 22 
aa peptide.  
 
 
 
 
Figure 2.13 (preceding page)  Conservation of the Netrin-binding motif in Draxin 
homologs 
Protein sequence alignment of the Draxin-derived 22 aa Netrin-binding peptide from 
different vertebrate species. The zebrafish (Danio rerio) Draxin paralog is si:dkey-1c11.1.  
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Figure 2.14  The Netrin-binding 22 aa peptide in Draxin is sufficient to compete 
with Netrin receptor for Netrin binding 
AVEXIS-based competition assay using three different Draxin versions fused to the Fc 
region of the human IgG protein as potential competitors. (A) Full-length Draxin-hFc 
(green) and the Netrin-binding 22aa-hFc (red) proteins were able to outcompete Dcc for 
binding to Netrin1a. Full-length Draxin carrying a deletion of the Netrin-binding motif 
(△231-252 aa, magenta) was not able to compete with the Netrin receptor for binding to 
Netrin. (B-D) None of the three Draxin-hFc fusion proteins was able to block binding 
between other receptor-ligand pairs tested: Cntn1a-Ptprz1b (B), Vasna-Islr2 (C), and 
EphB4a-EphrinB2a (D). Concentration normalized Fc fusion proteins were used. % 
binding: binding with inhibitor / binding without inhibitor X100 %; error bars show mean ± 
s.d., n = 3; two repeats. 
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2.2.2 The 3rd EGF domain of Netrin1a is sufficient for binding to 
Draxin 
2.2.2.1 Netrin1a domain boundary analysis and protein linker design 
In order to dissect the functional units of Netrin for the Draxin-binding-region 
mapping experiments, I first analyzed the domains of the Netrin1a protein. Netrin1a 
contains multiple known domains (Fig. 1.4 A), however, the exact boundaries of each 
EGF domains remains unclear. The SMART program was used for predicting the 
boundaries of these EGF domains. The key element to define a typical EGF domain is 
the spacing of the 8 conserved cysteines. The cysteines produce disulphide bonds that 
preserve the tertiary protein structure. The structure of an EGF domain is shown in the 
following diagram, and the disulphide bonds are indicated: 
+-------------------------------+
+----|------------------+               |       +---------------+      +----------------------------+
|     |                      |               |        |                   |       |                                   |
xx Cx Cxxxxxxxxxxx C xxxxxxx C xx C xxxxxGxx C xx C xxgaagxxxxxxxxxxx Cxx  
According to this prediction, aa 338 and aa 401 in zebrafish Netrin1a were proposed 
to correspond to the start of the 2nd EGF and the 3rd EGF domain.    
Since the first cysteine is located near the beginning of the EGF domain, the structure 
of a truncated protein can be easily affected if the truncation site is not accurately 
designed. In order to increase the likelihood of producing properly folded proteins for 
individual EGF domains, I optimized the protein expression constructs by adding 
protein linkers between the signal peptide and the respective EGF domains. The 
following protein linkers were used: 
a) SMFAAQTSPPDP (endogenous) 
b) PASPASPAS 
c) GSTGTT  
 
2.2.2.2 Mapping the Draxin-binding-interface to the 3rd EGF domain of Netrin1a 
To map the Draxin-binding-interface, I designed a set of Netrin1a constructs 
containing either individual domains or combinations of consecutive domains. These 
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truncated Netrin proteins were tested for binding activity against full-length Draxin. 
This set of truncated Netrins was also tested against Draxin △231-252 aa and Draxin 
231-252 aa peptide, and compared with full-length Draxin.  
Figure 2.15 A shows the result of the interaction screen using Netrin1a truncations 
against Draxin. The N-terminal domain and the C-terminal domain (C345C) of 
Netrin1a are not required for binding to Draxin. In contrast, the three-EGF domain 
(257-458 aa) in Netrin displayed strong binding. By screening individual EGF 
domains against Draxin, I was finally able to narrow down the Draxin-binding-region 
to the 3rd EGF domain of Netrin1a (401-458 aa). 
Furthermore, I was able to show that truncated-Draxin (containing a deletion of the 22 
aa motif) was unable to bind to any of the truncated Netrin1a constructs (Fig. 2.15 B). 
In contrast, the Draxin derived 22 aa peptide alone was able to bind to all of the 
truncated Netrin1a constructs which also bound to full-length Draxin (Fig. 2.15 B). 
Moreover, the binding activity of the 22 aa peptide to Netrin1a was similar to that of 
full-length Draxin. Interestingly, the 22 aa Draxin peptide was able to bind to the 3rd 
EGF domain of Netrin1a.  
In conclusion, I resolved the binding region of Netrin1a to Draxin to the 3rd EGF 
domain (401-458 aa) in Netrin1a. The 231-252 aa Draxin peptide was able to bind to 
the 3rd EGF domain of Netrin1a.    
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Figure 2.15 Identification of the Draxin-binding domain in Netrin1a  
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2.2.2.3 Binding specificity of the 3rd EGF domain in Netrin1a (library screen)        
To test whether the mapped binding domain in Netrin1a selectively interacts with 
Draxin, I screened the 3rd EGF domain of Netrin1a against a large set of proteins in 
our library. 88 bait proteins and 162 prey proteins were screened for protein-protein 
interactions using AVEXIS (see Tab. 4.4 for the protein identities).  
 
Figure 2.16 shows that only a single strong hit corresponding to Draxin was detected 
in both bait/prey orientations. The binding values presented in the library against the 
3rd EGF domain were below background threshold. This result demonstrates that the 
binding of the 3rd EGF domain in Netrin1a to Draxin is highly specific among a large 
set of proteins.   
 
 
 
 
 
 
 
 
 
Figure 2.15 (preceding page) Identification of the Draxin-binding domain in Netrin1a  
(A) AVEXIS binding results obtained by screening a set of 9 different Netrin protein 
truncations against Draxin proteins. The Draxin-binding interface in Netrin1a was 
narrowed down to the 3rd EGF domain (401-458 aa). Binding is indicated in black, 
no-binding in white. (B) Original data from the mapping experiments. Data showing 
interactions tests between Netrin truncations and Draxin version includeing full-length 
Draxin, Draxin 22 aa peptide (231-252 aa), and Draxin 22 aa deletion (Δ231-252 aa). Prey 
proteins were normalized to binding values 2-5 fold above background level using Matn4 
as a positive control; 2 % BSA is a negative control. The average of duplicates is shown. 
Comparable results were obtained in the reverse bait/prey orientation. “/”: not tested; “*”: 
the binding signal observed for the Netrin1a 450-603 aa prey protein might be derived 
from the known sugar-binding properties of this domain.  
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Figure 2.16  Binding selectivity of the 3rd EGF domain of Netrin1a 
The 3rd EGF domain of Netrin1a was tested against 88 bait and 162 prey proteins (see 
Tab. 4.4 for the list of the tested proteins). In both orientations, only one strong hit 
highlighting Draxin was detectable. 486 nm absorbance values were obtained after a 
two-hours’ incubation.  
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2.2.2.4 The 3rd Netrin EGF domain is highly conserved within γ-Netrins 
To determine the conservation of the mapped Draxin-binding-region in Netrin1a, I 
aligned the 3rd EGF domain from all known human and zebrafish Netrins. Figure 2.17 
shows that the 3rd Netrin EGF domain is highly conserved among Laminin γ-chain 
derived Netrins (γ-Netrins). It shows lower conservation when compared with other 
Netrins (e.g. Netrin-4 and Netrin-G). Indeed, among the three EGF domains in 
Netrin-1, the 3rd EGF domain is the most highly conserved domain within γ-Netrins. 
For example, the protein sequences of the 3rd EGF domain from zebrafish Netrin1b 
and human Netrin-1 are completely identical, whereas the 2nd EGF and the 1st EGF 
have lower conservation rates (Fig. 2.18).  
 
In summary, the binding interfaces of the Netrin-Draxin interaction were mapped to a 
22 aa peptide in Draxin (231-252 aa) and to the 3rd EGF domain in Netrin. Both 
binding sites displayed high binding specificity. The 22 aa peptide in Draxin is highly 
conserved and can only be found in vertebrate Draxins. The 3rd EGF domain of Netrin 
is also highly conserved within γ-Netrins. 
 
Collectively, my binding-site mapping experiments show that the interaction 
interfaces of both proteins are highly conserved among vertebrate Draxin and γ-Netrin 
proteins, which supports the cross-species binding results observed in the Results, 
section 2.1 in this dissertation.  
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Figure 2.17 The 3rd Netrin EGF domain is highly conserved within Laminin-γ-chain 
derived Netrins 
Protein sequence alignment of the 3rd EGF domain from human and zebrafish Netrins. Dr, 
Danio rerio; Hs, Homo sapiens. 
 
 
 
 
 
Figure 2.18  Pair wise protein sequence alignment of individual EGF domains from 
human and zebrafish Netrins 
The amino acidic identity percentage is indicated. “\”: not tested.  
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2.3 Characterization of the Draxin-Netrin interaction in zebrafish 
embryos  
 
My results, so far, favor an inhibitory role of Draxin in the Netrin signaling pathway. 
These results include: a) the competition between Draxin and Netrin receptors for 
Netrin binding; b) the finding of conserved Draxin-Netrin interactions in both 
zebrafish and human; and c) the mapping of highly conserved binding regions in both 
proteins. These data suggests that Draxin operates as a Netrin antagonist by 
competing with Netrin receptors for Netrin binding in vertebrates.   
 
In order to test the above hypothesis in vivo, I asked the following questions:  
1) Does the protein-protein interaction between Draxin and Netrin occur in vivo?  
2) Where are the two genes expressed in the embryo? Are there potential 
co-expression regions for the two secreted proteins?  
3) Is it possible to detect the binding between Draxin and Netrin in situ? 
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2.3.1 In vivo detection of the Draxin-Netrin interaction in zebrafish 
embryos 
2.3.1.1 Establishing an in vivo binding assay 
To test whether Draxin and Netrin are able to bind to each other in vivo, I designed a 
novel in vivo binding assay (Fig. 2.19 A). This assay is based on the transient 
co-expression of fluorescently tagged proteins in zebrafish embryos. Draxin was 
fused to superfolder-GFP (Draxin-sfGFP), and Netrin1a was fused to either mCherry 
(Ntn1a-mCherry) or superfolder-GFP (Ntn1a-sfGFP). mRNAs encoding these fusion 
proteins were injected into one-cell stage zebrafish embryos. Upon translation, the 
tagged proteins were secreted to the extrocellular space, leaded by the endogenous 
signal peptide in the created constructs. The distribution of the corresponding 
fluorophore-tagged proteins was analyzed in zebrafish embryos at sphere stage (4 
hours post fertilization, hpf). At this developmental stage, the amount of extracellular 
space between cells is very large, and therefore, it is ideally suited for visualizing the 
localization of secreted proteins.   
2.3.1.2 Result of the in vivo binding analysis 
Following mRNA injection, the signal of Draxin-sfGFP was evenly distributed 
throughout the extracellular milieu of 4 hpf zebrafish embryos (Fig. 2.19 B-a, a’, a’’, 
imaging plane is indicated in Fig. 2.19 A). In contrast, the distribution of 
Netrin1a-sfGFP was restricted to cell surface domains (Fig. 2.19 B-b, b’ b’’). When 
draxin-sfGFP mRNA was co-injected with netrin1a-mCherry mRNA, Draxin-sfGFP 
proteins relocated to membrane densities composed of Netrin1a fusion proteins 
(co-localization is indicated by arrowheads in Fig. 2.19 B-c, c’, c’’). This indicates 
that local Netrin1a-mCherry proteins are able to capture diffusible Draxin-sfGFP 
proteins.  
In conclusion, exogenous mRNAs expression experiments show that Draxin and 
Netrin1a are able to interact with each other in vivo in zebrafish embryos.  
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Box 1: In vivo binding assay  (This method was adapted from Ries et al., 2009; Yu et al., 2009)  
 The tested mRNAs were injected into zebrafish embryos at one-cell stage.  
 
 The injected mRNAs were then translated into proteins in zebrafish embryos. The encoded secreted proteins distributed throughout the extracellular space.   
 Distinct fluorophores were fused to proteins of interest to visualize protein distribution. The co-localization of fluorophore signals indicates detailed co-expression, a hint of binding events.   
 Draxin and Netrin show different extracellular localization when separately expressed. This observation enables the analysis of binding events in vivo.    
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Figure 2.19  in vivo detection of the Draxin-Netrin interaction in zebrafish embryos 
(A) Design of the in vivo binding assay. mRNAs encoding the indicated 
fluorophore-tagged proteins were injected into one-cell stage zebrafish embryos and 
imaged at blastula stages (4 hpf). The imaging plane corresponds to a region 
approximately 15 μm beneath the enveloping layer (dorsalmost layer) of the embryos. (B) 
Single optical section confocal images of sphere stage embryos. (B-a) Embryos injected 
with 100 pg Draxin-sfGFP mRNA displayed uniform protein distribution in the extracellular 
space. (B-b) Injection of 100 pg Ntn1a-sfGFP mRNA resulted in dense membrane 
associated speckles positive for Ntn1a-sfGFP protein. In (B-a’) and (B-b’) membrane RFP 
(memRFP) was used to label the cell surface. (B-c) Upon co-injection of 200 pg 
Draxin-sfGFP mRNA and 200 pg of Ntn1a-mCherry mRNA, Draxin-sfGFP and 
Ntn1a-mCherry proteins co-localized into membrane associated foci (arrowheads). Scale 
bars: 10 μm; n = 7.  
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2.3.2 draxin and netrin gene expression analysis in zebrafish 
The functional importance of the Draxin-Netrin interaction strongly depends on 
whether and where the two proteins encounter each other in a living organism. Since 
there is no standard assay available to sensitively detect the endogenous binding 
events of secreted proteins in vivo, I first determined the expression of draxin mRNA 
by in situ hybridization. Subsquently, I performed double in situ hybridization 
detection of both draxin and netrin in the same embryo to identify potential regions of 
co-expression.  
 
 
 
 
Box 2: Whole mount in situ hybridization in zebrafish embryos 
  
 In Situ Hybridization (ISH) is a method that detects mRNA expression. Main steps include: 1) Generation of antisense RNA probes  2) Hybridization of RNA probes to endogenous mRNA in fixed zebrafish embryos 3) Detection of hybridized RNA probes in zebrafish embryos  
 Fluorescence In Situ Hybridization (FISH) uses fluorescent substrates to visualize RNA probes. This method enables the detection of multiple gene expression domains using different fluorophores in the same specimen.    
 Double in situ hybridization was used in this study to detect the expression of draxin and netrin in the same embryo.   
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2.3.2.1 draxin mRNA expression analysis in zebrafish 
The spatial and temporal patterns of draxin mRNA were detected by whole mount in 
situ hybridization in zebrafish embryos (Fig. 2.20). draxin mRNA is expressed in a 
dynamic manner in the nervous system, the somites and the tail bud.    
In forebrain and hindbrain regions of 20 hpf embryos, the expression of draxin was 
detected in the telencephalon. Higher expression levels were detected in anterior and 
dorsal regions of the diencephalon as well as in the lateral hindbrain (Fig. 2.20 A and 
B). High expression within the diencephalon was associated with the post-optical 
commissure and the posterior commissure. At 24 hpf, there was strong expression 
along the border of telencephalon/diencephalon as well as in the lateral hindbrain (D 
and E). Strong expression was detected in these regions until at least 30 hpf (G and H). 
Starting from 48 hpf, the expression was restricted to the olfactory bulb in the 
telencephalon, and distinct regions within the hindbrain (J and K). By 76 hpf, strong 
expression was detected only in the regions of the olfactory bulb and lateral hindbrain 
(M and N).   
In the spinal cord, draxin displayed a dynamic expression pattern shown in the right 
panel of Figure 2.20. The spinal cord (SC) and the notochord (NC) are separated by a 
short bar indicating the boundary between the two regions. At 20 hpf, draxin was 
basically expressed throughout the entire spinal cord (Fig. 2.20 C). At 24 hpf, the 
ventral spinal cord expression diminished. From 30 hpf (Fig. 2.20 I) to at least 48 hpf 
(Fig. 2.20 L), the expression of draxin was detected only in the dorsal third of the 
spinal cord. Starting from 76 hpf, draxin expression in the spinal cord was below 
detection limit (Fig. 2.20 O).  
draxin expression was also detected in non-neuronal tissues. At 6.5 hpf, low levels of 
draxin mRNA were detected in the posterior part of the embryo. At segmentation 
stages (between 10.3 hpf and 24 hpf), strong draxin expression was detected along the 
trunk with the highest expression level located in the tail bud. In the embryonic trunk, 
draxin expression got restricted to posterior regions over time. At 24 hpf, 
non-neuronal expression was detected only in the tail bud.  
In summary, draxin mRNA was dynamically expressed in the nervous system and in 
non-neuronal tissues. Within the brain, it was mainly expressed in the telencephalon, 
in the anterior and dorsal diencephalon and in the lateral hindbrain. At 20 hpf, draxin 
was expressed uniformly throughout the spinal cord. draxin expression restricted to 
the dorsal spinal cord at about 30 hpf and disappeared before 76 hpf. During 
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segmentation stages, draxin was highly expressed in the tail bud.  
 
 
Figure 2.20  draxin mRNA expression in the CNS of zebrafish embryos 
draxin mRNA expression (blue) in the CNS was analyzed by whole mount NBT/BCIP in 
situ hybridization in zebrafish embryos from 20 hpf to 76 hpf. Lateral view of forebrain and 
hindbrain: A, D, G, J, M with anterior to the left, and dorsal to the top; dorsal view of 
forebrain and hindbrain of zebrafish heads: B, E, H, K, N with anterior to the left; lateral 
view of middle region of the spinal cord: C, F, I, L, O with anterior to the left and dorsal to 
the top. The small bars in the lateral view of the spinal cord panels showing the boundary 
between SC and NC. tel: telencephalon, di: diencephalon, FB: forebrain, MB: midbrain, 
HB: hindbrain, SC: spinal cord, NC: notochord.  
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2.3.2.2 Co-expression of draxin and netrin in zebrafish embryos 
draxin mRNA shows dynamic expression in the forebrain and hindbrain. Interestingly, 
netrin mRNA is known to be expressed in similar brain regions (Lauderdale et al., 
1997; Strähle et al., 1997). Thus, I wondered whether these two genes were 
co-expressed in certain regions of the brain.  
In order to detect potential co-expression domains, I performed double in situ 
hybridization experiments for both netrin and draxin mRNA. Zebrafish netrin1b was 
used in this experiment because it shares a largely overlapping expression pattern with 
netrin1a (Fig. 1.5 C and D, Lauderdale et al., 1997; Strähle et al., 1997). In addition, 
in order to examine the distribution of the mRNAs in relation to embryonic of axon 
tracts, I stained the embryos using anti acetylated tubulin antibodies, which labels the 
major axon tracts. I used 24 hpf embryos for the double in situ experiments, because 
major axon tracts are already founded at this stage (Fig. 1.2 A, Chitnis et al.,  1990; 
Kimmel, 1993; Ross et al., 1992).  
Figure 2.21 shows the double in situ results from single-plane confocal sections. 
Co-expression as well as adjacent expression of draxin and netrin1b mRNA was 
detected in forebrain regions of 24 hpf zebrafish embryos. Arrowheads indicate 
co-expression in Figure 2.21 a (dorsal view) and b (lateral view). The co-expression 
region located posteriorly to the postoptic commissure (POC), arrowheads in Figure 
2.21 a’and a’’. This region spreads dorsally in the forebrain and overlaps with the 
supraoptic tract (SOT), shown by arrowheads in Figure 2.21 b’ and b’’. The two 
mRNAs were also expressed in ventral regions of the hindbrain along the 
anterior-posterior axis.  
In summary, co-expression of draxin and netrin mRNA was detected in zebrafish 24 
hpf embryos. The co-expression regions partially overlap with the main axonal tracts, 
the postoptic commissure and the supraoptic tract in the forebrain.  
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Figure 2.21  Co-expression of draxin and netrin at axonal tracts in zebrafish 24 hpf 
embryos 
Whole mount double in situ hybridization of draxin (red) and netrin1b (green) mRNA in 
wild-type 24 hpf zebrafish embryos. The embryos were stained with an anti acetylated 
tubulin antibody (Acte-Tubulin, white), dorsal view (a-a’’, anterior to the left) and lateral 
view (b-b’’, anterior to the left and dorsal to the top). Arrowheads in (a) show 
co-expression of draxin and netrin1b mRNAs in the POC region (dorsal view). In (b), 
arrowheads show the co-expression in the SOT region (lateral view). tel: telencephalon; di: 
diencephalon; AC: Anterior Commissure, POC: Postoptic Commissure, TPOC: Tract of 
the Postoptic Commissure, SOT: Supraoptic Tract. Single plane confocal images were 
taken using 25X objective lens (Zeiss LSM 780 NLO confocal microscope); scale bar: 20 
μm. 
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2.3.3 Draxin-Netrin binding is detected in situ in zebrafish larvae 
2.3.3.1 Establishing an in situ protein detection assay             
In order to determine the distribution of secreted proteins in zebrafish embryos, a 
novel method for visualizing the expression pattern of Netrin protein was developed. 
From the previous competition assay (shown in Results, section 2.1.3 in this 
dissertation), I already obtained indications that Draxin bound to Netrin with high 
affinity. Thus, I fused a Netrin-binding fragment to a tag to generate an affinity probe 
for in vivo staining. I used the Draxin fragment 209-284 aa as the Netrin-binding 
probe (blue rectangle in Fig. 2.22 A), and the human IgG Fc (black ellipsoids in Fig. 
2.22 A) as tag. Human Fc tag can be detected by anti IgG antibody, thus, enabling the 
visualization of the distribution of proteins binding to the affinity probe (Fig. 2.22 A).   
Several key steps were optimized to conduct this in situ protein detection assay. I 
fixed the target protein in situ, while keeping the native binding epitope intact, which 
was required for binding. To do this, I kept the samples in paraformaldehyde for very 
short time prior to the staining and washed the sample quickly after the staining. The 
duration of the fixation and the balance between fixation and permeabilization are 
dependent on the target protein, while the duration of washing steps are dependent on 
the binding strength of the target protein and the probe. For these reasons, I 
experimentally modified the assay according to the stability of the binding partner and 
the probe used. I gently fixed zebrafish embryos (between 24 and 48 hpf) in a solution 
of 4 % PFA containing 1 % Triton X-100 for 5-10 minutes at room temperature. 
Longer fixation decreases the ability to detect bound proteins. I preformed quick 
washes between the staining and post-staining steps (3 minutes X 3 times). 
Short-washing can cause increased background staining, whereas excessive-washing 
can lead to loss of signal.  
I performed two sets of experiments to detect in situ Netrin distribution using the 
Draxin209-284aa -human Fc probe:  
1) Wild type fish embryos vs. Netrin-1 morphants in which the Netrin-1 protein levels 
were knocked down 
2) netrin1a mutant fish vs. siblings 
For both experiments, I chose 24 to 48 hpf zebrafish embryos because axonal fine 
tract mainly develop during this time.  
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2.3.3.2 In situ binding result 1: WT and morphant zebrafish larvae 
In wild type 48 hpf zebrafish embryos, I detected signal near floor plate cells using 
the Draxin209-284aa - hFc affinity probe (Fig. 2.22 B, arrowheads shown in a’’). The 
floor plate cells in the anterior hindbrain were labeled by the sonic hedgehog-GFP 
transgenic line (shh:GFP, Fig. 2.22 B, a’ and b’). Because floor plate cells are a known 
source for Netrin-1, I hypothesized that the signal detected by the Draxin209-284aa 
affinity probe corresponded to extracellular space localized Netrin-1 proteins.  
To test the above hypothesis, I injected morpholinos for zebrafish netrin-1 paralogs 
netrin1a and netrin1b, to knockdown both genes at the same time. Comparing the 
double-knockdown morphants to their WT siblings, the signal derived from the bound 
probe was barely detectable in the double-knockdown condition (Fig. 2.22 b, b’ and 
b’’). This indicates that the Draxin209-284aa affinity probe indeed detected Netrin-1 
proteins.  
Figure 2.23 shows the details of Netrin proteins detected by the Draxin209-284aa probe 
in 33 hpf WT embryos. An anti-VasnA antibody shows the membrane outline of floor 
plate cells (Paolo Panza et al., in preparation). The dashed box in Figure 2.23 (a) and 
(b) indicates the region which is scaled up in (c)-(c’’) and (d)-(d’). I used the most 
anterior region of the notochord as a reference location in the lateral views (the star in 
(b), (d) and (d’’)). The signal was detected in both dorsal and ventral regions of the 
single layer of floor plate cells (arrowheads in Fig. 2.23 (d), same location in (d’’)) as 
well as membrane associated densities at the dorsal tip of these cells (arrowhead in 
Fig. 2.23 (c) and (d)). This subcellular localization of Netrin1a protein confirmed the 
observation from Netrin1a overexpression experiments in Results, section 2.3.1 of 
this dissertation (Fig. 2.19). Both experiments show that Netrin proteins localized to 
membrane associated densities. In a middle coronal optical section, the floor plate 
lateral domains of the mindbrain were also highlighted (right two arrowheads in Fig. 
2.23 (c)).  
 
In sum, the results from the binding experiments using a Draxin209-284aa affinity probe 
provide strong evidence that Draxin and Netrin-1 are able to interact in situ in 
zebrafish embryos.  
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Figure 2.22  In situ detection of the Draxin-Netrin interaction in zebrafish larvae 
using an affinity probe 
(A) Schematic illustration of the experimental design of in situ detection of protein 
interactions. A Draxin fragment (209-284 aa, indicated by the blue rectangle) was fused to 
the human IgG protein Fc domain (indicated by the black ellipsoids). The fusion protein 
was generated in HEK293-6E cells as a probe to detect endogenous Netrins in zebrafish 
embryos. Mildly fixed embryos were incubated with the affinity probe. (B) Representative 
microscope images of a single confocal section (at confocal z-stacks of 10 μm in depth) 
showing the floor plate region of the anterior hindbrain (dorsal view, anterior to the left). 
The signal from the Draxin 209-284aa-Fc fusion probe is detectable in the floor plate 
region of 48 hpf WT embryos (B-a’’, arrowheads), but it it is strongly reduced or absent in 
netrin1a and netrin1b double-knockdown embryos (B-b’’). A shh:GFP transgenic line was 
used to visualize floor plate cells (B-a’, B-b’). Scale bar: 20 μm, n > 10 in two independent 
experiments.  
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Figure 2.23  Detailed representation of Netrin distributions detected by the 
Draxin-Fc probe in zebrafish embryos 
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2.3.3.3 In situ binding result 2: netrin1a mutant larvae 
Since the Draxin-binding-site mapped to the 3rd EGF domain in Netrin (Fig. 2.15), I 
asked whether the Draxin-Netrin interaction detected in vivo indeed requires the 3rd 
EGF domain in Netrin. A netrin1a mutant fish line, netrin1a SA12269, was obtained 
from the Sanger Institute Zebrafish Mutant Project (Kettleborough et al., 2013) for 
this purpose. The netrin1a SA12269 locus contains a premature nonsense mutation in the 
first half of the 3rd EGF domain (415Cys to stop) that leads to a protein truncation. 
The 3rd EGF domain is therefore, non functioned in the heterozegous mutants (Fig. 
2.24).   
I stained homozygous mutants and WT siblings from the netrin1a SA12269 fish line 
using a Draxin209-284aa - Fc probe to detect endogenous Netrin. In addition, I injected a 
morpholino for netrin1b, to obtain all combinations of netrin-1 gene expression (e.g. 
netrin1a + netrin1b, netrin1a only, and netrin1b only). This allowed me to uncover 
which netrin-1 gene, netrin1a and/or netrin1b, was the source of the floor plate 
located Netrin.   
 
 
 
 
Figure 2.23 (preceding page) Detailed representation of Netrin distributions 
detected by the Draxin-Fc probe in zebrafish larvae  
Representative microscope images showing the floor plate region of whole mount 
zebrafish larvae stained with the Draxin 209-284aa -Fc fusion protein and a VasnA antibody 
(figure a, c, c’ and c’’: dorsal view, figure b, d, d’ and d’’: lateral view, anterior to the left, 33 
hpf). The anti-VasnA antibody outlines the membrane of floor plate cells. Signal was 
detected at both dorsal and ventral regions of floor plate (arrowheads in d, same location 
in d’’) with membrane associated densities at the dorsal tip of the cells (arrowhead in c 
and d). At the middle coronal optical section, The floor plate cells lateral domains of the 
hindbrain were also highlighted (right two arrowheads in c). oe: olfactory epithelium, ov: 
olfactory vesicle, FB: forebrain, MB: midbrain, HB: hindbrain, FP: floor plate, NC: 
notochord, S: somite. Astrisks label the most anterior region of the notochord which was 
used as the reference location in b, d and d’’. The dashed box in a and b indicates the 
region which is scaled up in c-c’’ and d-d’’. Single plane confocal images were taken using 
10X (a and b) and 40X ((c and d)) objective lens of a Zeiss LSM 780 NLO confocal 
microscope; scale bar: 100 μm in a and b, 20 μm in c and d.   
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It is known from mRNA expression data that netrin1a but not netrin1b is expressed in 
the ventral eye region (Lauderdale et al., 1997; Park et al., 2005). Figure 2.25 shows 
signal from the Draxin209-284aa affinity probe in the ventral retina of WT sibling fish 
(arrowheads) but not in netrin1a SA12269 fish. The signal was not correlated to netrin1b 
knockdown. This result confirms that the protein detected in the ventral retina is 
Netrin1a in WT animals. Furthermore, the absence of signal in netrin1a SA12269 fish 
indicates that the 3rd EGF domain (lacking in the mutant Netrin1a protein) is indeed 
required for in situ detection of Netrin by the Draxin 209-284aa affinity probe. 
Figure 2.26 shows signal near the hindbrain floor plate. As opposed to the expression 
pattern in the ventral retina, strong signal in the floor plate was detected in both WT 
siblings and netrin1a SA12269 mutant fish (arrowheads), but not in the netrin1b 
knockdown condition. This indicates that Netrin1b is probably the major source of 
Netrin protein in the floor plate region.   
 
In conclusion, these experiments show that the 3rd EGF domain is required for in situ 
binding of endogenous Netrin-1 to the Draxin 209-284aa probe in the ventral retina. In 
addition, Netrin1a is the source of the Netrin proteins detected in the optic region, 
whereas Netrin1b is most likely the major source of Netrin localized to floor plate 
cells. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.24  Netrin1a mutant allele: netrin1aSA12269 
Left panel: the netrin1a SA12269 locus contains a premature stop codon in the first half of the 
3rd EGF domain (415Cys to stop). Right panel: genotyping results from WT and 
homozygous mutant fish. 
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Figure 2.25  The 3rd EGF domain in Netrin1a is required for in situ detection of  
Netrin by the Draxin 209-284aa affinity probe 
Representative microscope images show that the Draxin 209-284aa affinity probe detected 
Netrin protein in ventral retina in WT (arrowheads) but not in netrin1aSA12269 homozygous 
mutant fish. The signal was not affected in netrin1b knockdown fish. Lateral view of eyes 
from 33 hpf zebrafish. Anterior left, dorsal up. Single plane confocal images were taken 
using 25X objective lens and a Zeiss LSM 780 NLO confocal microscope.   
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Figure 2.26  Netrin1b but not Netrin1a is highly concentrated in the region of the 
zebrafish floor plate  
Representative microscope images show that the Draxin 209-284aa-Fc probe detected Netrin 
in close association with the floor plate. High levels of signal were detected only in 
uninjected embryos (arrowheads in a, a’’ for WT siblings, b and b’’ for netrin1aSA12269 
homozygous mutant fish). An Anti-VasnA antibody outlines the membrane of floor plate 
cells. Lateral view of the hindbrain floor plate from 33 hpf zebrafish; anterior to the left, 
dorsal to the top. FP: floor plate, NC: notochord. An asterisk labels the most anterior 
region of the notochord which was used as the reference location. Single plane confocal 
images were obtained using 25X objective lens and a Zeiss LSM 780 NLO confocal 
microscope; scale bar: 20 μm.  
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Chapter 3 
Discussion 
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3.1 Draxin as a Netrin antagonist  
The goal of this study was to discover new players in neural wiring and to explore 
their working mechanism. Here, I focused on the Netrin signaling system, which is 
fundamentally involved in the development of the nervous system. Specifically, the 
aim of this dissertation is to test the function of Draxin, a new binding partner of 
Netrin, in Netrin signaling during axon pathfinding decisions. 
Using biochemical approaches, I detected direct binding between Draxin and Netrin 
proteins from distinct vertebrate species. I determined how the interaction is able to 
affect Netrin signaling and showed that Draxin is able to compete with Netrin 
receptors for binding to Netrin-1. Furthermore, I was able to map the interaction 
interface to a highly conserved short peptide in Draxin and the 3rd EGF domain of 
Netrin. The interaction was also detected in vivo using two embryonic assays. Thus, I 
propose the hypothesis in which Draxin can serve as an antagonist in netrin signaling. 
In this chapter, I mainly discuss the in vitro and in vivo evidence for this inhibitory 
hypothesis.  
 
3.1.1 Inhibitory hypothesis 
The Netrin family comprises canonical secreted axon guidance cues important for the 
wiring of nervous systems. Distinct Netrins and Netrin receptors have been identified 
to carry out the guidance function. However, no direct Netrin modulator has been 
described yet. Notably, Draxin was found as a “chemorepulsive axon guidance 
molecule” (Islam et al., 2009). The current understanding is that Draxin functions as a 
repulsive ligand in axon guidance. Scientists were searching for its endogenous 
receptors that might carry out the repulsive guidance function (Ahmed et al., 2011).  
In my experiments, I observed that Draxin directly binds to several zebrafish Netrin 
family members. These interactions were also observed using orthologous human 
proteins (Fig. 2.1 and Fig. 2.2). The interactions between Netrins and Draxins linked 
the two known signaling systems, thus providing a hint towards a potential inhibitory 
function of Draxin.  
Here, I propose the inhibitory hypothesis: Draxin might modulate Netrin signaling, 
the physical interaction between Draxin and Netrin might block or modify Netrin’s 
ability to interact with its receptors (Fig. 3.1). 
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Figure 3.1  Inhibitory hypothesis for Draxin by direct binding to Netrin  
(A) and (B), the activation of Netrin signaling is highly dependent on the presence of 
Netrins. (C), Draxin might function in Netrin signaling by directly binding to the ligand 
Netrin. The binding blocks or modifies Netrin’s ability to interact with its receptors. Dra: 
Draxin 
 
This hypothesis is strongly supported by results of my in vitro binding experiments 
and the competition assay. Besides the detection of direct binding between Draxin and 
Netrin, I observed no binding of Draxin to Netrin receptors using our assays (Fig. 2.4 
and Fig.2.9). These experiments do not support the model that Draxin functions 
directly through Netrin receptors. There still was the possibility that Draxin, Netrin 
and the Netrin receptor form a complex, especially if Netrin shares different binding 
sites with Draxin and Netrin receptors. However, my results from the competition 
assay showed that the tagged Draxin is able to outcompete Netrin receptors for Netrin 
binding (Fig. 2.6 and Fig. 2.7). Also, the binding-sites mapping experiments showed 
that the Draxin binding site in Netrin is within the 3rd EGF domain (Fig. 2.15), which 
is the known binding site for Netrin to the Netrin receptors DCC and Neo1 (Finci et 
al., 2014; Xu et al., 2014). These data show that Netrin shares the same binding site 
with the Netrin receptors and Draxin, thus a ternary complex containing the three 
proteins through Netrin is unlikely to form. Hence, the proposed inhibitory hypothesis 
shown in Figure 3.1 most likely describes how Draxin works in Netrin signaling 
system inlight of the current results. 
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3.1.2 Zebrafish and human binding networks of Draxins, Netrins, 
and Netrin receptors 
Based on the obtained binding data by AVEXIS for Draxins, Netrins and the Netrin 
receptors (Fig. 2.1, Fig. 2.2 and Fig. 2.4 in this dissertation), I summarized the binding 
networks for both zebrafish and human proteins in Figure 3.2.  
In these binding networks, binding is detectable for both zebrafish and human 
Netrin-1 to the Netrin receptors DCC and UNC5s. This confirmed the previous 
observations from mammalian Netrin family members (Keino-Masu et al., 1996; 
Leonardo et al., 1997; Haddick et al., 2014). Both zebrafish and human Draxin 
proteins bound to laminin γ-chain derived Netrins (zebrafish and human Netrin-1, 
human Netrin-3), but not to other Netrin family members. No interactions were 
observed between Draxins and all the tested Netrin receptors.  
 
 
 
Figure 3.2  Summary of the Draxin-Netrin-Netrin receptor binding networks 
determined by AVEXIS 
Zebrafish (A) and human (B) Draxin-Netrin-Netrin receptor binding networks summarized 
from Fig. 2.1, Fig. 2.2 and Fig. 2.4. Lines indicate binding. Zebrafish Draxin paralog is 
si:dkey-1c11.1, Dcc: Netrin receptor deleted in colorectal cancer; Neo1: Netrin receptor 
neogenin. 
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How to explain the different connections compared to a previous report?  
A previous study claimed that Draxin directly bind to multiple Netrin receptors 
including DCC, Neogenin, Unc5s and DSCAM (Ahmed et al., 2011). This binding 
network was based on cell overlay assays as well as pull-down assays. The authors 
therefore concluded that the Netrin receptors are the missing receptors for Draxin.  
How to explain the different connectivity within binding networks? These differences 
could be due to the different assay systems used in the two studies. AVEXIS detects 
direct interactions between bait and prey proteins. On the contrary, cell based assay 
and pull-down assays are prone to detect also indirect binding events. These indirect 
events might be caused by either a natural complex or a nearest neighbor effect such 
as interactions mediated by cell surface heparan sulfate proteoglycans. In fact, all 
individual partners, Draxin, DCC and Netrin-1 are able to bind to heparin (Bennett et 
al., 1997; Chen et al., 2013; Matsumoto et al., 2007). These facts might support an 
indirect binding possibility.  
Clearly, there are several lines of evidence supporting that Draxin is not able to bind 
to the Netrin receptors. Direct binding between Draxin and DCC was not detectable 
by the SPR method (Haddick et al., 2014). Our group obtained similar results using 
the same assay (Fig. 2.9). SPR is the current golden-standard method to obtain kinetic 
data from direct binding events. The failure of detecting direct binding between 
Draxin and Netrin receptors therefore offers a strong argument against Netrin 
receptors serving also as Draxin receptors. Moreover, in my competition assay, I 
observed that Draxin is able to outcompete Netrin receptors for Netrin binding. This 
would not be the case if Draxin was able to directly bind to Netrin receptors. 
Furthermore, the binding of Draxin to Netrin is also detectable using in vivo assays 
(Fig. 2.19 and Fig. 2.22). All of my data suggest that Draxin is not able to bind to 
Netrin receptors.  
New findings in the Netrin binding networks 
Besides the interaction between Draxin and Netrin, there are other interesting findings 
in the Netrin-Netrin receptor binding networks in this study. The majority of the 
Netrin family members were identified through homology based searches, and most 
of the ligand-receptor pairs were assumed from either orthologous fruit fly or rodent 
interactions, frequently not supported by direct binding evidence. Often, the 
functional interpretation of a detected phenotype was only based on expression data 
and binding assumptions. In this study, the ligand-receptor binding networks in Figure 
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3.2 summarized from results obtained by AVEXIS, provide direct binding evidence.   
New findings from the Netrin-Netrin receptor binding networks: 
1) DCC and Unc5 family Netrin receptors did not bind to Netrin-4, Netrin-G1 and 
Netrin-G2 both in zebrafish and human. This confirms that Netrin-4 and Netrin-G 
family members have their own receptors (Schneiders et al., 2007; Lin et al., 2003) 
and further illustrates that Netrin-1 does not share known receptors with Netrin4 and 
Netrin-G family members. 
2) Receptors for Netrin1a are also the receptors for Netrin1b in zebrafish. Although 
the two zebrafish Netrin-1 paralogs—Netrin1a and Netrin1b—share over 88 % 
protein sequence identity (Lauderdale et al., 1998), this is the first experimental 
evidence showing that zebrafish Dcc, Unc5b and Neo1 serve as receptors for both 
Netrin1a and Netrin1b. It raises the possibility that Netrin1a and Netrin1b share a 
redundant function in regions of co-expression.  
3) Homo- and heterotypic- interactions were detected with zebrafish Netrin1a and 
Netrin1b. In addition, I also observed a very weak homotypic interaction for human 
Netrin-1 (see Fig. 3.2 for the binding value). This could be explained by a possible 
dimerization of the Netrin-1 protein (Xu et al., 2014).   
4) Surprisingly, using AVEXIS, human DCC and Unc5b did not bind to human 
Netrin-3. This is not in line with a previous study using the mouse Netrin-3 homolog 
(Fig. 7-8 in Wang et al.,1999). In that study, mouse Netrin-3 bound to rat DCC, Neo 
and Unc5s as well as mouse Unc5H3 in a cell based assay. Although cell based assays 
tend to detect indirect interactions, I cannot exclude the possibility that the protein 
levels of human Netrin-3 were not high enough for the detection in my AVEXIS 
experiments. This is because the binding value observed for Draxin, the only positive 
binding partner, was not high. Thus, these results need further validation.   
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3.1.3 Kinetic binding data of the Draxin-Netrin interaction indicates 
biological relevance 
The binding strength of an inhibitor to its target ligand needs to be strong in order to 
outcompete the interactions of the ligand to its endogenous receptors. The kinetic data 
obtained in SPR experiments show that the binding strength between Draxin and 
Netrin is in the low nM range. A similar binding strength had been reported for the 
Netrin-DCC and Netrin-Unc5b interactions (Keino-Masu et al., 1996; Leonardo et al., 
1997). In addition, the Draxin vs. Netrin receptor competition experiments showed 
that the applied Draxin concentrations are of biological relevance. Figure 2.7 shows 
50 % inhibition of the Netrin1a-Unc5b interaction by Draxin occurs around 10 nM, 
and 50 % inhibition of the Netrin1a-Dcc interaction occurs around 50 nM. This is 
consistent with a biologically relevant role in vivo.  
The different inhibition efficiencies of Draxin towards DCC, Unc5b and Neo1 
probably reflects the distinct binding strengths of Netrin to these receptors. The 
competition curve is different from a binding curve: the effect of the competition is 
not only depending on the affinity of the inhibitor to the ligand, it is also highly 
related to the binding strength of the ligand to the corresponding receptor:  
 
                 (A: Netrin, B: Netrin receptors, C: Draxin) 
 
It is possible that different ligand-receptor pairs require different inhibitor 
concentrations to break the interactions. Most likely, the Netrin-Unc5b interaction is 
more sensitive to the Draxin concentration than the Netrin-DCC or Netrin-Neo1 
interactions.  
 
3.1.4 Proposed working model based on in vitro experiments 
From the competition experiments and the binding site mapping experiments 
performed in this study, I propose a working model which is presented in Figure 3.3. 
By directly binding to Netrin-1, Draxin competes with Netrin receptors for Netrin 
binding. The binding interfaces were narrowed down to a highly conserved 22 aa 
fragment in Draxin and the 3rd EGF domain in Netrin-1. This suggests that Draxin 
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functions as an extracellular Netrin signaling modulator in vertebrates.  
 
Interestingly, recent Netrin-1/Netrin receptor structural studies (Finci et al., 2014; Xu 
et al., 2014) showed that the 3rd EGF domain in Netrin-1, which I identified as the 
Draxin-binding-domain, is also crucial for Netrin receptor binding. This indicates that 
Draxin and Netrin receptors are competing for the same binding site in Netrin-1, 
offering a mechanistic understanding for the proposed working model. 
 
 
 
 
 
 
Figure 3.3  Working model of Draxin’s function in Netrin signaling 
By directly binding to Netrin-1, Draxin competes with Netrin receptors for Netrin binding. The 
binding interfaces between Draxin and Netirn were narrowed down to a highly conserved 22 aa 
fragment in Draxin and the 3rd EGF domain in Netrin-1. 
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3.1.5 Different expression patterns of zebrafish nerin1a and netrin1b  
The two zebrafish netrin-1 genes, netrin1a and netrin1b, are mainly expressed in 
ventral regions of the CNS in early zerbafish embryos, but they have slightly different 
expression patterns in the eyes, spinal cord and floor plate.  
In the developing eyes, zebrafish netrin1a mRNA is expressed in the ventral optic 
stalk at 18 hpf, the expression is maintained in the ventral retina at the optic fissure 
through 32 hpf (Lauderdale et al., 1997). netrin1b mRNA, on the other hand, although 
highly expressed in the forebrain, is not detectable in the eyes (Stähle et al., 1997; 
Park et al., 2005). Protein expression at 33 hpf, as detected by a Netrin affinity probe 
shows Netrin protein in the ventral retina of WT fish and netrin1b morphants but not 
in netrin1a SA12269 homozygous mutant fish (Fig. 2.23). These findings support the 
idea proposed from a mouse study on Netrin-1 (Deiner et al., 1997), suggesting that 
the zebrafish retinal ganglion neurons use Netrin1a to exit the eyecup but not 
Netrin1b.   
In the trunk, zebrafish netrin1a is expressed in the ventral one third to half of the 
spinal cord from 15 hpf till at least 30 hpf whereas netrin1b is only strongly expressed 
in floor plate cells (Lauderdale et al., 1997; Lauderdale et al., 1998; Stähle et al., 
1997). The different expression patterns are supported by in vivo binding experiments 
in this study. Figure 2.26 shows that only Netrin1b but not Netrin1a protein is 
detectable at floor plate region. 
Altogether, the different expression patterns of zebrafish netrin1a and netrin1b 
suggest that the two paralogous genes have separate functions although they share the 
same set of receptors. Furthermore, the expressions of netrin1a and netirn1b are 
differently regulated by hedgehog genes (Lauderdale et al., 1998), supporting that the 
two genes have diverged and gained independent new functions.  
 
Interestingly, the two zebrafish netrin-1 genes share comparable expression patterns 
with two chick netrin genes in the spinal cord. The zebrafish netrin1a is expressed in 
the ventral half of the spinal cord, which is similar to the chick netrin-2. Likewise, the 
zebrafish netrin1b is extensively expressed in the floor plate region just like the chick 
netrin-1 (Kennedy et al., 1994; Wang et al., 1999). It is reasonable to hypothesize that 
zebrafish netrin1b shares similar functions with chick netrin-1, while zebrafish 
netrin1a is functional comparable to chick netrin-2.   
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3.1.6 Potential co-expression regions of Draxin and Netrin proteins 
To interact in vivo, Draxin and Netrin proteins need to encounter each other in the 
embryo. Although there is no direct evidence showing that the two proteins meet in 
vivo, the mRNA expression data shown in this study as well as Netrin mRNA and 
protein expression data shown in previous studies (Serafini et al., 1996; Kennedy et 
al., 2006) strongly indicate that both secreted molecules encounter each other mainly 
in the nervous system. In the following chapter, I discuss about the potential 
co-localization regions of draxin and netrin in vertebrates.    
 
mRNA co-expression and adjacent expression regions 
I) Nervous system 
 Forebrain and forebrain axon tracts 
In zebrafish, draxin and netrin are co-expressed in the ventral anterior diencephalon 
in 24 hpf embryos. The co-expression regions are overlapping with the major axonal 
tracts POC and SOT. In addition, adjacent expression regions are found in the 
forebrain: draxin is expressed along the border of the telencephalon, overlapping with 
the main forebrain commissure—AC whereas netrin1a and netrin1b are both 
expressed adjacently to the AC. Also, draxin and netrin1a are expressed adjacently in 
the dorsal diencephalon between the axon tracts of the DVDT and the PC (Fig. 2.20 
and Fig. 2.21 in this dissertation). In mouse, both draxin and netrin-1 are expressed in 
the regions of the forebrain commissures AC, CC and HC within E14.5 ± 2 embryos 
(Islam et al., 2009; Serafini et al., 1996). These adjacent and overlapping expression 
domains suggest a collaborated function between draxin and netrin in the formation 
of forebrain commissures in vertebrates.    
 Midbrain 
In zebrafish, draxin is expressed in the dorsal tectum with a lateral-ventral extension 
towards one third depth of the midbrain in 24 hpf embryos. On the other hand, 
netrin1a is expressed throughout two thirds of the ventral midbrain with the highest 
expression region around the ventral midline (compare transverse sections in Fig. 1.5 
K and Fig. 1.7 I in the introduction chapters). draxin and netrin1a show adjacent 
expression in the zebrafish midbrain.   
 Hindbrain 
In zebrafish, the two genes show strong expression regions located adjacently within 
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24 hpf embryos (compare transverse sections in Fig. 1.5 L and Fig. 1.7 J). It is also 
possible that the two genes are co-expressed in lateral parts of the hindbrain from 24 
hpf to 30 hpf. The adjacent strong expression domains in the hindbrain indicate a 
potential interaction of the two proteins along the expression boundary. In addition, 
overlapping region of draxin with netrin-2 in dorsal hindbrain are assumed from 36 
hpf to at least 72 hpf (compare Fig. 1.5 in this dessertation with Fig. 2M,Q,T,N,R,U in 
Park et al., 2005).   
 Spinal cord 
In zebrafish, both draxin and netrin1a show dynamic expression patterns, and the 
encoded proteins are likely to meet each other in the spinal cord between 20 hpf and 
48 hpf. draxin is expressed through out almost the entire spinal cord and netrin 1a and 
1b are strongly expressed in the ventral spinal cord in 24 hpf embryos. (compare Fig. 
1.5 C, D, M with Fig. 1.7 C, D, K in this study). At 30 hpf, draxin is expressed more 
dorsally and netrin1a expressed more ventrally with gradients towards each other. 
This dorsal-ventral expression in the spinal cord was also described in chick. In 15-19 
stage chick embryos, draxin is expressed dorsally and the expression of netrin-2 
spands the ventral two thirds of the spinal cord. Similar expression patterns were also 
observed in mice at E10.5 for draxin and netrin-1 (Islam et al., 2009; Kennedy et al., 
1994, Kennedy et al., 2006; Wang et al., 1999).   
 Olfactory bulb   
In zebrafish, draxin is strongly expressed in the ventral telencephalon at 30 hpf, 
intensive expression is visible in the olfactory bulb between 48 hpf until and 76 hpf. 
netrin1a is expressed at the telencephalic midline and netrin1b in the ventral part of 
the olfactory bulb at 27 to 53 hpf. Thus, draxin and netrins are probably partially 
co-expressed in the olfactory bulb and adjacently expressed between the border of the 
peripheral olfactory organs and the olfactory bulb at the time period when the 
olfactory axons are navigating to and extending into the central regions of the 
olfactory bulb (Fig. 1.5 in this study and Fig. 2 in Lakhina et al., 2012). In rat, 
netrin-1 is mainly expressed in the peripheral olfactory system on the road where the 
olfactory axons extend to the olfactory bulb, similar to netrin-1 expression in 
zebrafish (Astic et al., 2002).  
 Eye 
netrin-1 is expressed in the ventral retina, it is suggested to guide the optic nerve grow 
out of the retina in the mouse system (Deiner et al., 1997). In zebrafish, netrin1a 
expression is surrounding the optic fissure at 24 hpf, similar to the expression in 
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mouse. Notably, in the same embryonic stages, draxin is expressed in the ventral 
retina dorsal, adjacent to the optic fissure (Miyake et al., 2012).  
II)  Non neuronal tissues 
 Somites 
draxin is highly expressed in somites both in zebrafish (11-24 hpf) and chick (stage 
15). Strikingly, both zebrafish and chick netrins are expressed in large areas in the 
somites (Hale et al., 2011; Lauderdale et al., 1997; Kennedy et al., 1994 and Wang et 
al., 1999).   
 
Potential protein co-expression regions   
The Draxin and Netrin proteins have the ability to meet each other in vivo. Although 
gradients from secreted proteins are not easy to detect, there is evidence for the 
protein distribution of Draxin and Netrin in the spinal cord. Draxin protein is highly 
diffusible in stage 19 chick embryos. It is distributed along the basement membrane 
from the dorsal top to the ventral half of the spinal cord. Similar distribution was 
detected for mouse Draxin in E10.5 and 11.5 mouse embryos (Islam et al., 2009). 
Comparably, in stage 17 chick embryos, Netrin-1 is detectable from its source—floor 
plate—to the ventral two thirds of the spinal cord. A similar protein gradient has been 
shown for E9.5 mouse embryos. In the mouse spinal cord, Netrin-1 was detected 
along the lateral basement membrane till almost the ventral three quarters height 
(Kennedy et al., 2006). Combined, these findings indicate that Draxin and Netrin 
proteins are likely to encounter each other in the middle of the spinal cord in chick 
and mouse embryos.  
 
Secreted proteins form diffusible gradients in vivo 
The above described protein distribution shows that both Draxin and Netrin proteins 
are highly diffusible in chick and mouse embryos. Both proteins have the ability to 
travel far away—half depth of the spinal cord—from their original secreting centers. 
A quantitative measurement showed that Netrin-1 protein was able to travel 250 μm 
in the chick spinal cord at stage 17 and 150 μm at stage 23, which is about 20 neural 
epithelial cells away from the source (Kennedy et al., 2006).  
Theoretically, how far a secreted protein is able to travel in vivo depends on the 
mobility of the protein and the surrounding extracellular space. A recent study on the 
formation of Fgf8 morphogen gradient showed that, two factors—“fast, free diffusion 
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of single molecules” and “a source-sink mechanism”—contribute to the formation of 
the Fgf8 gradient (Yu et al., 2009). Where exactly the two secreted proteins—Draxin 
and Netrin—meet in the native environment needs further studies.     
 
3.1.7 In vivo working model for the Draxin-Netrin interaction  
In vivo evidence for Draxin’s role in Netrin signaling 
Relevant in vivo data for Draxin and Netrin-1 already exist in the literature. Analysis 
of knockout mice and ectopic expression conditions in chick support the idea that 
Draxin is a Netrin signaling inhibitor. For example, disorganized “thick bundles of 
TAG-1 positive axons along the basement membrane” were observed in draxin 
knockout mice (Islam et al., 2009, Fig. 4B). This phenotype could be explained by 
Draxin mediated perturbation of the Netrin-1 activity gradient. Another example is 
that chicken Draxin has the ability to “disrupt the routing of commissural axons in 
vivo” when ectopically expressed in the chick spinal cord (Islam et al., 2009, Fig. 3 
and Fig. S5). Based on this data, the authors concluded that Draxin acts as "a 
repulsive guidance protein” (Islam et al., 2009) although this finding is also consistent 
with the idea that Draxin antagonizes Netrin-1’s attraction. Together, these studies 
provide compelling evidence showing that Draxin plays a role in Netrin signaling.   
 
Advantages of the biochemical approach to determine the working mechanism  
 
The key point of this study is to establish Draxin “as an anti-attractant operating 
directly on Netrin” rather than “a repulsive guidance ligand”. The biochemical 
approach used in this study focusing on the analysis of direct interactions between 
Draxin and Netrin is suitable to distinguish the two possibilities. In vivo experiments, 
although informative, are not the best choice to address this question. For example, 
the above-mentioned literature data show that Draxin loss-of-function and 
gain-of-function experiments in mouse and chick cause phenotypes of commissural 
axons, like axon growth, midline crossing and fasciculation defects. These defects are 
all reminiscent of Netrin-1 perturbations and the phenotypes suggest that Draxin is 
part of the Netrin signaling pathway. However, they cannot tease apart the different 
working models. In contrast, the biochemical data obtained in this study help to 
explain the observed in vivo phenotypes and clearly point to the possibility that 
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Draxin acts “as an anti-attractant operating directly on Netrin”.   
 
In vivo working model for the Draxin-Netrin interaction in the vertebrate spinal 
cord 
In the in vivo working model, the inhibitory hypothesis coming from the protein 
interaction data and the results obtained by competition assay were brought in line 
with gene expression data and the published Draxin and Netrin-1 in vivo phenotypes.   
Opposing gradients of secreted molecules are frequently observed in early embryonic 
axis patterning (Lee et al., 2006; Reversade & De Robertis, 2005; De Robertis, 2006). 
The embryonic dorsal-ventral patterning is mediated by reciprocal gradients which are 
formed by ventrally expressed BMPs and dorsally expressed chordin/noggin. Much 
alike, according to the gene expression locations, Draxin and Netrin-1 possibly form 
reciprocal protein gradients along the dorsal-ventral axis of the developing spinal cord 
in vertebrates (Fig. 3.4).  
 
 
 
 
 
 
 
 
 
Figure 3.4  In vivo working model for the Draxin-Netrin interaction in the vertebrate 
spinal cord 
Draxin and Netrin-1 possibly form reciprocal protein gradients along the dorsal-ventral 
axis of the developing spinal cord in vertebrates. 
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Results from this study show that by directly binding to Netrin, Draxin prevents the 
binding of Netrin to its receptors. Draxin acts as a Netrin antagonist thus shaping or 
sharpening the active Netrin-1 gradient in the spinal cord. The regions where free 
Netrin is available for efficient activation of Netrin receptors on the growing 
commissural neurons would shift to a more ventral position due to the Draxin’s 
antagonistic function of Netrin.  
 
A similar mechanism might operate in other brain regions, for example, in the 
olfactory bulb and midbrain-hindbrain regions where draxin and netrin show 
reciprocal expressions. In the regions of co-expression (e.g. places surrounding 
forebrain commissures), Draxin might shape the functional Netrin gradient by directly 
occupying Netrin proteins. The next step of this research is to test this opposing 
gradient mechanism in vivo within the mentioned potential regions.  
 
Last, because Draxin only exists in vertebrates, the regulation of Netrin by Draxin 
might be an invention of vertebrates.  
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3.2 Potential usage of the Netrin-binding-peptide in Netrin 
dependent cancer cells  
The Netrin-binding partner Draxin, and its 22 aa Netrin-binding-fragment discovered 
in this study have high potential medical value.  
Besides a crucial role in embryonic development, Netrin serves as a survival factor in 
tumor cells (Arakawa, 2004; Bernet and Fitamant, 2008; Mehlen et al., 2011). Several 
tumors have been reported to express Netrin-1 and Netrin receptors from the DCC 
and Unc5 families (Fitamant et al., 2008; Delloye-Bourgeois et al., 2009). These 
Netrin receptors were described as “dependence receptors” in response to death 
signals (Mehlen et al., 1998; Forcet et al., 2001; Llambi et al., 2001). Without bound 
Netrin, the cell surface receptors—DCC and Unc5—are able to activate Caspase 
signaling, which induces apoptosis, whereas in presence of Netrin, the Netrin 
receptors are unable to activate cell death thus resulting in survival of the cancer cells. 
Hence, in order to induce apoptosis in cancer cells (a clean way to “kill” the tumor), a 
potential therapeutic strategy is to disrupt the interaction between the survival factor 
(Netrin) and its receptors (DCC and Unc5s).  
So far, to disrupt Netrin-Netrin receptor interactions in cancer cells, the strategy is to 
capture Netrin by decoy receptors (Bernet & Fitamant, 2008). In previous studies, 
Netrin binding fragments of  DCC and Unc5B were used as a “decoy” to interfere 
with the binding of Netrin to Netrin receptors in cell lines; meanwhile, mouse models 
were made to facilitate the analysis (Fitamant et al., 2008; Delloye-Bourgeois et al., 
2009; Castets et al., 2012; Paradisi et al., 2013). This strategy is successful, although 
there seems to be a potential problem: a residual binding of Netrin to the full length 
receptor cannot be prevented, even using high concentrations of the receptor 
fragments. 
 
In my AVEXIS-based-competition experiment, Draxin or the Draxin protein fragment 
fused to the Fc protein were able to compete with Netrin receptors for Netrin binding. 
This offers a potential new strategy to interfere with Netrin-Netrin receptor 
interactions. The advantage of this strategy is that Draxin is able to completely 
outcompete Netrin receptors from Netrin binding at biological relevant concentrations 
according to the competition results.  
 
95 
 
As a further step, the Draxin competition effect in Netrin-Netrin receptor binding 
could be tested using cell-based assays. The effect of Draxin on the survival rate of 
cells using Netrin dependent tumor induction could serve as a clear cut functional 
read out.   
 
3.3 Novel methods developed in this study 
AVEXIS-based-competition assay 
A powerful assay developed in this work is the AVEXIS-based-competition assay (Fig. 
2.5). This assay is an ELISA-style binding assay suitable for measuring the inhibition 
effect. Using this assay, it is possible to calculate the inhibition kinetics IC50, which is 
the inhibitor concentration at half maximal inhibition of the “natural ligand”. This 
value reflects the inhibition effect of an inhibitor—answering the centre question in 
this study. 
The data from AVEXIS-based-competition assays are more quantitative than the data 
from the original AVEXIS assay. The variability (measured by standard deviation) 
normally is within 10 % in my experiments. Though the original AVEXIS has the 
difficulty to accurately quantify the absolute protein amount as a high-through put 
screen assay, the AVEXIS-based-competition assay, on the other hand, does not 
calculate the absolute binding value but the relative amount — % binding with and 
without inhibitor. This improves the original AVEXIS in terms of accuracy.  
Compared to other existent in vitro competition methods, such as immunoassay 
(another ELISA-type competition assay), or variations of DELFIA assay and alpha 
screens, the design concept of the AVEXIS-based-competition assay is simple and 
similar. The AVEXIS-based competition assay is low-technology oriented, without 
complicated post-experimental data analysis procedures. Like AVEXIS, it is suitable 
for studying extracellular proteins, might be a good choice for labs in which the 
AVEXIS assay is already established or labs specifically interested in extracellular 
proteins.   
 
In vivo detection of protein-protein interaction in zebrafish embryos 
The in vivo detection assay (Fig. 2.19 A) was developed along the establishment of 
the Fluorescence correlation spectroscopy (FCS) method, with the initial aim to detect 
96 
 
protein mobility in living animals. It is suitable to detect binding events in vivo, when 
the extracellular distributions of the tested proteins are distinct from each other. It is a 
simple qualitative experiment to determine whether a protein-protein interaction is 
able to occur in living animals.  
In contrast to other known methods allowing to detect in vivo protein binding, such as 
co-immunoprecipitation (Co-IP) or affinity-tag purification, the developed in vivo 
detection assay enables to visualize protein localization in the living cell/animal. 
Compared with yeast-two-hybrid or mammalian two-hybrid assays, the assay is 
suitable to study extracellular proteins. Since the signal is directly from the tagged 
protein of interest and not dependent on the amplification of the signal, further 
quantitative analysis is possible. Furthermore, compared with traditional in vivo 
protein binding assays such as split-GFP, FRET (fluorescence resonance energy 
transfer) or GRASP (GFP Reconstitution Across Synaptic Partners), the in vivo 
detection assay is relatively simple. It is based on the difference in localization of the 
proteins of interest visualized by fused fluorophores.  
In situ detection of secreted Netrin in zebrafish embryos  
The in situ Netrin detection assay (Fig. 2.22 A) is one of very few methods that enable 
the detection of Netrin proteins in vivo. This assay allowed for the first time to 
visualize Netrin protein in zebrafish.  
Methodologically, it is not easy to fix and detect secreted proteins in situ. That is 
because the secreted proteins are located outside the cells and can easily diffuse away 
from their original source during the antibody staining procedures. Although 
numerous evidence showed a gradient expression of netrin mRNA in chick and mouse, 
only one group managed to visualize the Netrin protein gradient using one set of 
antibodies with very careful adjustment of the fixation conditions and antigen epitope 
enhancement procedures (Kennedy et al., 2006).   
The Draxin209-284aa affinity probe is a good in vivo Netrin-binding probe in zebrafish. 
Full-length Draxin and the Draxin231-252aa probe, both bind to Netrin, but have more 
binding background under identical staining conditions. Using the developed protocol, 
the Draxin 209-284aa probe most likely only allows detecting high Netrin concentrations, 
eg. membrane associated Netrin in vivo. Further optimize of the staining protocol is 
required in order to detect the full-range Netrin gradient.  
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Chapter 4 
 Materials & Methods 
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4.1 Zebrafish embryological methods 
4.1.1 Zebrafish maintenance 
All zebrafish experiments were carried out in accordance to the regulations enacted by 
the state of Baden-Württemberg, Germany. Zebrafish were bred and maintained as 
previously described (Nüsslein-Volhard and Dahm, 2002). Adult fish were maintained 
with 14 hour-light, 10 hour-dark cycle at 28.5 degree. Eggs were collected in E3 
medium (5 mM NaCl, 17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, 10-5 % 
methylene blue) and raised until larval stage day 7.  
 
Fish lines for raising were disinfected between 10 hpf and 28 hpf. Embryos were 
treated in bleaching solution (380 µl/L 12% NaClO, Carl Roth 9062.3) for 5 minutes 
followed by 5 minutes wash in water and repeated twice. 10 μl pronase (30 mg/ml, 
Roche 11459643001) were added per Petri dish (30 ml volume) to easy the hatching. 
 
The following zebrafish (Danio rerio) strains were used in this study: Tübingen wild 
type, alb (albino), shh:GFP, netrin1a mutant allele sa12269 (Sanger Institute 
Zebrafish Mutation Resource). 
 
4.1.2 PTU treatment and Anasthesia 
To keep the transparency of embryos, 0.003 % 1-phenyl 2-thiourea (PTU, 
Sigma-Aldrich P7629) in E3 was applied to prevent melanisation of embryos before 
stage 24 hpf. Staging were according to previous description (Nüsslein-Volhard and 
Dahm, 2002). Embryos and adult fishes were anesthetized using 1: 10 to 1:100 
dilutions of 0.4% ethyl -m-aminobenzoate methanesulfonate (MESAB, 
Sigma-Aldrich A5040). Higher doses of MESAB were used to euthanize fish.  
 
4.1.3 Genotyping 
Preparation of fin-clip and single larval genomic DNA was preformed according to 
Nüsslein-Volhard and Dahm, 2002. Tissue was digested using either Proteinas K (1.7 
mg/ml) incubated at 55 °C for 240 minutes or NaOH (50 mM) incubated at 95 °C for 
20 minutes (Meeker et al., 2007).  
 
Primer OligST#1877 and #1880 (Table 4.1) and JumpStarttm REDTaq® DNA 
polymerase (Sigma-Aldrich P1107) were used for amplify the genomic DNA from 
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netrin1a sa12269 fish, following by the sequencing.  
 
4.1.4 Morpholino injection 
Knockdown of netrin1a and netrin1b were used to generate zebrafish embryos with 
reduced Netrin protein expression levels using morpholino antisense oligonucleotides 
(Gene-Tools). Morpholino oligonucleotides were injected into the yolk of one-cell 
stage embryos under a dissection microscope (Zeiss, Stemi 2000).  
Morpholino sequences and concentrations were used as described in Kastenhuber et 
al., 2009; Suli et al., 2006:  
netrin1a:  5′-ATGATGGACTTACCGACACATTCGT-3′ 
netrin1b:  5′-CGCACGTTACCAAAATCCTTATCAT-3′  
 
4.1.5 Whole-mount in situ hybridization 
Embryos were fixed overnight at 4 °C using 4 % formaldehyde (Thermo Scientific 
28908)/PBS followed by dehydrated with MeOH series. In the cases of using perodiase 
to visualize signals, the embryos were incubated within 3 % H2O2 for 20 minutes to 
inhibit endogenous peroxidase activity prior to the hybridization. Embryos were then 
rehydrated and digested with Proteinase K (10 μg/ml, Merck 1245680100). Different 
duration of proteinase K treatment was performanced according to the stages of the 
embryos.  
 
RNA probes encoding full length draxin and netrin1b were labeled with either 
Digoxigenin (DIG) or Fluorescein (Roche labeling kits). DIG-labeled probe was used 
for single mRNA detection. The DIG probe was detected with antibodies conjugated 
to alkaline phosphatase, and visualized with 4-nitro blue tetrazolium (NBT) and 
5-bromo-4-chloro-3-indoyl-phosphate (BCIP). The in situ hybridization was carried 
out within 50 % formamide (Sigma, F9037) following the description in 
Nüsslein-Volhard and Dahm, 2002. The double in situ hybridization was preformed 
as previously described (Clay and Ramakrishnan, 2005). DIG and Fluorescein labeled 
probes were amplified with antibodies conjugated to horseradish peroxidase (HRP), 
and visualized using Tyramide Signal Amplification (TSA) (Invitrogen T30953, 
T20912). Embryos were kept in 88 % Glycerol protected from light until they were 
mounted and photographed 
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4.1.6 Immunohistochemistry   
For the acetylated Tubulin antibody staining, embryos were fixed in 4 % PFA at 4 °C 
overnight. The samples were washed in PBS, dehydrated with MeOH series and 
stored at -20 °C in 100 % MeOH until used. Embryos were premeabilized in 
pre-chilled acetone for 5 min at -20 °C and washed with 100 % MeOH. Afterwards, 
embryos were rehydrated and washed 3 times with PBST (PBS containing 0.5 % 
Triton X-100, Sigma-Aldrich T8787). For embryos that were already performed in 
situ hybridization, previous steps were omitted. Embryos were then blocked in 10 % 
normal goat serum (NGS, Gibco PCN5000) in PBST for 3-6 hours at room 
temperature. Subsequently, primary antibody (mouse monoclonal anti-acetylated 
Tubulin, 1: 1000, Sigma-Aldrich T6793) was added within 1 % NGS/PBST. After an 
overnight incubation at 4 °C, the samples were then washed several times with PBST, 
and again blocked with 10 % NGS. The secondary antibodies were added at a 1: 250 
dilution, incubated at 4 °C overnight and protected from light. After several washes 
with PBST, the embryos were post-fixed with 4 % PFA for 20 min, washed again and 
kept in 88 % glycerol for imaging.  
 
4.1.7 In situ protein detection  
A Netrin binding fragment of Draxin (209-284 aa) fused to the Fc region of human 
IgG (Draxin 209-284 aa-hFc) was expressed in HEK293-6E cells and used as an 
affinity probe to detect binding partners in zebrafish embryos. Draxin 209-284 aa-hFc 
in situ staining was performed in embryos of WT, netrin1b morphant and 
netrin1a/netrin1b morphant.  
 
WT embryos (24 hpf and 48 hpf) were dechorionated by incubation in 0.1 mg/ml 
Pronase at RT for 1-2 h. Embryos were then prefixed for 10 min at RT in 4 % PFA 
containing 1 % Triton X-100. After one and half hours permeabilization with PBST 
(1 % Triton X-100), the embryos were blocked with 10 % NGS/PBST (0.1 % Triton) 
at RT for 1-3 hours. Afterwards, the embryos were stained with fresh made 
supernatant containing the Draxin-hFc fusion probe (with dilutions up to 1:3) 
overnight at 4 °C. Followed by 3 short washes (10 min in total (key step)), the 
embryos were post-fixed in 4 % PFA overnight at 4°C. After several washes in PBST 
(0.1 % Triton), the embryos were blocked with 10 % NGS for 3-6 hours at RT and 
subsequently incubated with a secondary antibody (goat anti human IgG Alexa Fluor 
488 or 568, Invitrogen, 1:250 dilution) overnight at 4 °C. After 3 washes in PBST 
(0.1 % Triton), the embryos were post-fixed for 20 min at RT, and mounted for 
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imaging. 
  
4.1.8 In vivo binding detection  
Constructs to express Draxin and Netrin1a fluorescent fusion proteins were generated 
using the Gateway cloning system (Kwan et al., 2007). To identify functional fusion 
constructs, the constructs were expressed and tested using AVEXIS (see table 4.1 for 
used primers and Method section 4.3 for AVEXIS pair wise binding assay). The 
following functional constructs were selected: Draxin-sfGFP, Ntn1a-sfGFP and 
Ntn1a-mCherry.  
 
Capped mRNAs for injection were in vitro synthesized using the mMessage 
mMachine Kit with T7 or SP6 RNA polymerase according to the manufacturer’s 
instructions.   
 
The injection was preforemed in dechorionated embryos. Embryos were 
dechorionated with pronase (1 mg/ml pronase, ca. 5 min). 1 nl mRNA were injected 
into the central of the zygote at 1-2 cell stage. Draxin-sfGFP or Ntn1a-sfGFP mRNAs 
(100 pg/embryo) were injected in combination with membrane-tagged RFP (memRFP, 
10-15 pg/embryo). Echo amount of Draxin-sfGFP and Ntn1a-mCherry (100-200 
pg/embryo) were injected for the combinations. After injection, embryos were 
cultured in agar coated dish at 28.5 °C.  A glass pipet was used to carefully move the 
embryos when necessary. At sphere stages (4 hpf), living embryos were immobilized 
in 1 % low-melting point agarose/E2 (NuSieve GTG Agarose, Lonza 50080) 
containing MESAB in glass-bottom Petri dishes (MatTek, P35G-1.5-14-C). Embryos 
were arragned with the animal pole facing the coverslip. A signle confocal section 
were taken, which a region corresponding to approximately 15 μm beneath the 
enveloping layer of the embryos.  
 
4.1.9 Image acquisition 
A digital AxioCam camera attached to a Zeiss Axioplan 2 microscope was used to 
take images of NBT-BCIP in situ hybridization. Zeiss LSM 510 Meta concocal 
microscope and Zeiss LSM 780 NLO confocal microscope were used to image 
samples from double in situ assay and in vivo binding assays.
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4.2 Molecular Methods 
4.2.1 Generation of AVEXIS constructs  
Total RNA were isolated from different stages of WT zebrafish embryos, and used to 
generate cDNA. These mixed-staged cDNA were used as templates to amplify DNA 
sequences encoding the ectodomain of proteins of interest by PCR using KOD 
polymerase. Human genes (DRAXIN, NTN-1, NTN-2, NTN-4, NTN-G1, NTN-G2, 
DCC and UNC5B) were amplified from human fetal brain cDNA (Agilent 
Technologies, 780606). DNA constructs were transferred to Zero Blunt II-TOPO 
vector for sequence verification and amplification. The right clones were used to 
generate AVEXIS expression vectors for both bait (CD4d3+4-bio 
(http://www.addgene.org/32402/) and prey form CD4d3+4-blac 
(http://www.addgene.org/32403/). To enhance the expression yield, Kozak sequence 
were included at N-terminus. Recognition sites for restrictive enzyme NotI 
(N-terminus) and AscI (C-terminus) were added to easy the the DNA transferring 
between different vectors. (Primers are listed in Table 4.1 and Kits are listed in Table 
4.3.) 
 
4.2.2 Generation of truncated and deleted proteins  
To generate truncated and deleted proteins, overlap extension PCR was used 
(http://en.wikipedia.org/wiki/Overlap_extension_polymerase_chain_reaction).  
Primers containing at least 24 bp overlapping were designed to connect the two parts 
of the sequences. Signal peptide sequences were always kept at N-terminus to ensure 
the expression of the protein. A 3-aa linker (G-A-P) was used to link between the 
signal peptide and subsequent peptide sequence unless otherwise specified.  
 
4.2.3 Generation of variations of AVEXIS vectors 
To express C-terminal his-tagged proteins, a new vector was generated from the AVEXIS bait 
vector. Biotinylation site in bait vector (Fig. 1.9) was replaced with the DNA sequence encoding 6 
X hisidine. The monomoeric prey vector used for binding site mapping was generated from 
AVEXIS prey vector. To this end, COMP domain (Fig. 1.9) was removed by overlap extension 
PCR. The vector for expressing Fc fusion proteins was also generated from the AVEXIS vector. A 
sequence encoding human IgG Fc fragment was replaced with a sequence encoding 
CD4+biotinylation site.  
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4.3 Biochemical Methods 
4.3.1 Bioinformatics analysis of proteins 
Protein features were analyzed by online bioinformatics’ tools:  
SMART: http://smart.embl-heidelberg.de/, for protein domain annotation 
SignalP 4.0 server: http://www.cbs.dtu.dk/services/SignalP-4.0, for signal-peptid 
prediction  
HHpred server from the Tuebingen Bioinformatics Toolkit: 
http://toolkit.tuebingen.mpg.de/, for homologous protein detection and 
protein structure prediction 
TMHMM v 2.0 server: http://www.cbs.dtu.dk/services/TMHMM/, for transmembrane 
domain analysis and GPI identification.  
NetNGlyc 1.0 server: http://www.cbs.dtu.dk/services/NetNGlyc/, for the prediction of 
protein-sugar binding regions 
 
4.3.2 His-tagged Protein purification  
His6-tagged-Draxin were purified using HisTrap HP kit (GE Healthcare, 71-5027-68 
AH) and followed the manufactory instructions. Purified proteins were kept at -80 °C 
until used.  
 
4.3.3 Recombinant protein production 
All recombinant proteins used for AVEXIS assays and in situ experiments were 
expressed in HEK293-6E cells via polyethylenimine (PEI) mediated transient 
transfections (Durocher et al., 2002). HEK293-6E cells were grown in FreeStyle 
medium (Gibco, 12338-018) supplemented with 1 % fetal bovine serum (FBS). The 
culture supernatants (20 ml-200 ml) containing the secreted recombinant proteins 
were collected 5-6 days post transfection. Bait protein supernatants were dialyzed in 
HEPES-buffered saline (HBS) pH 7.4 (140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 
mM MgCl2, 10 mM HEPES) to remove excessive free biotin. Both bait and prey 
containing supernatants were stored at 4 °C until they were used.  
 
4.3.4 AVEXIS (library screen) 
AVEXIS (library screen), AVEXIS pair wise binding assay and the AVEXIS-based 
competition assay were preformed as described (Bushell et al., 2008). Modifications 
are indicated in the following paragraphs. Table 4.4 lists the identity of proteins used 
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in the library screens.  
 
For all of the AVEXIS assays, streptavidin coated 96-well microtiter plates (Nunc, 
10143632) were incubated with 2 % BSA/HBS for 1 hour at RT to block unspecific 
bindings prior to the addition of samples. Concentrations of tested proteins were 
normalized, either by diluting or concentrating. To reduce background binding that 
were potentially mediated by glycosaminoglycan (GAG) conditioned cell culture 
medium was used for diluting. And Vivaspin®20 concentrators (10, 000 MWCO for 
bait proteins, 30, 000 MWCO for prey protein) were used for concentrating. 
Nitrocefin (Calbiochem, 484400; 50 μl, 100 μg/ml)—the colorimetric substrate—was 
added for visualizing the binding events. 486 nm absorbance reads were taken after 30 
min, 1, 2 and 3 hours incubation (RT) as well as overnight incubation at 4 °C using a 
μQuant spectrophotometer (Bio-Tek Instruments). Moreover, all plates were visually 
inspected to identify rare cases of false positive wells. Wells with no visual detectable 
substrate turnover (still yellow) but substantially increased absorbance values at 
486nm, usually caused by presence of small particles, were taken out.   
 
4.3.5 AVEXIS pair wise binding assay  
In the AVEXIS pair wise binding assay, Matn4 (Mann et al., 2004) was used as an 
internal control for normalizing captured prey proteins. So that, for each prey protein 
tested, an additional well containing Matn4 bait protein was added. 486 nm 
absorbance values that were 1.5 fold above background level were defined as positive 
interactions.  
 
4.3.6 AVEXIS-based competition assay 
In the AVEXIS-based competition assay, after bait protein immobilization, prey 
proteins were added together with indicated concentrations of potential inhibitors. The 
concentration of prey proteins was adjusted to values ensuring 2 to 5 fold signal over 
background values reached within 1-2 hours incubation at RT for the tested 
unchallenged interactions. Purified full-length His6-tagged Draxin fused to rat CD4 
(domain3+4), and Draxin-hFc (full-length Draxin-hFc, Draxin aa231-252-hFc, Draxin 
aa231-252-hFc) versions were used as the tested inhibitors. 
 
Concentrations of hFc proteins were normalized as following: MaxiSorpTM 96-well 
plates (Thermo, 442404) were incubated with hFc proteins overnight at 4 °C, 
including commercial human IgG (Calbiochem, 401104) as a reference. All of the hFc 
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proteins and the human IgG reference were diluted with suitable series. Fc protein 
sample coated plate was washed once with PBS and blocked with 0.5 % BSA/PBS for 
1 hour at RT. After blocking, the plate was washed twice with PBS and incubated with 
human IgG antibody conjugated with alkaline phosphatase (Sigma-Aldrich A9544) 
diluted 1:2000 with 0.2 % BSA/PBS with 50 μl per well for 1 hour at RT. After three 
washes with PBS, para-Nitrophenylphosphate (pNPP, Sigma-Aldrich P7998) were 
added with 50 μl per well to visualize alkaline phosphatase activity. After incubating 
for 30 min to 1 hour at RT, 420 nm absorbance reads were taken using μQuant 
spectrophotometer. Samples with concentrations around 1000 μg/ml were used for the 
competition assay.  
 
4.3.7 Variation of AVEXIS-based competition assay 
Similar with AVEXIS-based competition assay, in the variation assay (Fig. 2.8), the 
concentration of prey proteins was adjusted to values ensuring 2 to 5 fold signal over 
background values. After bait proteins were immobilized on the microtiter plates and 
the unbound proteins were removed, His6-tagged full length Draxin was added 30 min 
before, together with or 30 min after addition of prey proteins. To keep the three 
groups in parallel, solutions of previous step were pull out and new solutions were 
added without washing the plate. To reduce the manipulating time, dilution series of 
Draxin within and without prey proteins were arranged in a plate prior to the 
competition step, and solutions were added using a multiple channel pipette.   
 
4.3.8 SPR 
Kinetic analysis of Draxin and Netrin interactions were preformed on a Biacore 3000 
(GE healthcare) at 25 °C using a SA sensor chip. 0.01 M HEPES, PH 7.4, 0.15 M 
NaCl, 0.005% Surfactant P20 (HBS-P) running buffer was at a flow rate of 30 μl/min. 
Serial dilutions of purified human Draxin (R&D systems, 6148-DR-025/CF, 0 nM, 
1.2 nM. 2.3 nM, 4.7 nM, 9.4 nM, 18.8 nM) were injected over immobilized 
C-terminal biotinylated human Netrin-1, ectodomains of DCC and UNC5B on a 
streptavidin-coated sensor chip. C-terminal biotinylated human Netrin-G1 
immobilized on the chip was used as a reference. Dissociation curves of interaction 
between Draxin and Netrin were fitted using the BIAevaluation software 4.1. The 
implemented heterogeneous ligand model was employed to estimate the binding 
constant.  
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Table 4.1  List of primers 
 
code name Sequence 
 
Genotyping of Netrin1a mutant sa12269:  
OligST1877 Netrin1a mutant_intron_Fw GCATTCTCAGGACACTACTTGTG 
OligST1880 Netrin1a mutant_intron_Rev CAAGACATTGTGCCAGATTCCAC 
   
Generating flurophore fusion proteins for binding activity test by AVEXIS  
OligST215 Draxin_fw_NotI gcggccgccaccATGGTGGCTCCTGGCTTGTGTCAACTCTT 
OligST43 Netrin1a_fw_NotI gcggccgccaccATGGTGAGAGTCTCTGATGCTTTGGTCAC 
OligST1776 sfGFP_rev_AscI ggcgcgccTTTGTACAGCTCATCCATGC 
OligST1635 eGFP_rev_AscI ggcgcgccTAGGGCTGCAGAATCTAGAGGCTCG 
OligST1636 mCherry_rev_AscI ggcgcgccCTTGTACAGCTCGTCCATGCCGCCG 
   
Human genes  
OligST1350 DRAXIN_fw_NotI gcggccgccaccATGGCTGGGCCTGCCATCCACACCGCTC 
OligST1351 DRAXIN_rev_AscI ggcgcgccGACGTTGATGAAGGATCCCTGGTC 
OligST1352 NTN1_fw_NotI gcggccgccaccatggTGCGCGCAGTGTGGGAGGCGCTGG 
OligST1353 NTN1_rev_AscI ggcgcgccGGCCTTCTTGCACTTGCCCTTCTT 
OligST1814 NTN3_fw_NotI gcggccgccaccATGCCTGGCTGGCCCTGGGGGCTGCTGC 
OligST1815 NTN3_rev_AscI_v1 ggcgcgccGGCGGCGCTGCAGCGCCCCCGCCGTT 
OligST1816 NTN3_rev_AscI_v3 ggcgcgccGCTGATGCGGTAGCTGCCACGGGCAG 
OligST1809 NTN4_fw_NotI gcggccgccaccATGGGGAGCTGCGCGCGGCTGCTGCTGC 
OligST1810 NTN4_rev_AscI_v1 ggcgcgccCTTGCACTCTCTTTTTAAAATATCCA 
OligST1811 NTN4_rev_AscI_v2 ggcgcgccATTTCCTAATGTCTGTTCCTTACATT 
OligST1805 NTNG1_fw_NotI gcggccgccaccATGTATTTGTCAAGATTCCTGTCGATTC 
OligST1806 NTNG1_rev_AscI ggcgcgccGCAGCTGCCAGCCTCCTCGCACCGCA 
OligST1795 NTNG2_fw_NotI gcggccgccaccATGCTGCATCTGCTGGCGCTCTTCCTGC 
OligST1796 NTNG2_rev_AscI_v2 ggcgcgccGGGCGCGCGGTCGCAGTCCAGACCGC 
OligST1797 NTNG2_rev_AscI_v1 ggcgcgccCAGACCGCCGTCATCGTCGGCGGGGT 
OligST1339 hDCC_fw GTGCATGTGTGTGAGTGCTG 
OligST1340 hDCC_rev AGTTCCCGGAAAATTCACCT 
OligST1348 UNC5B_fw_NotI gcggccgccaccATGGGGGCCCGGAGCGGAGCTCGGGGCG 
OligST1349 UNC5B_rev_AscI ggcgcgccCGCCGCATCCCCTGAGGCCTCCAG 
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Zebrafish genes  
OligST215 Draxin_fw_NotI gcggccgccaccATGGTGGCTCCTGGCTTGTGTCAACTCTT 
OligST216 Draxin_rev_AscI ggcgcgccGACGGTAATAAAAGCTCCTTGGTTG 
OligST1215 Draxin_paralogue_fw_NotI gcggccgccaccATGGCAGTTTCCTGTTGGTATT 
OligST1216 Draxin_paralogue_rev_AscI ggcgcgccGATGGACATCTCCCTTGTGTACTTC 
OligST43 Netrin1a_fw_NotI gcggccgccaccATGGTGAGAGTCTCTGATGCTTTGGTCAC 
OligST44 Netrin1a_rev_AscI ggcgcgccTGCTTTCTTGCATTTTCCTTTCTTC 
OligST1148 Ntn1b_fw_NotI gcggccgccaccATGGTAAGGATTTTGGTAACGTGC 
OligST1486 Ntn1b_rev_AscI ggcgcgccGGGAGCAGCAACTGGAATTT 
OligST1124 Ntn2_fw_NotI gcggccgccaccATGGGGAGATTTCAGACTTTGCTTTCTAT 
OligST1487 Ntn2_rev_AscI ggcgcgccTGCAGGCTCCTCTGTAGTGC 
OligST1482 Ntn4_fw_NotI gcggccgccaccATGGAGCTGACGGGGAGATG 
OligST1488 Ntn4_rev_AscI ggcgcgccGTCTCCGGTGTAAGGGTCAC 
OligST965 Dcc_fw_NotI gcggccgccaccATGGGCTGCGTCACTGG 
OligST930 Dcc_rev_AscI ggcgcgccCGGGGTCACGCTGCCG 
OligST966 Dscam_fw_NotI gcggccgccaccATGTGGATATTGGCCATCATC 
OligST933 Dscam_rev_AscI ggcgcgccGGGGTCCTTCACCAGAGTCTTC  
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 Table 4.2  List of antibodies  
 
Primary antibodies Source Working dilution 
   
mouse monoclonal anti-acetylated Tubulin Sigma-Aldrich T6793 1:1000 
sheep anti Digoxigenin Roche 1333089 1:5000 
sheep anti Fluorscein, conjugated with HRP Roche 11426346910 1:500 
rabbit anti VasnA Paolo Panza 1:1000 
   
Secondary antibodies Source Working dilution 
   
goat polyclonal anti-mouse IgG Alexa 488 Molecular Probes A-11029 1:250 
goat polyclonal anti-mouse IgG Alexa 546 Molecular Probes A-11030 1:250 
goat polyclonal anti-mouse IgG Alexa 647 Molecular Probes A-21236 1:250 
goat anti human IgG Alexa 488 Invitrogen A-11013 1:250 
goat anti human IgG Alexa 568 Invitrogen A-21090 1:250 
goat anti human IgG Alexa 633 Invitrogen A-21091 1:250 
Rabbit anti sheep, conjugated with HRP Invitrogen 618620  1:2000 
sheep anti Digoxigenin conjugated with alkaline 
phosphatase 
Roche 11093274910  1:2000 
Goat anti-Human IgG (Fc specific) conjugated 
with Alkaline Phosphatase 
Sigma-Aldrich A9544  1:2000 
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           Table 4.3  List of molecular kits 
 
Name of the Kit company Purpose 
 
TRIzol® Reagent  Invitrogen 15596-018 isolate total RNA from embryos 
Cloned AMV Reverse Transcriptase Invitrogen 12328-019 synthesize cDNA from RNA 
KOD Hot Start DNA Polymerase  Merck Millipore 71086 amplify PCR products from cDNA 
Zero Blunt® TOPO® PCR Cloning Kit  Invitrogen 45-0245 blunt PCR cloning  
NEB Quick LigationTM Kit  NEB M2200 ligation 
QIAquick® PCR Purification Kit  QIAGEN 28106 gel purificaiton 
One Shot® TOP10 Chemially Competent 
E.coli Invitrogen C4040 transformation of plasmid DNA into E.coli 
Subcloining EfficiencyTM DH5aTM 
Competent Cells Invitrogen 18265 transformation 
QIAprep® Spin Miniprep Kit  QIAGEN 27106 plasmid mini prep 
Antarctic Phosphatase Kit NEB M0289 removes 5' phosphates from DNA 
QIAGEN® Plasmid Maxi Kit  QIAGEN 12165 plasmid maxi prep 
JumpStartTM REDTaq® DNA polymerase  Sigma-Aldrich P1107 genotyping 
mMESSAGE mMACHINE® Kit  Ambion AM1340 or AM1344 in vitro synthesize mRNA for injections  
MEGAscript® Kit Ambion AM1330 or AM1334 
transcribe RNA for in situ hybridization 
probes 
MEGAclearTM Kit Ambion 1908 pruify RNA molecules 
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Table 4.4  Protein identities used for library screen 
 Draxin prey Draxin bait Netrin-1a EGF3 prey Netrin-1a EGF3 bait 
1 Ntn1a Ntn1a Draxin Draxin 
2 Vwde Ngf Efna2 Neo1 
3 Lum Flrt1a Nrp1a Ek1 V2 
4 Draxin Cxadr Ephb4b Vcam1 
5 Calr3b Draxin_V2 Hapln1 Cxcl12a 
6 Cdh2 Elfn2a Dlb Mpzl2 
7 Efna3b Efna2 Ror2 Calrl2 
8 Epha4a Fgfrl1a Tac3a Ednra 
9 Efna3a Igfbp7 Wnt11 Ngf 
10 Pcdh17 Igsf11 Alcama Robo3 
11 Frzb  Bsg Neo1 Lrrtm1 
12 Metrnl Ildr2 Ednra Glra1 
13 Tnw Lrrc38 Vwde Galn V2 
14 Alcama sc:d0413 Lrrc4c Metrnl  
15 Neo1 Calr3b Csf1b Cspg4 
16 Cd59 Cdon Kal1a Optc 
17 Cntn2 Ednrab Cdh2 Cntfr 
18 Creld2 Mxra8b Fgfr4 Bcan 
19 Nenf Nradd Cadm4 Tsku 
20 Mdka Opcml Cntn1a Lrtm2 
21 Csf1ra Robo1 Erbb2F Ncam1b 
22 Si:ch211-286c4.6 sc:d0316 Epha4a Sc:d411 
23 Fgf3 Spon2a  m1036 Jam2b 
24 Igfbp1a Tmem59l Si:ch211-251b21.1 Cadm4 
25 Nrp2b Tpbgb Pcdh17 Wfdc1 
26 Lrrn1 Cadm1b Nradd Calua  
27 Mpz Cadm2a Sparc  Rgma 
28 Sparc  Cdh2 Chodl Met 
29 Cxcl12b  Zgc:165604 Mpzl2 Creld2 
30 Oc90  Fgfr2 Clu Mpzl3 
31 Fsta Jam3b Mpz Igfbp7 
32 Mpzl2 Lrit1a Igfbp1a Efna5b 
33 Kal1a Lrit2 Fgf3 Flrt1a 
34 m1036 Slc22a7a (M964) Oc90  Flrt1a 
35 Fstl1a  Alcamb Fsta Sc:d0348 
36 Rnaset2 Nptna Epha7 Nptnb 
37 Sfrp1a Nrp2b Galn V2 sc:d0413 
38 Fgfr2 Ret Unc5b Cart4 
39 Dkk1b si:zfos-1011f11.1 Calr3b Kal1a 
40 Igsf21b Slitrk2 Cspg4 Vstm4a 
41 Dla Unc5b Cxcl12b  Pcdh10a 
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42 Wnt1 Wfdc1 Nrp2b Nrp1a 
43 Calr3a Calua  Efna5b Nrp1b 
44 Clu Chodl Fgfr2 Tmem59l 
45 Ednrab Creld2 Csf1ra Calr3a 
46 Igsf11 Cxcl12b  Lum Ptpra 
47 si:zfos-1011f11.1 Edn3b Elfn2a Cadm2a 
48 Si:ch211-251b21.1 Efna5b Tnw Fgfrl1a 
49 Efna2 Efnb2a Fibina Ephb4a  
50 Epha7 Ek1 V2 Wu:fc46h12 Hfe2 
51 Lrrc4c Ek1 Calua  Epha7 
52 Erbb2F Epha7 Pcdh18a Ntm 
53 Wu:fc46h12 Ephb4a  Cntn2 Flrt2 
54 Ephb4b Fstl1a  Tnfrsf21 Elfn2a 
55 Tac3a Glra1 Efnb3b Tnw 
56 Nradd Jam2b Calr3a Urp2 
57 Cadm4 Lingo1b Jam2a Slc22a7a 
58 Cntn1a Sc:d0348 Igsf11 Cd59 
59 Mdkb Lrrc4c Ror1 Igfbp1a 
60 Urp2 Lum si:zfos-1011f11.1 Vasna 
61 Sema3d m1036 Fstl1a  Nradd 
62 Efna5b m1038 Pttg1ipb Lft2  
63 m1038 Manf zgc:161979 Sparc  
64 zgc:110239 Met Nenf Lrit1a 
65 zgc:161979 Mpzl3 Defbl1 Prnpb 
66 Wnt11r Ncam1a Mdka Nrp2b 
67 Ror1 Lrrc4.1 Prnpb Sema6dl 
68 Chga Pik3ipl Frzb  Jam2a 
69 Ephb3a Ptpra Creld2 Efnb2a 
70 Dlb Hfe2 Wnt1 Chodl 
71 Lrrc4.1 Rtn4rl2a Dkk1b Chodl 
72 Fibina si:ch1073-70f20.1 Lrrn1 Fstl1a  
73 Prnpb Ntrk2b Lrrc4.1 Tpbga 
74 Galn V2 Tpbga Rnaset2 Zgc:165604 
75 Fgfr4 Tac3a Igsf21b Cadm1b 
76 Hapln1 Cd276 Chga Lrrc4.1 
77 Chodl Bcan Ednrab Robo1 
78 Nrp1a Cadm3 Prtgb Lrrc3 
79 Ednra Calr3a m1038 Opcml 
80 Calua  Cspg4 zgc:110239 Lingo1b 
81 Unc5b Dla Rgma sc:d0316 
82 Rgma Efnb3 Dla Cdon 
83 Pcdh18a Fgfbp1 Sema3d Mxra5 
84 Tnfrsf21 Fgfr4 Sfrp1a Ramp2 
85 Ror2 Flrt2 Ptpra Fibina 
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86 Ptpra Fsta Ephb3a Spon2a  
87 Csf1b Gas1b Wnt11r Egfra 
88 22aa-Draxin Igsf21a Efna3b Ednrab 
89 Bcan Lrrc24  wu:fc46h12 
90 Efnb3b Islr2  Rbp4l 
91 Pttg1ipb Jam2a  Rnaset2 
92 Cspg4 Kal1a  C6 
93 Jam2a Lingo1a  Cdh2 
94 Prtgb Cd59  Oc90  
95 Islr2 Mxra5  Dla 
96 Wfdc1 Lrrtm1  Lrit2 
97 Cart4 Lrtm2  Calr3b 
98 Ltk Ltk  Ncam1a 
99 Igfbp7 Matn4   Ret 
100 Edn3 Mpzl2  Fsta 
101 Epha3like Negr1  Lrrc4c 
102 Ptn Nrp1b  Igsf21a 
103 Wnt11 Nrp1a  Ildr2 
104 Elfn2a Optc  Nptna 
105 Defbl1 Pcdh10a  Cxadr 
106 Vasna Pcdh17  Rtn4rl1b 
107 Notchl Igdcc3  Ek1 V2 
108 Dner Sc:d189  Efna2 
109 Manf Rbp4l  Efnb3 
110 Galn Rgmb  Tnfrsf21 
111 Notch3 Sema6dl  Matn4  
112 Ntm Tnfrsf21   Sc:d189 
113 Edn3b Tnw  Slitrk2 
114 Ryk Vstm4a  Lrrc24 
115 Vasnb A2BID0  Fgfr2 
116 Si:dkey-1c11.1 Bmper  Fgfr2 
117 Dlc C6  Mxra8b 
118 Jag2 Cntfr  Tpbgb 
119 Jag2_2 Csf1a  Ntrk2b 
120 Dlk1 Dkk1b  Fgfr4 
121 Ephb4a  Draxin  Mxra5 
122 Lrrtm1 Edn3  Ltk 
123 Mxra8a Ednra  A2BID0 
124 Dcc Efna3b  m1028 
125 Jag1a Epha4a  Csf1a 
126 Jag1b Rtn4rl1b  Csf1b 
127 Ctgfa Fibina  Igsf21b 
128 Spon1b  Galn  Tac3a 
129 Spon2a  Zmp:0000000665  m1036 
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130 Lrit2 Igfbp1a  C8a 
131 Dld Igsf21b  Tac3a 
132 Notch2-like Lrrc3  Cd276 
133  m922  m1038 
134  Rnaset2  Bmper 
135  Ntm  Pik3ipl 
136  Rgma  Ctsba 
137  Loc100004582  Lrrn1 
138  Sc:d411  m1098 
139  Tsku  Epha4a 
140  Vcam1  Cxcl12b  
141  Kitb  Rtn4rl2a 
142  C8a  Lrrc38 
143  Cadm4  Unc5b 
144  Calrl2  Cadm3 
145  Cntn2  Gas1b 
146  Egfra  Csf1ra 
147  Lft2   Tnw 
148  m1028  Fgfbp1 
149  Neo1  Pcdh17 
150  Nptnb  Manf 
151  Oc90   Alcamb 
152  Prnpb  Jam3b 
153  Ramp2  Bsg 
154  Sparc   Lrrtm4l1 
155  Vasnb  Ryk 
156  Cart4  Dkk1b 
157  Ctsba  Kitb 
158  Lrrtm4l1  Pttg1ipb 
159  Lrrn1  Zmp:0000000665 
160  Pttg1ipb  C8b 
161  Q567y1  Galn 
162  Ryk  Igdcc3 
163  Vasna 
164  wu:fc46h12 
165  Csf1b 
166  m1098 
167  Npb 
168  Csf1ra 
169  Galn v2 
170  Ncam1b 
171  Metrnl  
172  Urp2                         
 
Proteins are listed according to desending
values of detected binding strength 
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Table 4.4  Protein identities used for library screen (continue*) 
# Protein Name 
ECD 
 (aa 1 to indicated Nr.) Type Genbank Accession # Source 
1 Calr3a 418 SEC KM655574 Cloned from cDNA 
2 Calr3b 417 SEC KM655575 Cloned from cDNA 
3 Calua 317 SEC KM655576 Cloned from cDNA 
4 Cxcl12b 97 SEC KM655577 Cloned from cDNA 
5 Ephb4a 543 TM KM655578 Cloned from cDNA 
6 Fgf8a 210 SEC KM655579 Cloned from cDNA 
7 Fstl1a 314 SEC KM655580 Cloned from cDNA 
8 Lft2 362 SEC KM655581 Cloned from cDNA 
9 Matn4 616 SEC KM655582 Cloned from cDNA 
10 Metrnl 286 SEC KM655583 Cloned from cDNA 
11 Ntn1a 603 SEC KM655584 Cloned from cDNA 
12 Oc90 939 SEC KM655585 Cloned from cDNA 
13 Ptn 158 SEC KM655586 Cloned from cDNA 
14 Shha 418 SEC KM655587 Cloned from cDNA 
15 Shhb 416 SEC KM655588 Cloned from cDNA 
16 Sparc 291 SEC KM655589 Cloned from cDNA 
17 Tnfrsf21 352 TM KM655590 Cloned from cDNA 
18 Spon2a 334 SEC KM655591 Cloned from cDNA 
19 Manf 180 SEC KM655592 Cloned from cDNA 
20 Si:ch1073-70f20.1 131 SEC KM655593 Cloned from cDNA 
21 Clu 449 SEC KM655594 Cloned from cDNA 
22 Urp2 243 SEC KM655595 Cloned from cDNA 
23 CD59 92 GPI KM655596 Cloned from cDNA 
24 Bcan 361 SEC CU458953 Gift from G.J. Wright 
25 Ntm 311 GPI CU458872 Gift from G.J. Wright 
26 Igfbp7 248 SEC CU458927 Gift from G.J. Wright 
27 Optc 321 SEC CU468787 Gift from G.J. Wright 
28 Bgnb 375 SEC CU468793 Gift from G.J. Wright 
29 Cadm4 328 TM CU638749 Gift from G.J. Wright 
30 Islr2 567 TM CU468789 Gift from G.J. Wright 
31 Rgmb 410 GPI KM655597 Cloned from cDNA 
32 Mdkb 147 SEC KM655598 Cloned from cDNA 
33 Mdka 148 SEC KM655599 Cloned from cDNA 
34 Dlc 508 TM CU458991 Gift from G.J. Wright 
35 Ngf 194 SEC KM655600 Cloned from cDNA 
36 Nradd 237 TM KM655601 Cloned from cDNA 
37 Pcdh17 679 TM KM655602 Cloned from cDNA 
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38 Cdh2 710 TM KM655603 Cloned from cDNA 
39 Cspg4 1012 TM KM655604 Gift from H. Knaut 
40 Cspg4 V2 1081 TM KM655605 Gift from H. Knaut 
41 Pcdh10b 679 TM KM655606 Cloned from cDNA 
42 Npb 136 SEC KM655607 Cloned from cDNA 
43 Nrp1b 894 TM KM655608 Cloned from cDNA 
44 Ephb4b 539 TM KM655609 Cloned from cDNA 
45 Tmem59l 253 TM KM655610 Cloned from cDNA 
46 Neo1 1060 TM CU458829 Gift from G.J. Wright 
47 Cntfr 325 TM CU458971 Gift from G.J. Wright 
48 Bsg 214 TM CU458968 Gift from G.J. Wright 
49 Mpzl2 146 TM CU458956 Gift from G.J. Wright 
50 Dla 534 TM CU458989 Gift from G.J. Wright 
51 Epha4a 546 TM KM655611 Cloned from cDNA 
52 Ptpra 179 TM KM655612 Cloned from cDNA 
53 Rgma 418 GPI KM655613 Cloned from cDNA 
54 Lrit2 459 TM CU468740 Gift from G.J. Wright 
55 Met 933 TM KM655614 Cloned from cDNA 
56 Creld2 341 SEC KM655615 Cloned from cDNA 
57 Vstm4a 156 TM CU638745 Gift from G.J. Wright 
58 Cadm2a 328 TM CU458965 Gift from G.J. Wright 
59 Lrit1a 546 TM CU468741 Gift from G.J. Wright 
60 Fgfrl1a 356 TM CU458922 Gift from G.J. Wright 
61 Kirrela 501 TM CU458877 Gift from G.J. Wright 
62 Ncam1a 700 TM CU458885 Gift from G.J. Wright 
63 Ret 633 TM KM655616 Cloned from cDNA 
64 Fsta 322 SEC KM655617 Cloned from cDNA 
65 Sfrp1a 296 SEC KM655618 Cloned from cDNA 
66 Hfe2 384 GPI KM655619 Cloned from cDNA 
67 Lrrc4c 534 TM CU468806 Gift from G.J. Wright 
68 Ildr2 176 TM CU638797 Gift from G.J. Wright 
69 Nptna 218 TM CU458932 Gift from G.J. Wright 
70 Cxadr 241 TM CU458753 Gift from G.J. Wright 
71 Rtn4rl1b 447 TM CU468752 Gift from G.J. Wright 
72 Nrp2b 853 TM KM655620 Cloned from cDNA 
73 Sema6dl 659 TM CU458860 Gift from G.J. Wright 
74 Mpzl3 148 TM CU458906 Gift from G.J. Wright 
75 Jam2a 226 TM CU458944 Gift from G.J. Wright 
76 Efna5b 201 GPI KM655621 Cloned from cDNA 
77 Efnb2a 223 TM KM655622 Cloned from cDNA 
78 Chodl 235 TM KM655623 Cloned from cDNA 
79 Epha7 550 TM KM655624 Cloned from cDNA 
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80 Ek1 v2 551 TM KM655625 Cloned from cDNA 
81 Ek1 544 TM KM655626 Cloned from cDNA 
82 Efna3b 194 GPI KM655627 Cloned from cDNA 
83 Efna2 173 GPI KM655628 Cloned from cDNA 
84 Efnb3b 218 TM KM655629 Cloned from cDNA 
85 Vcam1 766 TM CU458903 Gift from G.J. Wright 
86 Lrrtm4l1 456 TM CU468766 Gift from G.J. Wright 
87 Rtn4rl2a 458 TM CU468805 Gift from G.J. Wright 
88 Kal1a 652 SEC KM655630 Cloned from cDNA 
89 Tpbga 307 TM CU468751 Gift from G.J. Wright 
90 Tsku 366 SEC CU468770 Gift from G.J. Wright 
91 Sc:d189 342 TM CU458946 Gift from G.J. Wright 
92 Lrrc38 245 TM CU468759 Gift from G.J. Wright 
93 Zgc:165604 234 TM CU458996 Gift from G.J. Wright 
94 Unc5b 376 TM CU458889 Gift from G.J. Wright 
95 Alcamb 504 TM CU458904 Gift from G.J. Wright 
96 Jam3b 236 TM CU458938 Gift from G.J. Wright 
97 Wfikkn1 431 SEC CU638805 Gift from G.J. Wright 
98 Slitrk2 622 TM CU468746 Gift from G.J. Wright 
99 Lrrc24 444 TM CU468764 Gift from G.J. Wright 
100 Cadm3 349 TM CU638752 Gift from G.J. Wright 
101 Igdcc3 589 TM CU638789 Gift from G.J. Wright 
102 Cadm1b 310 TM CU638788 Gift from G.J. Wright 
103 Fgfr2 24-295 TM CU458909 Gift from G.J. Wright 
104 Cd276 238 TM CU638774 Gift from G.J. Wright 
105 Mxra8b 285 TM CU638746 Gift from G.J. Wright 
106 Tpbgb 316 TM CU468771 Gift from G.J. Wright 
107 Lrrc4.1 543 TM CU468781 Gift from G.J. Wright 
108 Robo1 866 TM CU458748 Gift from G.J. Wright 
109 Prtgb 935 TM KM655631 Cloned from cDNA 
110 Lrfn5a 528 TM CU468768 Gift from G.J. Wright 
111 Lrrtm4l2 445 TM CU468765 Gift from G.J. Wright 
112 Sema3d 764 SEC KM655632 Cloned from cDNA 
113 Bsg 319 TM CU638778 Gift from G.J. Wright 
114 Mxra8a 296 TM CU638765 Gift from G.J. Wright 
115 Galn 142 SEC KM655633 Cloned from cDNA 
116 Csf1b 212 TM KM655634 Cloned from cDNA 
117 Gas1b 263 SEC KM655635 Cloned from cDNA 
118 Zmp:0000000665 335 SEC KM655636 Cloned from cDNA 
119 Ryk 224 TM KM655637 Gift from G. Weidinger 
120 Kitb 204 TM CU458998 Gift from G.J. Wright 
121 Fgfr1b 283 TM CU458868 Gift from G.J. Wright 
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122 Lrrtm1 429 TM CU468794 Gift from G.J. Wright 
123 Flrt2 541 TM CU468790 Gift from G.J. Wright 
124 Elfn2a 403 TM CU468797 Gift from G.J. Wright 
125 Lrtm2 306 TM CU468758 Gift from G.J. Wright 
126 Lrrtm2 447 TM CU468747 Gift from G.J. Wright 
127 Flrt1a 558 TM CU468788 Gift from G.J. Wright 
128 Ntrk2b 401 TM CU468742 Gift from G.J. Wright 
129 Sc:d0348 542 TM CU468772 Gift from G.J. Wright 
130 Ncam1b 710 TM CU458747 Gift from G.J. Wright 
131 Sema4c 666 TM CU458995 Gift from G.J. Wright 
132 Jam2b 240 TM CU458870 Gift from G.J. Wright 
133 Lrrc3 209 TM CU468760 Gift from G.J. Wright 
134 Opcml 311 GPI CU638768 Gift from G.J. Wright 
135 Cntn1a 1013 GPI CU458969 Gift from G.J. Wright 
136 Lingo1b 553 TM CU468744 Gift from G.J. Wright 
137 Sc:d0316 508 TM CU468743 Gift from G.J. Wright 
138 Sc:d0413 656 TM CU468799 Gift from G.J. Wright 
139 Negr1 317 GPI CU458871 Gift from G.J. Wright 
140 Cntn2 576 GPI CU458883 Gift from G.J. Wright 
141 Lingo1a 549 TM CU468767 Gift from G.J. Wright 
142 Dlb 518 TM CU458990 Gift from G.J. Wright 
143 Pcdh10a 679 TM KM655638 Cloned from cDNA 
144 Si:zfos-1011f11.1 236 TM CU458914 Gift from G.J. Wright 
145 Lum 344 SEC CU468778 Gift from G.J. Wright 
146 Igsf11 247 TM CU458869 Gift from G.J. Wright 
147 Glra1 245 TM KM655639 Gift from R.J. Harvey 
148 Wnt11 353 SEC KM655640 Gift from G. Weidinger 
149 Fgfr4 476 TM CU458754 Gift from G.J. Wright 
150 Csf1ra 513 TM CU458899 Gift from G.J. Wright 
151 Mxra5 861 SEC KM655641 Cloned from cDNA 
152 Tnw 932 SEC KM655642 Cloned from cDNA 
153 Cdon 825 TM KM655643 Cloned from cDNA 
154 Galn V2 118 SEC KM655644 Cloned from cDNA 
155 Zgc:110239 326 SEC KM655645 Cloned from cDNA 
156 Nenf 158 SEC KM655646 Cloned from cDNA 
157 Pttg1ipb 89 TM KM655647 Cloned from cDNA 
158 Grem2 166 SEC KM655648 Cloned from cDNA 
159 Wfdc1 220 SEC KM655649 Cloned from cDNA 
160 Si:dkey-251i10.2 170 SEC KM655650 Cloned from cDNA 
161 Cart4 105 SEC KM655651 Cloned from cDNA 
162 Olfml2bb 466 SEC KM655652 Cloned from cDNA 
163 Igfbp1a 262 SEC KM655653 Cloned from cDNA 
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164 Rbp4l 196 GPI KM655654 Cloned from cDNA 
165 Pik3ip1 169 TM KM655655 Cloned from cDNA 
166 C7b 229 SEC KM655656 Cloned from cDNA 
167 C6 280 SEC KM655657 Cloned from cDNA 
168 Zgc:174888 226 GPI KM655658 Cloned from cDNA 
169 Csf1a 482 TM KM655659 Cloned from cDNA 
170 C8a 297 SEC KM655660 Cloned from cDNA 
171 Fibina 226 SEC KM655661 Cloned from cDNA 
172 Si:ch211-286c4.6 96 GPI KM655662 Cloned from cDNA 
173 Fgfbp1 196 SEC KM655663 Cloned from cDNA 
174 Loc100004582 205 TM KM655664 Cloned from cDNA 
175 Tac3a 125 SEC KM655665 Cloned from cDNA 
176 Ltk 453 TM KM655666 Gift from R.N. Kelsh 
177 Ednraa 93 TM KM655667 Cloned from cDNA 
178 Ppp3r1a 170 TM XP_692770.2 Cloned from cDNA 
179 Calr 417 SEC KM655668 Cloned from cDNA 
180 Rnaset2 240 SEC KM655669 Cloned from cDNA 
181 Ctsba 330 SEC KM655670 Cloned from cDNA 
182 Slc22a7a 106 Multiple TM KM655671 Cloned from cDNA 
183 Si:ch211-243a20.3 186 SEC KM655672 Cloned from cDNA 
184 Nrp1a 584 TM KM655673 Cloned from cDNA 
185 Igsf21b 473 SEC KM655674 Cloned from cDNA 
186 Ednrab 68 Multiple TM KM655675 Cloned from cDNA 
187 Odc1 105 SEC XP_005169396.1 Cloned from cDNA 
188 Wu:fc46h12 164 SEC KM655676 Cloned from cDNA 
189 Ramp2 93 TM KM655677 Cloned from cDNA 
190 Egfra 389 TM AAS45493.1* identity: 98% Cloned from cDNA 
191 Bmper 609 SEC KM655678 Cloned from cDNA 
192 Edn3a 143 SEC XP_009293151.1 Cloned from cDNA 
193 Edn3b 153 SEC XP_001919586.1 Cloned from cDNA 
194 Ptprz1b 411 TM KM655679 Gift from C. Winkler 
195 Ptprz1b 624 TM KM655680 Gift from C. Winkler 
196 Musk 565 TM CU458887 Gift from G.J. Wright 
197 Efna3a 196 GPI KM655681 Cloned from cDNA 
198 Ptprz1a 416 TM KM655682 Cloned from cDNA 
199 Ntn1b 458 SEC KM655683 Cloned from cDNA 
200 Ntn2 473 SEC KM655684 Cloned from cDNA 
201 Ntn4 434 SEC KM655685 Cloned from cDNA 
202 Vasna 583 TM CU468763 Gift from G.J. Wright 
203 Draxin 360 SEC KM655686 Cloned from cDNA 
204 Si:dkey-1c11.1 351 SEC KM655687 Cloned from cDNA 
205 Ctgfa 345 SEC KM655688 Cloned from cDNA 
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206 Frzb 315 SEC KM655689 Cloned from cDNA 
207 Prnpb 578 GPI KM655690 Cloned from cDNA 
208 Spon1b 803 SEC KM655691 Cloned from cDNA 
209 Hapln1 328 SEC KM655692 Cloned from cDNA 
210 Hhip 693 SEC KM655693 Cloned from cDNA 
211 Wnt4b 358 SEC KM655694 Cloned from cDNA 
212 Fzd8a 238 7TM KM655695 Cloned from cDNA 
213 Fgf3 249 SEC KM655696 Cloned from cDNA 
214 Pcdh18a 701 TM KM655697 Cloned from cDNA 
215 Ndr2 501 SEC KM655698 Cloned from cDNA 
216 Shisa9a 134 TM KM655699 Cloned from cDNA 
217 Ephb3a 535 TM KM655700 Cloned from cDNA 
218 Wnt1 370 SEC KM655701 Cloned from cDNA 
219 Alcama 497 TM CU458879 Cloned from cDNA 
220 Ror1 412 TM KM655702 Gift from G. Weidinger 
221 Vwde 212 SEC KM655703 Cloned from cDNA 
222 Mpz 143 TM CU458863 Gift from G.J. Wright 
223 Igfbp1 version 2 262  AJG05999.1 Cloned from cDNA 
224 Erbb2 645 TM KM655704 Cloned from cDNA 
225 Wnt11r 352 SEC KM655705 Cloned from cDNA 
226 Si:ch211-170d8.2 297 SEC KM655706 Cloned from cDNA 
227 Plxna3 1240 TM KM655707 Cloned from cDNA 
228 Dkk1b 241 SEC KM655708 Gift from G. Weidinger 
229 Defbl1 67 SEC KM655709 Cloned from cDNA 
230 Zgc:161979 130 SEC KM655710 Cloned from cDNA 
231 Chga 371 SEC KM655711 Cloned from cDNA 
232 Ror2 404 TM KM655712 Cloned from cDNA 
233 Musk sv1 300 TM CU458888 Gift from G.J. Wright 
234 Musk sv2 217 TM CU458887 Gift from G.J. Wright 
235 Dcc 1069 TM KM655713 Cloned from cDNA 
236 Wif1 378 SEC KM655714 Cloned from cDNA 
237 Gdf11 389 SEC KM655715 Cloned from cDNA 
238 zgc:110372 306 SEC CU458930 Gift from G.J. Wright 
239 Cntn2 1022 GPI KM655716 Cloned from cDNA 
240 Wnt4a 352 SEC KM655717 Cloned from cDNA 
241 Gpc1b 559 SEC KM655718 Cloned from cDNA 
242 Phb 271 SEC KM655719 Cloned from cDNA 
243 Robo4 591 TM CU458880 Gift from G.J. Wright 
244 Hepacam2 336 TM CU458977 Gift from G.J. Wright 
245 Zgc:66118 220 SEC CU458950 Gift from G.J. Wright 
246 Tapbp 401 SEC CU458751 Gift from G.J. Wright 
247 Igdcc4 421 TM CU638782 Gift from G.J. Wright 
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248 Amigo1 368 TM CU468749 Gift from G.J. Wright 
249 Lrfn1 523 TM CU468795 Gift from G.J. Wright 
250 Lngo3a 539 TM CU468775 Gift from G.J. Wright 
251 Nptnb 331 TM CU458926 Gift from G.J. Wright 
252 Elfn1b 420 TM CU468785 Gift from G.J. Wright 
253 Pdgfra 786 TM CU458757 Gift from G.J. Wright 
254 Spon1a 808 SEC KM655720 Cloned from cDNA 
255 Scube2 854 SEC KM655721 Cloned from cDNA 
256 Grin1a 226 TM KM655722 Cloned from cDNA 
257 Wnt8a 359 SEC KM655723 Gift from G. Weidinger 
258 Nfasca 727 TM CU458816 Gift from G.J. Wright 
259 Lrrn3 624 TM CU468756 Gift from G.J. Wright 
260 Fzd7b 238 7TM KM655724 Cloned from cDNA 
261 Glrbb 266 4TM KM655725 Gift from R.J. Harvey 
262 Pmelb 547 TM KM655726 Cloned from cDNA 
263 Si:ch211-251b21.1 394 TM KM655727 Cloned from cDNA 
264 Wnt8b 358 SEC KM655728 Cloned from cDNA 
265 C1qc 244 SEC KM655729 Cloned from cDNA 
266 C8b 262 SEC KM655730 Cloned from cDNA 
267 Wnt10b 427 SEC KM655731 Cloned from cDNA 
268 Megf10 850 TM KM655732 Cloned from cDNA 
269 Cart3 117 SEC KM655733 Cloned from cDNA 
270 Si:dkey-226k3.4 102 SEC KM655734 Cloned from cDNA 
271 Tgfbi 677 SEC KM655735 Cloned from cDNA 
272 Nrg2b 705 TM XP_005157176.1 Cloned from cDNA 
  
*Table S3, Gao et al., 2015 
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